JPS6411037B2 - - Google Patents
Info
- Publication number
- JPS6411037B2 JPS6411037B2 JP56108755A JP10875581A JPS6411037B2 JP S6411037 B2 JPS6411037 B2 JP S6411037B2 JP 56108755 A JP56108755 A JP 56108755A JP 10875581 A JP10875581 A JP 10875581A JP S6411037 B2 JPS6411037 B2 JP S6411037B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- hydroxy
- compound
- general formula
- carboxylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 174
- -1 methyl chloroethoxy Chemical group 0.000 claims description 25
- 125000000217 alkyl group Chemical group 0.000 claims description 20
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 19
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 17
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 claims description 12
- 125000001153 fluoro group Chemical group F* 0.000 claims description 8
- 229910052731 fluorine Inorganic materials 0.000 claims description 7
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 5
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 5
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 5
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 125000001188 haloalkyl group Chemical group 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 238000012360 testing method Methods 0.000 description 55
- 238000006243 chemical reaction Methods 0.000 description 38
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 26
- 239000000543 intermediate Substances 0.000 description 23
- 238000000034 method Methods 0.000 description 23
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 22
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 21
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 20
- 230000003110 anti-inflammatory effect Effects 0.000 description 19
- 239000002904 solvent Substances 0.000 description 19
- 239000007858 starting material Substances 0.000 description 19
- 210000001541 thymus gland Anatomy 0.000 description 19
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 17
- 230000009885 systemic effect Effects 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 150000003431 steroids Chemical class 0.000 description 14
- 241000700159 Rattus Species 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 150000003839 salts Chemical class 0.000 description 12
- 229960000890 hydrocortisone Drugs 0.000 description 11
- 238000002844 melting Methods 0.000 description 11
- 230000008018 melting Effects 0.000 description 11
- 239000002253 acid Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 230000003637 steroidlike Effects 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000002585 base Substances 0.000 description 9
- SNHRLVCMMWUAJD-SUYDQAKGSA-N betamethasone valerate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O SNHRLVCMMWUAJD-SUYDQAKGSA-N 0.000 description 9
- 238000002425 crystallisation Methods 0.000 description 9
- 230000008025 crystallization Effects 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- 235000009161 Espostoa lanata Nutrition 0.000 description 7
- 240000001624 Espostoa lanata Species 0.000 description 7
- 206010033546 Pallor Diseases 0.000 description 7
- 239000006260 foam Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 125000001424 substituent group Chemical group 0.000 description 7
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 7
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- 239000000460 chlorine Substances 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 6
- 229910052736 halogen Inorganic materials 0.000 description 6
- 150000002367 halogens Chemical class 0.000 description 6
- 239000012442 inert solvent Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 5
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 229940117173 croton oil Drugs 0.000 description 5
- 238000000921 elemental analysis Methods 0.000 description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 150000003512 tertiary amines Chemical class 0.000 description 5
- 206010063560 Excessive granulation tissue Diseases 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical group N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000000443 aerosol Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 210000001126 granulation tissue Anatomy 0.000 description 4
- 230000033687 granuloma formation Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000007800 oxidant agent Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000003380 propellant Substances 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Chemical group COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 230000002992 thymic effect Effects 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- 206010009900 Colitis ulcerative Diseases 0.000 description 3
- 241000792859 Enema Species 0.000 description 3
- 206010018691 Granuloma Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 201000006704 Ulcerative Colitis Diseases 0.000 description 3
- XSCHRSMBECNVNS-UHFFFAOYSA-N benzopyrazine Chemical group N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 3
- 229960002537 betamethasone Drugs 0.000 description 3
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 125000004965 chloroalkyl group Chemical group 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 239000007920 enema Substances 0.000 description 3
- 229940079360 enema for constipation Drugs 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 150000008282 halocarbons Chemical class 0.000 description 3
- 125000005843 halogen group Chemical group 0.000 description 3
- UKJFVOWPUXSBOM-UHFFFAOYSA-N hexane;oxolane Chemical compound C1CCOC1.CCCCCC UKJFVOWPUXSBOM-UHFFFAOYSA-N 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical group CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N 3H-indole Chemical group C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 2
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- WRJPSSPFHGNBMG-UHFFFAOYSA-N acetic acid 1-azabicyclo[2.2.2]octan-3-yl ester Chemical compound C1CC2C(OC(=O)C)CN1CC2 WRJPSSPFHGNBMG-UHFFFAOYSA-N 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 2
- PJGJQVRXEUVAFT-UHFFFAOYSA-N chloroiodomethane Chemical compound ClCI PJGJQVRXEUVAFT-UHFFFAOYSA-N 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 239000000039 congener Substances 0.000 description 2
- 229960004544 cortisone Drugs 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 2
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229960001524 hydrocortisone butyrate Drugs 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000004968 inflammatory condition Effects 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical group C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 231100001274 therapeutic index Toxicity 0.000 description 2
- 125000004149 thio group Chemical group *S* 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 229960005294 triamcinolone Drugs 0.000 description 2
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical group O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 2
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 2
- 229940029284 trichlorofluoromethane Drugs 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- XNZSRYSTBKQWGZ-XLXYOEISSA-N (8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthrene-17-carboxylic acid Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(O)=O)[C@@H]4[C@@H]3CCC2=C1 XNZSRYSTBKQWGZ-XLXYOEISSA-N 0.000 description 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- PXHHIBMOFPCBJQ-UHFFFAOYSA-N 1,2-dimethylpyrrolidine Chemical compound CC1CCCN1C PXHHIBMOFPCBJQ-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- OXHNLMTVIGZXSG-UHFFFAOYSA-N 1-Methylpyrrole Chemical group CN1C=CC=C1 OXHNLMTVIGZXSG-UHFFFAOYSA-N 0.000 description 1
- VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical compound CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 1
- 125000001478 1-chloroethyl group Chemical group [H]C([H])([H])C([H])(Cl)* 0.000 description 1
- 125000004776 1-fluoroethyl group Chemical group [H]C([H])([H])C([H])(F)* 0.000 description 1
- XLJQPXVBQNJNLW-UHFFFAOYSA-N 1-methylaziridine Chemical compound CN1CC1 XLJQPXVBQNJNLW-UHFFFAOYSA-N 0.000 description 1
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 1
- QXBUYALKJGBACG-UHFFFAOYSA-N 10-methylphenothiazine Chemical group C1=CC=C2N(C)C3=CC=CC=C3SC2=C1 QXBUYALKJGBACG-UHFFFAOYSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical group OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- JHWIEAWILPSRMU-UHFFFAOYSA-N 2-methyl-3-pyrimidin-4-ylpropanoic acid Chemical compound OC(=O)C(C)CC1=CC=NC=N1 JHWIEAWILPSRMU-UHFFFAOYSA-N 0.000 description 1
- ZLWIMPFRPFWOGK-UHFFFAOYSA-N 2-methylisoindole Chemical group C1=CC=CC2=CN(C)C=C21 ZLWIMPFRPFWOGK-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QJNLUNBGDFUULX-UHFFFAOYSA-N 4-n,4-n'-dimethyl-3h-pyridine-4,4-diamine Chemical compound CNC1(NC)CC=NC=C1 QJNLUNBGDFUULX-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010027654 Allergic conditions Diseases 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000872931 Myoporum sandwicense Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 1
- UQFQONCQIQEYPJ-UHFFFAOYSA-N N-methylpyrazole Chemical group CN1C=CC=N1 UQFQONCQIQEYPJ-UHFFFAOYSA-N 0.000 description 1
- 229910003202 NH4 Inorganic materials 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- MKPDWECBUAZOHP-AFYJWTTESA-N Paramethasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]2(C)C[C@@H]1O MKPDWECBUAZOHP-AFYJWTTESA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Chemical group C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- SYCBXBCPLUFJID-UHFFFAOYSA-N Pramoxine hydrochloride Chemical compound Cl.C1=CC(OCCCC)=CC=C1OCCCN1CCOCC1 SYCBXBCPLUFJID-UHFFFAOYSA-N 0.000 description 1
- 206010036774 Proctitis Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical group C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 208000015815 Rectal disease Diseases 0.000 description 1
- 206010036775 Rectal inflammations Diseases 0.000 description 1
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- MGVGMXLGOKTYKP-ZFOBEOMCSA-N acetic acid;(6s,8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-one Chemical compound CC(O)=O.C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 MGVGMXLGOKTYKP-ZFOBEOMCSA-N 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 208000017515 adrenocortical insufficiency Diseases 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910001516 alkali metal iodide Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 229950000210 beclometasone dipropionate Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- JWMLCCRPDOIBAV-UHFFFAOYSA-N chloro(methylsulfanyl)methane Chemical compound CSCCl JWMLCCRPDOIBAV-UHFFFAOYSA-N 0.000 description 1
- VTHIKKVKIVQWHV-UHFFFAOYSA-N chromium(6+) oxygen(2-) pyridine Chemical compound [O-2].[O-2].[O-2].[Cr+6].C1=CC=NC=C1 VTHIKKVKIVQWHV-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- BMCQMVFGOVHVNG-TUFAYURCSA-N cortisol 17-butyrate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)CO)(OC(=O)CCC)[C@@]1(C)C[C@@H]2O BMCQMVFGOVHVNG-TUFAYURCSA-N 0.000 description 1
- 125000003306 cortisone group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- CMMUKUYEPRGBFB-UHFFFAOYSA-L dichromic acid Chemical compound O[Cr](=O)(=O)O[Cr](O)(=O)=O CMMUKUYEPRGBFB-UHFFFAOYSA-L 0.000 description 1
- LGTLXDJOAJDFLR-UHFFFAOYSA-N diethyl chlorophosphate Chemical compound CCOP(Cl)(=O)OCC LGTLXDJOAJDFLR-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000032625 disorder of ear Diseases 0.000 description 1
- 239000003221 ear drop Substances 0.000 description 1
- 229940047652 ear drops Drugs 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229960002011 fludrocortisone Drugs 0.000 description 1
- AAXVEMMRQDVLJB-BULBTXNYSA-N fludrocortisone Chemical compound O=C1CC[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 AAXVEMMRQDVLJB-BULBTXNYSA-N 0.000 description 1
- 125000003709 fluoroalkyl group Chemical group 0.000 description 1
- 125000003784 fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 125000003838 furazanyl group Chemical group 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical group C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical group C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- IBIKHMZPHNKTHM-RDTXWAMCSA-N merck compound 25 Chemical compound C1C[C@@H](C(O)=O)[C@H](O)CN1C(C1=C(F)C=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C1CC1 IBIKHMZPHNKTHM-RDTXWAMCSA-N 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229960001293 methylprednisolone acetate Drugs 0.000 description 1
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 125000006682 monohaloalkyl group Chemical group 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000010925 negative regulation of granuloma formation Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229960002858 paramethasone Drugs 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 239000008196 pharmacological composition Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical group C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 229940019974 pramoxine hydrochloride Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- USPWKWBDZOARPV-UHFFFAOYSA-N pyrazolidine Chemical compound C1CNNC1 USPWKWBDZOARPV-UHFFFAOYSA-N 0.000 description 1
- DNXIASIHZYFFRO-UHFFFAOYSA-N pyrazoline Chemical group C1CN=NC1 DNXIASIHZYFFRO-UHFFFAOYSA-N 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical group N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical compound C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 description 1
- 150000008584 quinuclidines Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229940096017 silver fluoride Drugs 0.000 description 1
- REYHXKZHIMGNSE-UHFFFAOYSA-M silver monofluoride Chemical compound [F-].[Ag+] REYHXKZHIMGNSE-UHFFFAOYSA-M 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000002294 steroidal antiinflammatory agent Substances 0.000 description 1
- 101150035983 str1 gene Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229910052716 thallium Inorganic materials 0.000 description 1
- BKVIYDNLLOSFOA-UHFFFAOYSA-N thallium Chemical compound [Tl] BKVIYDNLLOSFOA-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000003096 thymolvtic effect Effects 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
ç£æ¥äžã®å©çšåé
æ¬çºæã¯ãæ°èŠãªæççæ§ã¹ããã€ãé¡åã³ã
ããæå¹æåãšããŠå å«ããæççå€ã«é¢ããã çºæã®é瀺 æ¬çºæã¯ãæççäœçšãæããæ°èŠãªã¹ããã€
ãé¡ãæäŸãããã®ã§ããã該ã¹ããã€ãé¡ã¯ã
äžèšäžè¬åŒïŒïŒã§è¡šããããã åŒäžãR1ã¯C1-6ã¢ã«ãã«åºãã¢ãããâC1-6
ã¢ã«ãã«åºãâCH2COOR6åºïŒR6ã¯C1-6ã¢ã«ãã«
åºïŒãâCH2ââïŒC1-6ã¢ã«ãã«ïŒåºïŒïŒ¹ã¯â
âãâSOâãâSO2âåã¯ââã瀺ãïŒåã¯â
CH2âOCOR6ïŒR6ã¯äžèšã«åãïŒã瀺ãã R2ã¯C1-6ã¢ã«ãã«åºãC3-8ã·ã¯ãã¢ã«ãã«åºã
ãã³ãžã«åºåã¯ã¢ãããâC1-6ã¢ã«ãã«åºã瀺
ãã R3ã¯æ°ŽçŽ ååãαâã¡ãã«åºãβâã¡ãã«åº
åã¯Î±âOCOOR6åºïŒR6ã¯äžèšã«åãïŒã瀺ãã R4ã¯æ°ŽçŽ åååã¯åŒçŽ ååã瀺ãã R5ã¯æ°ŽçŽ åååã¯åŒçŽ ååã瀺ãã ã¯ã«ã«ããã«åºåã¯Î²âããããã·ã¡ãã¬ã³
åºã瀺ãã ãŸãç°ã«ãããç¹ç·ã¯ïŒïŒïŒâäœçµåã飜å
åã¯äžé£œåçµåã§ããããšã瀺ãã æ¬çºæã¯ãæŽã«äžèšäžè¬åŒïŒïŒã§è¡šãããã
ååç©ã®æççæ§ç¬¬ïŒçŽã¢ã³ã¢ããŠã å¡©ããæäŸ
ãããã®ã§ããããã®è©³çŽ°ã¯åŸè¿°ããéãã§ã
ãã äžè¬åŒïŒïŒã§è¡šããããã¹ããã€ãé¡åã³ã
ã®ç¬¬ïŒçŽã¢ã³ã¢ããŠã å¡©ã¯ãåªããæççäœçšã
æããæççå€ãšããŠæçšã§ãããæ®ã«åŒ·åãªå±
ææççå€ãšããŠæçšã§ããã æ¬æ现æžã«ãããŠã¯ååºã«ã€ãçšããããå®çŸ©
åã³èª¬æã¯ã以äžã®ããšãæå³ãããã®ã§ããã R1åã¯R2ã®ååºãšããŠåã³R1ãR2åã³R3ã®å
åºã®éšåãšããŠãäžè¬åŒïŒïŒã«å å«ããã
ãC1-6ã¢ã«ãã«åºããªãèªã¯ãççŽ æ°ïŒãïŒã®çŽ
éç¶ãããã¯åæç¶ã¢ã«ãã«åºãäŸãã°ã¡ãã«ã
ãšãã«ãïœâãããã«ãã€ãœãããã«ãïœâãã
ã«ãã€ãœããã«ãsecâããã«ãtertâããã«ã
ïœâãã³ãã«ãïœâããã·ã«åºçãæå³ããããŸ
ããã¢ãããâC1-6ã¢ã«ãã«ããªãèªã¯ãïŒåã®
ããã²ã³ååã§çœ®æãããççŽ æ°æ°ïŒãïŒã®çŽé
ç¶ãããã¯åæç¶ã¢ã«ãã«åºãæå³ãããã®ã§ã
ãããããã²ã³ååãã¯ãå¡©çŽ ååãèçŽ ååã
æ²çŽ åååã³åŒçŽ ååãå«ããäžèšã¢ãããã¢ã«
ãã«å ·äœäŸãšããŠã¯ãã¯ããã¡ãã«ãããã¢ã¡ã
ã«ããã«ãªãã¡ãã«ãïŒâãã«ãªããšãã«ãïŒâ
ã¯ãããšãã«ãïŒâã¯ãããšãã«ãïŒâã¯ããã
ããã«ãïŒâã¯ãããããã«ãïŒâã¯ãããã
ã«ãïŒâã¯ãããã³ãã«ãïŒâã¯ããããã·ã«ã
ïŒâã¯ããããã«åºçãäŸç€ºã§ããããŸããC3-8
ã·ã¯ãã¢ã«ãã«åºããªãèªã¯ãççŽ æ°ïŒãïŒã®ã·
ã¯ãã¢ã«ãã«åºãå³ã¡ã·ã¯ããããã«ãã·ã¯ãã
ãã«ãã·ã¯ããã³ãã«ãã·ã¯ãããã·ã«ãã·ã¯ã
ãããã«åã³ã·ã¯ããªã¯ãã«åºãæå³ããã äžè¬åŒïŒïŒã§è¡šããããååç©äžãR1ãα
âããã¢ã«ãã«åºã§ããååç©ã¯ã容æã«å¯Ÿå¿ã
ã第ïŒçŽã¢ã³ã¢ããŠã å¡©ã圢æãåŸãããã亊å
æ§ã«æççå€ãšããŠæçšã§ãããäŸãã°äžèšæå®
ã®äžè¬åŒïŒïŒã§è¡šããããããã¢ã«ãã«èªå°äœ
ã¯ã第ïŒçŽã¢ãã³ïŒïŒ®ïŒåã¯äžé£œåã¢ãã³ïŒã
ïŒãšå®¹æã«åå¿ããŠãçžåœãã第ïŒçŽã¢ã³ã¢ã
ãŠã å¡©ãšãªãåŸããäžèšåå¿è©Šè¬ã¯ãéåžžã»ãŒç
ã¢ã«éçšããããåå¿ã¯äžæŽ»æ§æº¶åªäŸãã°ãšãŒã
ã«ãã¢ã»ããããªã«ãCH2Cl2çã®ååšäžã宀枩
ä¹è³æº¶åªã®éæµæž©åºŠäžã«ãçŽïŒã24æéãèŠããŠ
è¡ãªãåŸãã溶åªãçšãã代ãã«ãäºçš®ã®åå¿å
æãæ··åããä¹çã宀枩ãããã¯20ã70âäžã«ïŒ
ã24æéãèŠããŠãè¡ãªãåŸãããããã®å Žåã
çæããçµæ¶æ§å¡©ã¯ãšãŒãã«âãšã¿ããŒã«æ··æ¶²ç
ããåçµæ¶ããŠç²Ÿè£œããããšãã§ããã ãäžé£œåã¢ãã³ããªãèªã¯ïŒã10å¡ã®å«çªçŽ äž
飜åè€çŽ ç°åã³ãã®çœ®æãããèªå°äœãæå³ã
ããããã§äžé£œåçµåæ°ã¯é£æ¥äºéçµåãå«ãŸãª
ãæ倧æ°ã«çžåœããããçªçŽ ååã¯çœ®æåºãšããŠ
æ°ŽçŽ ååãæããªããã®ãšãããäžèšå®çŸ©ã®ç¯å²
ã¯æ¬¡ã®äŸç€ºååç©ããæããã§ããã ïŒâã¡ãã«ã¢ãžãªãžã³ãïŒâã¡ãã«ãããŒã«ã
ïŒâã¡ãã«ã€ãããŸãŒã«ãïŒâã¡ãã«ãã©ãŸãŒ
ã«ãããªãžã³ããã©ãŸãªã³ãããªããžã³ãããªã
ãžã³ãïŒâã¡ãã«ã€ãœã€ã³ããŒã«ã3Hâã€ã³ã
ãŒã«ããããªã³ãã€ãœãããªã³ããã¿ã©ãžã³ãã
ãããµãªã³ããããŸãªã³ãããšããžã³ãã€ãœãã¢
ãŸãŒã«ã10âã¡ãã«ããšããã¢ãžã³ãã€ãœãªããµ
ãŸãŒã«ããã©ã¶ã³ 眮æäžé£œåã¢ãã³èªå°äœã«ã¯ãïŒãããã¯ãã
以äžã®ã¢ã«ãã«åºãâCOOïŒã¢ã«ãã«ïŒåºåã¯â
OCOïŒã¢ã«ãã«ïŒåºã眮æåºãšããŠæããäžèšäŸ
瀺ã®ååç©ãå å«ãããã ãŸãã第ïŒçŽã¢ãã³ããªãèªã¯ãçªçŽ ååäžã«
æ°ŽçŽ ååãæããŠããããäžèšãäžé£œåã¢ãã³ã
ãªãèªã«ãã€ãŠè¡šããããå«çªçŽ äžé£œåè€çŽ ç°ã
é€ãã¢ãã³é¡ãæå³ããããã®ç¬¬ïŒçŽã¢ãã³ã®ä»£
è¡šäŸãšããŠã¯ã奜ãŸããã¯ççŽ æ°ïŒãïŒã®ãåäž
åã¯çžç°ãªãã¢ã«ãã«åºãæããããªã¢ã«ãã«ã¢
ãã³ïŒåã¢ã«ã³ãã·åºãççŽ æ°ïŒãïŒã§ããããª
ã¢ã«ã³ãã·ã¢ãã³ïŒç¬¬ïŒçŽé£œåç°ç¶ã¢ãã³äŸãã°
ããã¯ãªãžã³ãããã¯çœ®æããã¯ãªãžã³ïŒïŒâã¢
ã»ããã·ããã¯ãªãžã³çïŒïŒåã³ç¬¬ïŒçŽé£œåç°ç¶
ã¢ãã³ã®ïŒ®â眮æèªå°äœäŸãã°ïŒ®â眮æã®ã¢ã«ã
ãªã³ããããªãžã³ãã€ãããŸãªãžã³ããã©ãŸãªãž
ã³ããããªãžã³ãããã©ãžã³çïŒïŒ®â眮æåºã¯äŸ
ãã°C1-8ã¢ã«ãã«åºïŒã§ããããããã¯æŽã«ä»»æ
ã«ã¡ãã«åºçã®ä»ã®çœ®æåºãæããŠããŠãããã 奜ãŸãã第ïŒçŽã¢ã³ã¢ããŠã å¡©ãšããŠã¯ãäŸã
ã°ïŒïŒïŒâãžã¡ãã«ãããªãžã³ãïŒâã¢ã»ããã·
ããã¯ãªãžã³ãïŒâã¡ãã«ãããªãžã³ãããªãšã
ã«ã¢ãã³åã³ïŒ®âã¡ãã«ã€ãããŸãŒã«ããèªå°ã
ãããã®ãäŸç€ºã§ãããç¹ã«å¥œãŸãã第ïŒçŽã¢ã³
ã¢ããŠã å¡©ã¯ãäžèšã§è¿°ã¹ãã¢ãã³ãšãäžè¬åŒ
ïŒïŒäžïŒºãβâããããã·ã¡ãã¬ã³åºã§ããäž
ã€R1ãã¯ããã¡ãã«åºã§ããååç©ç¹ã«R2ã
C1-6ã¢ã«ãã«åºã§ããååç©ãšã®åå¿ã«ããåŸã
ããå¡©ã§ããã äžè¬åŒïŒïŒã§è¡šãããããã¹ãŠã®ååç©ã¯ã
åºæ¬çã«æ¬çºæã®ç®çã«å®å šãªãã®ã§ãããã奜
ãŸããååãšããŠã¯ãäžè¿°ããéãã§ããã ä»ã®å¥œãŸãã矀ã¯ãäžè¬åŒïŒïŒäžïŒºãã
R1åã³R2ãäžèšããåºã§ãããæ®ãã®æ§é å¯å€
éšããã€ããã³ãŒããŸã³ïŒhydrocortisoneãå³ã¡
R3ãR4åã³R5ã倫ã æ°ŽçŽ ååã§ãããïŒïŒïŒâ
äœã飜åã§ããïŒã®ããåã¯ãã¬ãããŸãã³
ïŒprednisoloneãå³ã¡R3ãR4åã³R5ã倫ã æ°ŽçŽ å
åã§ãããïŒïŒïŒâäœãäžé£œåã§ããïŒã®ãããš
åäžã§ããååç©ãç¹ã«å¥œãŸããååç©ãšããŠ
ã¯ãåèšã®å¥œãŸããååç©ã«ãããŠR1åã³R2ã
åäžåºã§ããååç©ãæããããšãã§ããã ãŸãäžèšããååç©ã®6αâåã³ïŒåã¯9αâã
ã«ãªãåã³16αâåã¯16βâã¡ãã«åå±äœã奜ãŸ
ããããã®ååç©ã®äžã§ç¹ã«ïŒºããR1åã³R2
ãäžèšããåºã§æ®ãã®æ§é å¯å€éšããã«ããã³ãŒ
ããŸã³ïŒfludrocortisoneïŒãããŒã¿ãŒã¡ã¿ãŸã³
ïŒbetamethasoneïŒåã³ãã¯ãµã¡ã¿ãŸã³
ïŒdexamethasoneïŒã®ããããšåäžã§ããååç©
ã奜ãŸããããã®ãã¡ã§ãR1åã³R2ã第ïŒã®å¥œ
ãŸãã矀ã«å±ããååç©ã®ããããšåäžåºã§ãã
ãã®ãæã奜ãŸããããŸããã®çŸ€ã®äžã§èå³ã®ã
ãä»ã®ååç©ã¯ïŒºããR1åã³R2ãäžèšããåº
ã§æ®ãã®æ§é å¯å€éšãããªã¢ã ã·ããã³
ïŒtriamcinoloneïŒããã«ã¡ã¿ãŸã³
ïŒflumethasoneïŒããã«ãã¬ãããŸãã³
ïŒfluprednisoloneïŒåã¯ãã©ã¡ã¿ãŸã³
ïŒparamethasoneïŒã®ããããšåäžã§ãããç¹ã«
R1åã³R2ã第ïŒã®å¥œãŸãã矀ã«å±ããååç©ã®
ããããšåäžã®ãã®ã§ãããæŽã«ä»ã®èå³ã®ãã
ååç©ã¯ïŒºããR1åã³R2ãäžèšããåºã§ãR3
ã
ããæå¹æåãšããŠå å«ããæççå€ã«é¢ããã çºæã®é瀺 æ¬çºæã¯ãæççäœçšãæããæ°èŠãªã¹ããã€
ãé¡ãæäŸãããã®ã§ããã該ã¹ããã€ãé¡ã¯ã
äžèšäžè¬åŒïŒïŒã§è¡šããããã åŒäžãR1ã¯C1-6ã¢ã«ãã«åºãã¢ãããâC1-6
ã¢ã«ãã«åºãâCH2COOR6åºïŒR6ã¯C1-6ã¢ã«ãã«
åºïŒãâCH2ââïŒC1-6ã¢ã«ãã«ïŒåºïŒïŒ¹ã¯â
âãâSOâãâSO2âåã¯ââã瀺ãïŒåã¯â
CH2âOCOR6ïŒR6ã¯äžèšã«åãïŒã瀺ãã R2ã¯C1-6ã¢ã«ãã«åºãC3-8ã·ã¯ãã¢ã«ãã«åºã
ãã³ãžã«åºåã¯ã¢ãããâC1-6ã¢ã«ãã«åºã瀺
ãã R3ã¯æ°ŽçŽ ååãαâã¡ãã«åºãβâã¡ãã«åº
åã¯Î±âOCOOR6åºïŒR6ã¯äžèšã«åãïŒã瀺ãã R4ã¯æ°ŽçŽ åååã¯åŒçŽ ååã瀺ãã R5ã¯æ°ŽçŽ åååã¯åŒçŽ ååã瀺ãã ã¯ã«ã«ããã«åºåã¯Î²âããããã·ã¡ãã¬ã³
åºã瀺ãã ãŸãç°ã«ãããç¹ç·ã¯ïŒïŒïŒâäœçµåã飜å
åã¯äžé£œåçµåã§ããããšã瀺ãã æ¬çºæã¯ãæŽã«äžèšäžè¬åŒïŒïŒã§è¡šãããã
ååç©ã®æççæ§ç¬¬ïŒçŽã¢ã³ã¢ããŠã å¡©ããæäŸ
ãããã®ã§ããããã®è©³çŽ°ã¯åŸè¿°ããéãã§ã
ãã äžè¬åŒïŒïŒã§è¡šããããã¹ããã€ãé¡åã³ã
ã®ç¬¬ïŒçŽã¢ã³ã¢ããŠã å¡©ã¯ãåªããæççäœçšã
æããæççå€ãšããŠæçšã§ãããæ®ã«åŒ·åãªå±
ææççå€ãšããŠæçšã§ããã æ¬æ现æžã«ãããŠã¯ååºã«ã€ãçšããããå®çŸ©
åã³èª¬æã¯ã以äžã®ããšãæå³ãããã®ã§ããã R1åã¯R2ã®ååºãšããŠåã³R1ãR2åã³R3ã®å
åºã®éšåãšããŠãäžè¬åŒïŒïŒã«å å«ããã
ãC1-6ã¢ã«ãã«åºããªãèªã¯ãççŽ æ°ïŒãïŒã®çŽ
éç¶ãããã¯åæç¶ã¢ã«ãã«åºãäŸãã°ã¡ãã«ã
ãšãã«ãïœâãããã«ãã€ãœãããã«ãïœâãã
ã«ãã€ãœããã«ãsecâããã«ãtertâããã«ã
ïœâãã³ãã«ãïœâããã·ã«åºçãæå³ããããŸ
ããã¢ãããâC1-6ã¢ã«ãã«ããªãèªã¯ãïŒåã®
ããã²ã³ååã§çœ®æãããççŽ æ°æ°ïŒãïŒã®çŽé
ç¶ãããã¯åæç¶ã¢ã«ãã«åºãæå³ãããã®ã§ã
ãããããã²ã³ååãã¯ãå¡©çŽ ååãèçŽ ååã
æ²çŽ åååã³åŒçŽ ååãå«ããäžèšã¢ãããã¢ã«
ãã«å ·äœäŸãšããŠã¯ãã¯ããã¡ãã«ãããã¢ã¡ã
ã«ããã«ãªãã¡ãã«ãïŒâãã«ãªããšãã«ãïŒâ
ã¯ãããšãã«ãïŒâã¯ãããšãã«ãïŒâã¯ããã
ããã«ãïŒâã¯ãããããã«ãïŒâã¯ãããã
ã«ãïŒâã¯ãããã³ãã«ãïŒâã¯ããããã·ã«ã
ïŒâã¯ããããã«åºçãäŸç€ºã§ããããŸããC3-8
ã·ã¯ãã¢ã«ãã«åºããªãèªã¯ãççŽ æ°ïŒãïŒã®ã·
ã¯ãã¢ã«ãã«åºãå³ã¡ã·ã¯ããããã«ãã·ã¯ãã
ãã«ãã·ã¯ããã³ãã«ãã·ã¯ãããã·ã«ãã·ã¯ã
ãããã«åã³ã·ã¯ããªã¯ãã«åºãæå³ããã äžè¬åŒïŒïŒã§è¡šããããååç©äžãR1ãα
âããã¢ã«ãã«åºã§ããååç©ã¯ã容æã«å¯Ÿå¿ã
ã第ïŒçŽã¢ã³ã¢ããŠã å¡©ã圢æãåŸãããã亊å
æ§ã«æççå€ãšããŠæçšã§ãããäŸãã°äžèšæå®
ã®äžè¬åŒïŒïŒã§è¡šããããããã¢ã«ãã«èªå°äœ
ã¯ã第ïŒçŽã¢ãã³ïŒïŒ®ïŒåã¯äžé£œåã¢ãã³ïŒã
ïŒãšå®¹æã«åå¿ããŠãçžåœãã第ïŒçŽã¢ã³ã¢ã
ãŠã å¡©ãšãªãåŸããäžèšåå¿è©Šè¬ã¯ãéåžžã»ãŒç
ã¢ã«éçšããããåå¿ã¯äžæŽ»æ§æº¶åªäŸãã°ãšãŒã
ã«ãã¢ã»ããããªã«ãCH2Cl2çã®ååšäžã宀枩
ä¹è³æº¶åªã®éæµæž©åºŠäžã«ãçŽïŒã24æéãèŠããŠ
è¡ãªãåŸãã溶åªãçšãã代ãã«ãäºçš®ã®åå¿å
æãæ··åããä¹çã宀枩ãããã¯20ã70âäžã«ïŒ
ã24æéãèŠããŠãè¡ãªãåŸãããããã®å Žåã
çæããçµæ¶æ§å¡©ã¯ãšãŒãã«âãšã¿ããŒã«æ··æ¶²ç
ããåçµæ¶ããŠç²Ÿè£œããããšãã§ããã ãäžé£œåã¢ãã³ããªãèªã¯ïŒã10å¡ã®å«çªçŽ äž
飜åè€çŽ ç°åã³ãã®çœ®æãããèªå°äœãæå³ã
ããããã§äžé£œåçµåæ°ã¯é£æ¥äºéçµåãå«ãŸãª
ãæ倧æ°ã«çžåœããããçªçŽ ååã¯çœ®æåºãšããŠ
æ°ŽçŽ ååãæããªããã®ãšãããäžèšå®çŸ©ã®ç¯å²
ã¯æ¬¡ã®äŸç€ºååç©ããæããã§ããã ïŒâã¡ãã«ã¢ãžãªãžã³ãïŒâã¡ãã«ãããŒã«ã
ïŒâã¡ãã«ã€ãããŸãŒã«ãïŒâã¡ãã«ãã©ãŸãŒ
ã«ãããªãžã³ããã©ãŸãªã³ãããªããžã³ãããªã
ãžã³ãïŒâã¡ãã«ã€ãœã€ã³ããŒã«ã3Hâã€ã³ã
ãŒã«ããããªã³ãã€ãœãããªã³ããã¿ã©ãžã³ãã
ãããµãªã³ããããŸãªã³ãããšããžã³ãã€ãœãã¢
ãŸãŒã«ã10âã¡ãã«ããšããã¢ãžã³ãã€ãœãªããµ
ãŸãŒã«ããã©ã¶ã³ 眮æäžé£œåã¢ãã³èªå°äœã«ã¯ãïŒãããã¯ãã
以äžã®ã¢ã«ãã«åºãâCOOïŒã¢ã«ãã«ïŒåºåã¯â
OCOïŒã¢ã«ãã«ïŒåºã眮æåºãšããŠæããäžèšäŸ
瀺ã®ååç©ãå å«ãããã ãŸãã第ïŒçŽã¢ãã³ããªãèªã¯ãçªçŽ ååäžã«
æ°ŽçŽ ååãæããŠããããäžèšãäžé£œåã¢ãã³ã
ãªãèªã«ãã€ãŠè¡šããããå«çªçŽ äžé£œåè€çŽ ç°ã
é€ãã¢ãã³é¡ãæå³ããããã®ç¬¬ïŒçŽã¢ãã³ã®ä»£
è¡šäŸãšããŠã¯ã奜ãŸããã¯ççŽ æ°ïŒãïŒã®ãåäž
åã¯çžç°ãªãã¢ã«ãã«åºãæããããªã¢ã«ãã«ã¢
ãã³ïŒåã¢ã«ã³ãã·åºãççŽ æ°ïŒãïŒã§ããããª
ã¢ã«ã³ãã·ã¢ãã³ïŒç¬¬ïŒçŽé£œåç°ç¶ã¢ãã³äŸãã°
ããã¯ãªãžã³ãããã¯çœ®æããã¯ãªãžã³ïŒïŒâã¢
ã»ããã·ããã¯ãªãžã³çïŒïŒåã³ç¬¬ïŒçŽé£œåç°ç¶
ã¢ãã³ã®ïŒ®â眮æèªå°äœäŸãã°ïŒ®â眮æã®ã¢ã«ã
ãªã³ããããªãžã³ãã€ãããŸãªãžã³ããã©ãŸãªãž
ã³ããããªãžã³ãããã©ãžã³çïŒïŒ®â眮æåºã¯äŸ
ãã°C1-8ã¢ã«ãã«åºïŒã§ããããããã¯æŽã«ä»»æ
ã«ã¡ãã«åºçã®ä»ã®çœ®æåºãæããŠããŠãããã 奜ãŸãã第ïŒçŽã¢ã³ã¢ããŠã å¡©ãšããŠã¯ãäŸã
ã°ïŒïŒïŒâãžã¡ãã«ãããªãžã³ãïŒâã¢ã»ããã·
ããã¯ãªãžã³ãïŒâã¡ãã«ãããªãžã³ãããªãšã
ã«ã¢ãã³åã³ïŒ®âã¡ãã«ã€ãããŸãŒã«ããèªå°ã
ãããã®ãäŸç€ºã§ãããç¹ã«å¥œãŸãã第ïŒçŽã¢ã³
ã¢ããŠã å¡©ã¯ãäžèšã§è¿°ã¹ãã¢ãã³ãšãäžè¬åŒ
ïŒïŒäžïŒºãβâããããã·ã¡ãã¬ã³åºã§ããäž
ã€R1ãã¯ããã¡ãã«åºã§ããååç©ç¹ã«R2ã
C1-6ã¢ã«ãã«åºã§ããååç©ãšã®åå¿ã«ããåŸã
ããå¡©ã§ããã äžè¬åŒïŒïŒã§è¡šãããããã¹ãŠã®ååç©ã¯ã
åºæ¬çã«æ¬çºæã®ç®çã«å®å šãªãã®ã§ãããã奜
ãŸããååãšããŠã¯ãäžè¿°ããéãã§ããã ä»ã®å¥œãŸãã矀ã¯ãäžè¬åŒïŒïŒäžïŒºãã
R1åã³R2ãäžèšããåºã§ãããæ®ãã®æ§é å¯å€
éšããã€ããã³ãŒããŸã³ïŒhydrocortisoneãå³ã¡
R3ãR4åã³R5ã倫ã æ°ŽçŽ ååã§ãããïŒïŒïŒâ
äœã飜åã§ããïŒã®ããåã¯ãã¬ãããŸãã³
ïŒprednisoloneãå³ã¡R3ãR4åã³R5ã倫ã æ°ŽçŽ å
åã§ãããïŒïŒïŒâäœãäžé£œåã§ããïŒã®ãããš
åäžã§ããååç©ãç¹ã«å¥œãŸããååç©ãšããŠ
ã¯ãåèšã®å¥œãŸããååç©ã«ãããŠR1åã³R2ã
åäžåºã§ããååç©ãæããããšãã§ããã ãŸãäžèšããååç©ã®6αâåã³ïŒåã¯9αâã
ã«ãªãåã³16αâåã¯16βâã¡ãã«åå±äœã奜ãŸ
ããããã®ååç©ã®äžã§ç¹ã«ïŒºããR1åã³R2
ãäžèšããåºã§æ®ãã®æ§é å¯å€éšããã«ããã³ãŒ
ããŸã³ïŒfludrocortisoneïŒãããŒã¿ãŒã¡ã¿ãŸã³
ïŒbetamethasoneïŒåã³ãã¯ãµã¡ã¿ãŸã³
ïŒdexamethasoneïŒã®ããããšåäžã§ããååç©
ã奜ãŸããããã®ãã¡ã§ãR1åã³R2ã第ïŒã®å¥œ
ãŸãã矀ã«å±ããååç©ã®ããããšåäžåºã§ãã
ãã®ãæã奜ãŸããããŸããã®çŸ€ã®äžã§èå³ã®ã
ãä»ã®ååç©ã¯ïŒºããR1åã³R2ãäžèšããåº
ã§æ®ãã®æ§é å¯å€éšãããªã¢ã ã·ããã³
ïŒtriamcinoloneïŒããã«ã¡ã¿ãŸã³
ïŒflumethasoneïŒããã«ãã¬ãããŸãã³
ïŒfluprednisoloneïŒåã¯ãã©ã¡ã¿ãŸã³
ïŒparamethasoneïŒã®ããããšåäžã§ãããç¹ã«
R1åã³R2ã第ïŒã®å¥œãŸãã矀ã«å±ããååç©ã®
ããããšåäžã®ãã®ã§ãããæŽã«ä»ã®èå³ã®ãã
ååç©ã¯ïŒºããR1åã³R2ãäžèšããåºã§ãR3
ã
ãåŒãã§ãä»ã®æ§é å¯å€éšãããªã¢ã
ã·ããã³ã§ãããã®ãç¹ã«R1åã³R2ã第ïŒã®å¥œ
ãŸãã矀ã®ååç©ã®ããããšåãã§ãããã®ã§ã
ãã äžèšäžã€çŸ€ã®å矀ã«ãããŠãæã奜é©ãªååç©
ã¯ããβâããããã·ã¡ãã¬ã³åºã§ãããR2
ãC1-6ã¢ã«ãã«åºïŒç¹ã«ã¡ãã«ããšãã«ãããã
ã«åã¯ã€ãœãããã«åºïŒã§ããããŸãR1ãC1-6
ã¢ã«ãã«åºãã¢ãããâC1-6ã¢ã«ãã«åºïŒç¹ã«ã¯
ããã¡ãã«åºïŒåã¯âCH2ââïŒC1-6ã¢ã«ãã«ïŒ
åºïŒäœãã¯äžè¿°ããåºãç¹ã«C1-6ã¢ã«ãã«ãã¡
ãã«åºïŒã®ãã®ã§ããã äžè¬åŒïŒïŒã§è¡šããããååç©ã¯ãéåžžå ¬ç¥
ã®æ¹æ³ã«æºããŠè£œé ãããããã®æ¹æ³ã¯ææã®æ
çµååç©ã®å皮眮æåºã«å¿ããŠé©å®éžæãããã äžèšäžè¬åŒïŒïŒã§è¡šããããæ¬çºæååç©ã®
ãã¡ãäžè¬åŒ ãåŒäžãR1ãR2ãR3ãR4ãR5åã³ïŒ¡ç°ã®ç¹ç·ã¯
äžèšã«åããã ã§è¡šããããååç©ã®è£œé ã¯ãäŸãã°ãã¹ããã€
ãæ§åºçºåæãšããŠäžèšäžè¬åŒïŒïŒã§è¡šããã
ãååç©ãçšããŠè¡ãªãããã ãåŒäžR4ãR5åã³ïŒ¡ç°ã®ç¹ç·ã¯äžèšã«åãã
R3â²ã¯æ°ŽçŽ ååãαâã¡ãã«ãβâã¡ãã«åã¯Î±
âOHåºã瀺ãã äžèšäžè¬åŒïŒïŒã§è¡šããããååç©ã¯ãéåžž
察å¿ããäžè¬åŒ ãåŒäžR4ãR5ãR3â²åã³ïŒ¡ç°ã®ç¹ç·ã¯äžèšã«å
ããã ã§è¡šãããã21âããããã·ãã¬ã°ãããã³é¡
ïŒ21âhydroxypregnenolonesïŒãé©åœãªææ©æº¶åª
äžå®€æž©ãããã¯ãã以äžã®æž©åºŠäžã«NaIO4ã§åŠç
ããããšã«ããåŸãããã æ¬çºæã®äžèšæ¹æ³ã«ãããŠã¯ãäžè¬åŒïŒïŒã§
è¡šããããåºçºååç©ããç¡æ°Žæ¡ä»¶äžãé©åœãªäž
掻æ§æº¶åªäŸãã°ãžã¯ããã¡ã¿ã³ãã¯ãããã«ã å
ã¯ããã©ããããã©ã³çã®æº¶åªäžã§ãR2OCOCl
åã¯R2OCOBrïŒR2OHãšCOCl2åã¯COBr2ãšã®å
å¿ã«ããåŸããããR2ã¯äžèšã«åãïŒã§è¡šãã
ããååç©ãšåå¿ããããäžèšåå¿ã¯ã奜ãŸãã
ã¯é©åœãªé žå容äœäŸãã°ããªãšãã«ã¢ãã³ãããª
ãžã³ãçé žã«ã«ã·ãŠã åã¯ä»ã®é©åœãªå¡©åºã®ååš
äžã«è¡ãªããããåå¿æéåã³æž©åºŠã¯ç¹ã«å¶éã¯
ãªãããéåžžåå¿ã¯çŽïŒâä¹è³å®€æž©äžçŽïŒãïŒæ
éã§æå©ã«è¡ãªããããåŸãããæ°èŠãª17βâã«
ã«ãã³é žâ17αâã«ã«ãããŒãã¯äžèšäžè¬åŒ
ïŒïŒã§è¡šããããã ãåŒäžR2ãR3ãR4ãR5åã³ïŒ¡ç°ã®ç¹ç·ã¯äžèšã«
åããã äžè¬åŒïŒïŒã§è¡šããããåºçºåæãšããŠ
R3â²ãαâOHã®ãã®ãçšããå Žåãå åéã®
R2OCOClåã¯R2OCOBrãçšããããšã«ããã16
âäœåã³17âäœã®ã«ã«ãããŒãã®åœ¢æã確å®ãšãª
ãïŒå³ã¡äžè¬åŒïŒïŒã«ãããR3â²ãOHã®å Žåã
åŸãããäžè¬åŒïŒïŒã®äžéäœã«åããR3ã¯Î±
âOCOOR6ã§ããïŒã äžèšããããã«17αâ眮æåºãå°å ¥åŸãåŸãã
ãäžè¬åŒïŒïŒã§è¡šããããæ°èŠãªäžéäœã¯ã次
ãã§ãã®å¯Ÿå¿ããéå±å¡©ã«å€æãããã該éå±å¡©
ã¯äžèšäžè¬åŒïŒïŒã§è¡šããããã ãåŒäžR2ãR3ãR4ãR5åã³ïŒ¡ç°ã®ç¹ç·ã¯äžèšã«
åããïŒã¯éå±äŸãã°ãããªãŠã ãã«ãªãŠã çã®
ã¢ã«ã«ãªéå±ã1/2ã¢ã«ã«ãªåé¡éå±åã¯ã¿ãªãŠ
ã æã¯NH4ã瀺ãã äžèšäžè¬åŒïŒïŒã®æ°èŠãªå¡©ã¯ãäŸãã°äžè¬åŒ
ïŒïŒã®ã¹ããã€ããšæ°Žé žåç©ïŒMOHïŒåã¯ã¢
ã«ã³ãã·ãïŒMORïŒãšããé©åœãªææ©æº¶åªäŸã
ã°ãšãã«ãšãŒãã«åã¯ããã©ããããã©ã³äžã§ã
ïŒâä¹è³å®€æž©äžã«çŽ0.5ãïŒæéåå¿ãããããš
ã«ããåŸãããã ããããŠåŸãããäžè¬åŒïŒïŒã®å¡©ãã次ãã§
äžè¬åŒR1âïŒåŒäžR1ã¯äžèšã«åããã¯ããã²
ã³ååã瀺ãïŒã§è¡šããããååç©ãšåå¿ããã
ããšã«ããã察å¿ããææã®äžè¬åŒïŒïœïŒã§è¡š
ããããæ¬çºæååç©ãååŸã§ãããäžèšåå¿å·¥
çšã¯ãé垞宀枩äžã«çŽïŒã24æéã§ãåã¯æº¶åªäŸ
ãã°ã¢ã»ããããªã«ãããã©ããããã©ã³çã®æ²ž
隰枩床äžã«è¡ãªãããã äžèšã¹ããã€ãã®R1ãšããŠã¢ãããâC1-6ã¢
ã«ãã«åºãå°å ¥ãããå ŽåãäŸãã°äžè¬åŒïŒïŒ
äžã®R1ãã¯ããã¡ãã«åºã§ããååç©ãææã
ãå Žåã溶åªãšããŠãããµã¡ãã«ãªã³é žã¢ããã
çšããäœã枩床ïŒïŒâ10âïŒã§äžã€R1â詊è¬
ãšããŠïŒ·ãæ²çŽ ååã®ãã®äŸãã°ãšãŒãã¯ããã¡
ã¿ã³ãçšããããšã«ãããåå¿ã¯å®¹æã«é²è¡ãã
ããšãå€ã€ãããŸãããã²ã³ãå«ãŸãªãR1åºã
æãŸããå ŽåãäŸãã°R1ãã¢ã«ãã«åã¯â
CH2COOR6ïŒR6ã¯äžèšã«åãïŒã§ããå Žåãäžèš
ã®åŠã溶åªåã³R1â詊è¬ã®äœ¿çšå¶éã¯äžå¿ èŠ
ã§ãããäžèšïŒ·ã¯åçš®ã®ããã²ã³ã§ãã€ãŠãã
ïŒå¥œãŸããã¯å¡©çŽ ãããã¯èçŽ ååïŒãŸãéåžžã®
ææ©æº¶åªäŸãã°ãžã¡ãã«ãã«ã ã¢ããããžã¯ãã
ã¡ã¿ã³ãã¢ã»ããããªã«ãããã©ããããã©ã³ã
ã¯ãããã«ã çããå¿ èŠã«å¿ããããµã¡ãã«ãªã³
é žã¢ããã«ä»£æ¿äœ¿çšã§ãããæŽã«R1ãã¹ã«ãã€
ãã«åã¯ã¹ã«ããã«åºã§ããäžè¬åŒïŒïœïŒã®å
åç©ãæãŸããå Žåãä¹çã®åºã¯éåžžR1âã
çšããåå¿ã§ã¯å°å ¥ã§ãããåŒãç¶ãåŸè¿°ããã
ãã«å¯Ÿå¿ããããªã¹ããã€ããã補é ãããã R1ãã¹ã«ãã€ãã«åã¯ã¹ã«ããã«åºå«æåºã§
ããäžè¬åŒïŒïœïŒã®ååç©ã¯ã察å¿ããããªã¹
ããã€ãã®é žåã«ãã補é ããããšãã§ãããäŸ
ãã°ãäžè¬åŒ ãåŒäžãR2ãR3ãR4ãR5åã³ïŒ¡ç°ã®ç¹ç·ã¯äžèš
ã«åããR8ã¯âCH2SâïŒC1-6ã¢ã«ãã«åºïŒåºã
瀺ãããã§è¡šããããååç©ããïœâã¯ããéå®
æ¯éŠé žã®ïŒåœéãšãïŒã25âäžïŒã24æéãé©åœ
ãªæº¶åªäŸãã°ã¯ãããã«ã äžã§åå¿ãããããšã«
ãããR1ãâCH2âSOâïŒC1-6ã¢ã«ãã«ïŒåºã§ã
ãäžè¬åŒïŒïœïŒã®ååç©ãåŸãããšãã§ããã
ãŸãäžèšã«ãããŠïœâã¯ããéå®æ¯éŠé žã®ïŒåœé
ãçšããã°ãR1ãâCH2âSO2âïŒC1-6ã¢ã«ãã«ïŒ
åºã§ããäžè¬åŒïŒïœïŒã®ååç©ãååŸã§ããã äžè¬åŒïŒïœïŒã®ååç©ã®ä»ã®è£œé æ¹æ³ã«ãã
ãŠã¯ãäžèšåæå·¥çšã§çšãããšåäžã®äžè¬åŒ
ïŒïŒã§è¡šãããã17αâããããã·â17βâã«ã«
ãã³é žãåºçºåæãšããŠå©çšã§ãããããã®æ¹æ³
ã¯17αâOCOOR2眮æåºã®å°å ¥ã«å ç«ã€ãŠåã¯ã
ãããã®åŸã«17βâCOOR1åºã®åœ¢æãè¡ãªãã
ããååºã®å°å ¥ã«ã¯ãåºæ¬çã«ã¯äžèšãããšåäž
ã®éâã¹ããã€ãæ§è©Šè¬ãåå¿æ¡ä»¶çãæ¡çšãã
ããããããŠäžè¬åŒïŒïŒã®åºçºåæããŸã
MOHåã¯MORãšåå¿ãããŠäžèšäžè¬åŒïŒïŒ
ã§è¡šãããã察å¿ããäžéäœãåŸãã ãåŒäžR4ãR5ãR3â²ãïŒåã³ïŒ¡ç°ã®ç¹ç·ã¯äžèšã«
åãã 該äžéäœã次ãã§R1WïŒR1åã³ïŒ·ã¯äžèšã«å
ãïŒã§è¡šããããååç©ãšåå¿ãããŠãäžåŒã§è¡š
ãããã察å¿ãã17βâã«ã«ãã³é žãšã¹ãã«ãåŸ
ãã ãåŒäžR1ãR3â²ãR4ãR5åã³ïŒ¡ç°ã®ç¹ç·ã¯äžèšã«
åããã äžèšååç©ã次ãã§R2OCOClåã¯R2OCOBr
ïŒR2ã¯äžèšã«åãïŒãšåå¿ãããããšã«ããäžè¬
åŒïŒïœïŒã§è¡šãããã察å¿ãã17αâã«ãŒãã
ãŒããååŸã§ããã ååç©ïŒïŒããååç©ïŒïŒã«è³ãåå¿ã®å
çš®æ¡ä»¶ã¯ãäžè¿°ããååç©ïŒïŒããååç©
ïŒïŒã«è³ãåå¿ã®ãããšåãã§ãããåæ§ã«å
åç©ïŒïŒãååç©ïŒïŒã«å€æããåå¿ã®æ¡ä»¶
çã¯ãååç©ïŒïŒãäžè¬åŒïŒïœïŒã«å€æãã
åå¿ã®ããããšåäžã§ãããäžèšã«è©³è¿°ããéã
ã§ããããŸãååç©ïŒïŒãäžè¬åŒïŒïœïŒã«å€
ããåå¿ã®æ¡ä»¶çããååç©ïŒïŒãååç©
ïŒïŒã«å€ããåå¿ã®ããããšå®è³ªçã«åäžã§ã
ããç¹°ãè¿ãã°16âããããã·åºãå«æããåºçº
åæãçšããå Žåãäžè¬åŒïŒïœïŒã®16ïŒ17âãž
ã«ãŒãããŒããçæããããã¯æ¬¡ãã§å¿ èŠãªãã°
éžæçã«å æ°Žå解ãããŠå¯Ÿå¿ããäžè¬åŒïŒïœïŒ
ã®16âããããã·â17âã«ãŒãããŒãã«å€æãã
åŸãããŸãR1ãã¹ã«ãã€ãã«âåã¯ã¹ã«ããã«
âå«æåºã§ããäžè¬åŒïŒïœïŒã®ååç©ã¯ãéåžž
察å¿ããäžè¬åŒïŒïœïŒã®ããªåºå«æååç©ã®é ž
åã«ããåŸããããã®è©³çŽ°ã¯åèšããéãã§ã
ããæŽã«R1ãã¹ã«ãã€ãã«âåã¯ã¹ã«ããã«â
å«æåºïŒäŸãã°R1ãâCH2âSOâïŒC1-6ã¢ã«ã
ã«ïŒåã¯âCH2âSO2âïŒC1-6ã¢ã«ãã«ïŒåºïŒã§
ããäžè¬åŒïŒïœïŒã®ååç©ã¯ãR1ãããªâå«
æåºã§ãã察å¿ããäžè¬åŒïŒïŒã®ååç©ã®é žå
åå¿ã奜ãŸããã¯ïœâã¯ããéå®æ¯éŠé žãçšãã
é žååå¿åã³ããã«åŒãç¶ãåŸãããã¹ã«ãã€ã
ã«åã¯ã¹ã«ããã«ååç©ãžã®17αâOCOOR2眮æ
åºå°å ¥åå¿ã«ããååŸãããã äžè¬åŒïŒïœïŒã§è¡šããããæ¬çºæååç©ã®ä»
ã®è£œé æ¹æ³ã«ãããŠã¯ãäžèšäžè¬åŒïŒïŒã®17β
âã«ã«ãã³é žâ17αâã«ãŒãããŒãäžéäœãçšã
ãããããã®æ¹æ³ã«ããã°ãäžè¬åŒïŒïŒã®äžé
äœããŸãæž©åãªå¡©åã¢ã·ã«åœ¢æè©Šè¬äŸãã°ãžãšã
ã«ã¯ãããªã³é žåã¯å¡©åãªããµãªã«ã§åŠçãã
ãŠãäžèšäžè¬åŒïŒïŒã§è¡šãããã察å¿ããæ°èŠ
ãªé žã¯ãã©ã€ããçæããã ãåŒäžR2ãR3ãR4ãR5åã³ïŒ¡ç°ã®ç¹ç·ã¯äžèšã«
åããã äžèšé žã¯ãã©ã€ãã¯åŒãç¶ãR1XMâ²ïŒåŒäžR1å
ã³ïŒžã¯äžèšã«åããMâ²ã¯æ°ŽçŽ åååã¯äžèšïŒã
瀺ãïŒãçšããŠãäžæŽ»æ§æº¶åªäŸãã°CHCl3ã
THFãã¢ã»ããããªã«åã¯DMFäžãçŽïŒâä¹è³
溶åªã®æ²žç¹æž©åºŠç¯å²ã§çŽïŒãïŒæéåŠçãããã
ãã«ãã察å¿ããäžè¬åŒïŒïœïŒã®ååç©ãååŸ
ããããå°R1MXâ²ãšããŠMâ²ãæ°ŽçŽ ååã瀺ãå
åç©ãçšããå Žåãåå¿ç³»å ã«é žã¹ã«ãã³ãžã€ãŒ
äŸãã°ããªãšãã«ã¢ãã³ãååšãããã®ãããã äžèšæ¹æ³ã«ãããäºã€ã®æ®µéã¯åäžæº¶åªäžã§å®¹
æã«é²è¡ãã第ïŒæ®µéã§çæããäžè¬åŒïŒïŒã®
é žã¯ãã©ã€ãã¯ç¹ã«åé¢ããå¿ èŠã¯ãªããäžè¬åŒ
ïŒïœïŒã®ååç©ã®è£œé ã®ä»ã®å¥œãŸããæ æ§ã«ã
ããŠã¯ãäžèšããäžè¬åŒïŒïŒã®17αâãããã
ã·â17βâã«ã«ãã³é žãšã¹ãã«ãçšãããããã
ã®æ¹æ³ã«ããã°äžè¬åŒïŒïŒã®äžéäœããé©åœãª
ææ©æº¶åªäŸãã°ãã«ãšã³ããã³ãŒã³ãCH2Cl2å
ã¯ã¢ã»ããããªã«äžãäœæž©ïŒâ20âä¹è³å®€æž©ã奜
ãŸããã¯ïŒâä»è¿ïŒäžã«çŽïŒæéïŒåã¯åå¿ãå®
çµãããŸã§ïŒããã¹ã²ã³ãšåå¿ãããã溶åªåã³
éå°éã®ãã¹ã²ã³ãçå»ããŠææã®æ°èŠãª17αâ
ã¯ããã«ã«ããã«ãªãã·â17βâã«ã«ãã³é žãšã¹
ãã«äžéäœãåŸããããããã¯äžèšäžè¬åŒïŒïŒ
ã§è¡šããããã ãåŒäžR1ãR4ãR5åã³ïŒ¡ç°ã¯äžèšã«åããR3â³ã¯
æ°ŽçŽ ååãαâã¡ãã«ãβâã¡ãã«åã¯Î±â
OCOClåºã瀺ã åºçºåæãšããäžè¬åŒïŒïŒã®ååç©ã®R3â²ã
ããããã·åºã§ããå Žåã16âäœåã³17âäœãžã®
ã¯ããã«ã«ããã«ãªãã·åºã®åœ¢æã確å®ãªãã®ãš
ããããã«å åéã®ãã¹ã²ã³ãéåžžçšãããã
ïŒå³ã¡äžè¬åŒïŒïŒã®R3â²ãαâOHã§ããå Žåã
åŸãããäžè¬åŒïŒïŒã®äžééäœã«ãããR3â³ã¯
αâOCOClåºã§ããïŒãäžè¬åŒïŒïŒã®äžéäœ
ãã次ãã§äžæŽ»æ§æº¶åªäžã奜ãŸããã¯é žã¹ã«ãã³
ãžã€ãŒäŸãã°ããªãšãã«ã¢ãã³ã®ååšäžã«
R2OMâ²ã§ç€ºãããååç©ãšåå¿ãããŠã察å¿ã
ãäžè¬åŒïŒïŒã®ååç©ãåŸããR2OMâ²ãšããŠ
R2OHã§ç€ºãããã¢ã«ã³ãŒã«ãçšããå Žåãåå¿
æ¹æ³ã¯äžè¿°ããååç©ïŒïŒããååç©ïŒïŒã®
åå¿ãšåæ§ã§ããããŸãR2OMâ²ãšããŠR2OMã§
瀺ãããååç©ãçšããå Žåãåå¿æ¹æ³ã¯äžè¿°ã
ãååç©ïŒïŒããååç©ïŒïœïŒã®åå¿ãšåæ§
ã§ãããäžè¬åŒïŒïŒã®ååç©ã«ãããR3â³ã
OCOClåºã®å Žåãéåžžå åéã®R2OMâ²ãçšãã
ãã16âåã³17αâ眮æåºã®äž¡è å ±OCOOR2åºã«
å€æãããããŸããã®åæå·¥çšã®æçµæ®µéãšããŠ
éåžžäžè¬åŒïŒïœïŒã®16âããããã·åã³ã¹ã«ã
ã€ãã«âåã³ã¹ã«ããã«âåºå«æååç©ãçæã
ãã äžèšæ¹æ³ã®å€æ³ãšããŠãã¹ããã€ãæ³17αâã
ãããã·â17βâã«ã«ãã³é žïŒäžè¬åŒïŒïŒã®åº
çºåæïŒãäžèšããããã«ãã¹ã²ã³ãšåå¿ããã
ããšãã§ããããã«ããäžåŒã§è¡šãããã17αâ
ã¯ããã«ã«ããã«ãªãã·â17βâã«ã«ãã³é žäžé
äœãååŸã§ããã ãåŒäžR3â³ãR4ãR5åã³ïŒ¡ç°ã¯äžèšã«åããã ããã次ãã§åè¿°ããããã«R2OMâ²ãšåå¿ã
ããŠã察å¿ããäžè¬åŒïŒïŒã®ååç©ãåŸããã
ã®æ°èŠãªäžéäœã¯æ¬¡ãã§å¯Ÿå¿ããäžè¬åŒïŒïœïŒ
ã®ååç©ã«å€æã§ãããã¹ã«ãã€ãã«åã³ã¹ãã
ã«èªå°äœãæçµå·¥çšã§è£œé ã§ããã äžè¬åŒïŒïœïŒã®ååç©ã補é ããããã®ä»ã®
ã²ãšã€ã®æ¹æ³ã§ã¯ãäžèšäžè¬åŒïŒïŒã®17αâã
ãããã·â17βâã«ã«ãã³é žãšã¹ãã«ãçšããã
ãã®æ¹æ³ã«ããã°äžè¬åŒïŒïŒã®äžéäœããåŒ
ãŸãã矀ã®ååç©ã®ããããšåãã§ãããã®ã§ã
ãã äžèšäžã€çŸ€ã®å矀ã«ãããŠãæã奜é©ãªååç©
ã¯ããβâããããã·ã¡ãã¬ã³åºã§ãããR2
ãC1-6ã¢ã«ãã«åºïŒç¹ã«ã¡ãã«ããšãã«ãããã
ã«åã¯ã€ãœãããã«åºïŒã§ããããŸãR1ãC1-6
ã¢ã«ãã«åºãã¢ãããâC1-6ã¢ã«ãã«åºïŒç¹ã«ã¯
ããã¡ãã«åºïŒåã¯âCH2ââïŒC1-6ã¢ã«ãã«ïŒ
åºïŒäœãã¯äžè¿°ããåºãç¹ã«C1-6ã¢ã«ãã«ãã¡
ãã«åºïŒã®ãã®ã§ããã äžè¬åŒïŒïŒã§è¡šããããååç©ã¯ãéåžžå ¬ç¥
ã®æ¹æ³ã«æºããŠè£œé ãããããã®æ¹æ³ã¯ææã®æ
çµååç©ã®å皮眮æåºã«å¿ããŠé©å®éžæãããã äžèšäžè¬åŒïŒïŒã§è¡šããããæ¬çºæååç©ã®
ãã¡ãäžè¬åŒ ãåŒäžãR1ãR2ãR3ãR4ãR5åã³ïŒ¡ç°ã®ç¹ç·ã¯
äžèšã«åããã ã§è¡šããããååç©ã®è£œé ã¯ãäŸãã°ãã¹ããã€
ãæ§åºçºåæãšããŠäžèšäžè¬åŒïŒïŒã§è¡šããã
ãååç©ãçšããŠè¡ãªãããã ãåŒäžR4ãR5åã³ïŒ¡ç°ã®ç¹ç·ã¯äžèšã«åãã
R3â²ã¯æ°ŽçŽ ååãαâã¡ãã«ãβâã¡ãã«åã¯Î±
âOHåºã瀺ãã äžèšäžè¬åŒïŒïŒã§è¡šããããååç©ã¯ãéåžž
察å¿ããäžè¬åŒ ãåŒäžR4ãR5ãR3â²åã³ïŒ¡ç°ã®ç¹ç·ã¯äžèšã«å
ããã ã§è¡šãããã21âããããã·ãã¬ã°ãããã³é¡
ïŒ21âhydroxypregnenolonesïŒãé©åœãªææ©æº¶åª
äžå®€æž©ãããã¯ãã以äžã®æž©åºŠäžã«NaIO4ã§åŠç
ããããšã«ããåŸãããã æ¬çºæã®äžèšæ¹æ³ã«ãããŠã¯ãäžè¬åŒïŒïŒã§
è¡šããããåºçºååç©ããç¡æ°Žæ¡ä»¶äžãé©åœãªäž
掻æ§æº¶åªäŸãã°ãžã¯ããã¡ã¿ã³ãã¯ãããã«ã å
ã¯ããã©ããããã©ã³çã®æº¶åªäžã§ãR2OCOCl
åã¯R2OCOBrïŒR2OHãšCOCl2åã¯COBr2ãšã®å
å¿ã«ããåŸããããR2ã¯äžèšã«åãïŒã§è¡šãã
ããååç©ãšåå¿ããããäžèšåå¿ã¯ã奜ãŸãã
ã¯é©åœãªé žå容äœäŸãã°ããªãšãã«ã¢ãã³ãããª
ãžã³ãçé žã«ã«ã·ãŠã åã¯ä»ã®é©åœãªå¡©åºã®ååš
äžã«è¡ãªããããåå¿æéåã³æž©åºŠã¯ç¹ã«å¶éã¯
ãªãããéåžžåå¿ã¯çŽïŒâä¹è³å®€æž©äžçŽïŒãïŒæ
éã§æå©ã«è¡ãªããããåŸãããæ°èŠãª17βâã«
ã«ãã³é žâ17αâã«ã«ãããŒãã¯äžèšäžè¬åŒ
ïŒïŒã§è¡šããããã ãåŒäžR2ãR3ãR4ãR5åã³ïŒ¡ç°ã®ç¹ç·ã¯äžèšã«
åããã äžè¬åŒïŒïŒã§è¡šããããåºçºåæãšããŠ
R3â²ãαâOHã®ãã®ãçšããå Žåãå åéã®
R2OCOClåã¯R2OCOBrãçšããããšã«ããã16
âäœåã³17âäœã®ã«ã«ãããŒãã®åœ¢æã確å®ãšãª
ãïŒå³ã¡äžè¬åŒïŒïŒã«ãããR3â²ãOHã®å Žåã
åŸãããäžè¬åŒïŒïŒã®äžéäœã«åããR3ã¯Î±
âOCOOR6ã§ããïŒã äžèšããããã«17αâ眮æåºãå°å ¥åŸãåŸãã
ãäžè¬åŒïŒïŒã§è¡šããããæ°èŠãªäžéäœã¯ã次
ãã§ãã®å¯Ÿå¿ããéå±å¡©ã«å€æãããã該éå±å¡©
ã¯äžèšäžè¬åŒïŒïŒã§è¡šããããã ãåŒäžR2ãR3ãR4ãR5åã³ïŒ¡ç°ã®ç¹ç·ã¯äžèšã«
åããïŒã¯éå±äŸãã°ãããªãŠã ãã«ãªãŠã çã®
ã¢ã«ã«ãªéå±ã1/2ã¢ã«ã«ãªåé¡éå±åã¯ã¿ãªãŠ
ã æã¯NH4ã瀺ãã äžèšäžè¬åŒïŒïŒã®æ°èŠãªå¡©ã¯ãäŸãã°äžè¬åŒ
ïŒïŒã®ã¹ããã€ããšæ°Žé žåç©ïŒMOHïŒåã¯ã¢
ã«ã³ãã·ãïŒMORïŒãšããé©åœãªææ©æº¶åªäŸã
ã°ãšãã«ãšãŒãã«åã¯ããã©ããããã©ã³äžã§ã
ïŒâä¹è³å®€æž©äžã«çŽ0.5ãïŒæéåå¿ãããããš
ã«ããåŸãããã ããããŠåŸãããäžè¬åŒïŒïŒã®å¡©ãã次ãã§
äžè¬åŒR1âïŒåŒäžR1ã¯äžèšã«åããã¯ããã²
ã³ååã瀺ãïŒã§è¡šããããååç©ãšåå¿ããã
ããšã«ããã察å¿ããææã®äžè¬åŒïŒïœïŒã§è¡š
ããããæ¬çºæååç©ãååŸã§ãããäžèšåå¿å·¥
çšã¯ãé垞宀枩äžã«çŽïŒã24æéã§ãåã¯æº¶åªäŸ
ãã°ã¢ã»ããããªã«ãããã©ããããã©ã³çã®æ²ž
隰枩床äžã«è¡ãªãããã äžèšã¹ããã€ãã®R1ãšããŠã¢ãããâC1-6ã¢
ã«ãã«åºãå°å ¥ãããå ŽåãäŸãã°äžè¬åŒïŒïŒ
äžã®R1ãã¯ããã¡ãã«åºã§ããååç©ãææã
ãå Žåã溶åªãšããŠãããµã¡ãã«ãªã³é žã¢ããã
çšããäœã枩床ïŒïŒâ10âïŒã§äžã€R1â詊è¬
ãšããŠïŒ·ãæ²çŽ ååã®ãã®äŸãã°ãšãŒãã¯ããã¡
ã¿ã³ãçšããããšã«ãããåå¿ã¯å®¹æã«é²è¡ãã
ããšãå€ã€ãããŸãããã²ã³ãå«ãŸãªãR1åºã
æãŸããå ŽåãäŸãã°R1ãã¢ã«ãã«åã¯â
CH2COOR6ïŒR6ã¯äžèšã«åãïŒã§ããå Žåãäžèš
ã®åŠã溶åªåã³R1â詊è¬ã®äœ¿çšå¶éã¯äžå¿ èŠ
ã§ãããäžèšïŒ·ã¯åçš®ã®ããã²ã³ã§ãã€ãŠãã
ïŒå¥œãŸããã¯å¡©çŽ ãããã¯èçŽ ååïŒãŸãéåžžã®
ææ©æº¶åªäŸãã°ãžã¡ãã«ãã«ã ã¢ããããžã¯ãã
ã¡ã¿ã³ãã¢ã»ããããªã«ãããã©ããããã©ã³ã
ã¯ãããã«ã çããå¿ èŠã«å¿ããããµã¡ãã«ãªã³
é žã¢ããã«ä»£æ¿äœ¿çšã§ãããæŽã«R1ãã¹ã«ãã€
ãã«åã¯ã¹ã«ããã«åºã§ããäžè¬åŒïŒïœïŒã®å
åç©ãæãŸããå Žåãä¹çã®åºã¯éåžžR1âã
çšããåå¿ã§ã¯å°å ¥ã§ãããåŒãç¶ãåŸè¿°ããã
ãã«å¯Ÿå¿ããããªã¹ããã€ããã補é ãããã R1ãã¹ã«ãã€ãã«åã¯ã¹ã«ããã«åºå«æåºã§
ããäžè¬åŒïŒïœïŒã®ååç©ã¯ã察å¿ããããªã¹
ããã€ãã®é žåã«ãã補é ããããšãã§ãããäŸ
ãã°ãäžè¬åŒ ãåŒäžãR2ãR3ãR4ãR5åã³ïŒ¡ç°ã®ç¹ç·ã¯äžèš
ã«åããR8ã¯âCH2SâïŒC1-6ã¢ã«ãã«åºïŒåºã
瀺ãããã§è¡šããããååç©ããïœâã¯ããéå®
æ¯éŠé žã®ïŒåœéãšãïŒã25âäžïŒã24æéãé©åœ
ãªæº¶åªäŸãã°ã¯ãããã«ã äžã§åå¿ãããããšã«
ãããR1ãâCH2âSOâïŒC1-6ã¢ã«ãã«ïŒåºã§ã
ãäžè¬åŒïŒïœïŒã®ååç©ãåŸãããšãã§ããã
ãŸãäžèšã«ãããŠïœâã¯ããéå®æ¯éŠé žã®ïŒåœé
ãçšããã°ãR1ãâCH2âSO2âïŒC1-6ã¢ã«ãã«ïŒ
åºã§ããäžè¬åŒïŒïœïŒã®ååç©ãååŸã§ããã äžè¬åŒïŒïœïŒã®ååç©ã®ä»ã®è£œé æ¹æ³ã«ãã
ãŠã¯ãäžèšåæå·¥çšã§çšãããšåäžã®äžè¬åŒ
ïŒïŒã§è¡šãããã17αâããããã·â17βâã«ã«
ãã³é žãåºçºåæãšããŠå©çšã§ãããããã®æ¹æ³
ã¯17αâOCOOR2眮æåºã®å°å ¥ã«å ç«ã€ãŠåã¯ã
ãããã®åŸã«17βâCOOR1åºã®åœ¢æãè¡ãªãã
ããååºã®å°å ¥ã«ã¯ãåºæ¬çã«ã¯äžèšãããšåäž
ã®éâã¹ããã€ãæ§è©Šè¬ãåå¿æ¡ä»¶çãæ¡çšãã
ããããããŠäžè¬åŒïŒïŒã®åºçºåæããŸã
MOHåã¯MORãšåå¿ãããŠäžèšäžè¬åŒïŒïŒ
ã§è¡šãããã察å¿ããäžéäœãåŸãã ãåŒäžR4ãR5ãR3â²ãïŒåã³ïŒ¡ç°ã®ç¹ç·ã¯äžèšã«
åãã 該äžéäœã次ãã§R1WïŒR1åã³ïŒ·ã¯äžèšã«å
ãïŒã§è¡šããããååç©ãšåå¿ãããŠãäžåŒã§è¡š
ãããã察å¿ãã17βâã«ã«ãã³é žãšã¹ãã«ãåŸ
ãã ãåŒäžR1ãR3â²ãR4ãR5åã³ïŒ¡ç°ã®ç¹ç·ã¯äžèšã«
åããã äžèšååç©ã次ãã§R2OCOClåã¯R2OCOBr
ïŒR2ã¯äžèšã«åãïŒãšåå¿ãããããšã«ããäžè¬
åŒïŒïœïŒã§è¡šãããã察å¿ãã17αâã«ãŒãã
ãŒããååŸã§ããã ååç©ïŒïŒããååç©ïŒïŒã«è³ãåå¿ã®å
çš®æ¡ä»¶ã¯ãäžè¿°ããååç©ïŒïŒããååç©
ïŒïŒã«è³ãåå¿ã®ãããšåãã§ãããåæ§ã«å
åç©ïŒïŒãååç©ïŒïŒã«å€æããåå¿ã®æ¡ä»¶
çã¯ãååç©ïŒïŒãäžè¬åŒïŒïœïŒã«å€æãã
åå¿ã®ããããšåäžã§ãããäžèšã«è©³è¿°ããéã
ã§ããããŸãååç©ïŒïŒãäžè¬åŒïŒïœïŒã«å€
ããåå¿ã®æ¡ä»¶çããååç©ïŒïŒãååç©
ïŒïŒã«å€ããåå¿ã®ããããšå®è³ªçã«åäžã§ã
ããç¹°ãè¿ãã°16âããããã·åºãå«æããåºçº
åæãçšããå Žåãäžè¬åŒïŒïœïŒã®16ïŒ17âãž
ã«ãŒãããŒããçæããããã¯æ¬¡ãã§å¿ èŠãªãã°
éžæçã«å æ°Žå解ãããŠå¯Ÿå¿ããäžè¬åŒïŒïœïŒ
ã®16âããããã·â17âã«ãŒãããŒãã«å€æãã
åŸãããŸãR1ãã¹ã«ãã€ãã«âåã¯ã¹ã«ããã«
âå«æåºã§ããäžè¬åŒïŒïœïŒã®ååç©ã¯ãéåžž
察å¿ããäžè¬åŒïŒïœïŒã®ããªåºå«æååç©ã®é ž
åã«ããåŸããããã®è©³çŽ°ã¯åèšããéãã§ã
ããæŽã«R1ãã¹ã«ãã€ãã«âåã¯ã¹ã«ããã«â
å«æåºïŒäŸãã°R1ãâCH2âSOâïŒC1-6ã¢ã«ã
ã«ïŒåã¯âCH2âSO2âïŒC1-6ã¢ã«ãã«ïŒåºïŒã§
ããäžè¬åŒïŒïœïŒã®ååç©ã¯ãR1ãããªâå«
æåºã§ãã察å¿ããäžè¬åŒïŒïŒã®ååç©ã®é žå
åå¿ã奜ãŸããã¯ïœâã¯ããéå®æ¯éŠé žãçšãã
é žååå¿åã³ããã«åŒãç¶ãåŸãããã¹ã«ãã€ã
ã«åã¯ã¹ã«ããã«ååç©ãžã®17αâOCOOR2眮æ
åºå°å ¥åå¿ã«ããååŸãããã äžè¬åŒïŒïœïŒã§è¡šããããæ¬çºæååç©ã®ä»
ã®è£œé æ¹æ³ã«ãããŠã¯ãäžèšäžè¬åŒïŒïŒã®17β
âã«ã«ãã³é žâ17αâã«ãŒãããŒãäžéäœãçšã
ãããããã®æ¹æ³ã«ããã°ãäžè¬åŒïŒïŒã®äžé
äœããŸãæž©åãªå¡©åã¢ã·ã«åœ¢æè©Šè¬äŸãã°ãžãšã
ã«ã¯ãããªã³é žåã¯å¡©åãªããµãªã«ã§åŠçãã
ãŠãäžèšäžè¬åŒïŒïŒã§è¡šãããã察å¿ããæ°èŠ
ãªé žã¯ãã©ã€ããçæããã ãåŒäžR2ãR3ãR4ãR5åã³ïŒ¡ç°ã®ç¹ç·ã¯äžèšã«
åããã äžèšé žã¯ãã©ã€ãã¯åŒãç¶ãR1XMâ²ïŒåŒäžR1å
ã³ïŒžã¯äžèšã«åããMâ²ã¯æ°ŽçŽ åååã¯äžèšïŒã
瀺ãïŒãçšããŠãäžæŽ»æ§æº¶åªäŸãã°CHCl3ã
THFãã¢ã»ããããªã«åã¯DMFäžãçŽïŒâä¹è³
溶åªã®æ²žç¹æž©åºŠç¯å²ã§çŽïŒãïŒæéåŠçãããã
ãã«ãã察å¿ããäžè¬åŒïŒïœïŒã®ååç©ãååŸ
ããããå°R1MXâ²ãšããŠMâ²ãæ°ŽçŽ ååã瀺ãå
åç©ãçšããå Žåãåå¿ç³»å ã«é žã¹ã«ãã³ãžã€ãŒ
äŸãã°ããªãšãã«ã¢ãã³ãååšãããã®ãããã äžèšæ¹æ³ã«ãããäºã€ã®æ®µéã¯åäžæº¶åªäžã§å®¹
æã«é²è¡ãã第ïŒæ®µéã§çæããäžè¬åŒïŒïŒã®
é žã¯ãã©ã€ãã¯ç¹ã«åé¢ããå¿ èŠã¯ãªããäžè¬åŒ
ïŒïœïŒã®ååç©ã®è£œé ã®ä»ã®å¥œãŸããæ æ§ã«ã
ããŠã¯ãäžèšããäžè¬åŒïŒïŒã®17αâãããã
ã·â17βâã«ã«ãã³é žãšã¹ãã«ãçšãããããã
ã®æ¹æ³ã«ããã°äžè¬åŒïŒïŒã®äžéäœããé©åœãª
ææ©æº¶åªäŸãã°ãã«ãšã³ããã³ãŒã³ãCH2Cl2å
ã¯ã¢ã»ããããªã«äžãäœæž©ïŒâ20âä¹è³å®€æž©ã奜
ãŸããã¯ïŒâä»è¿ïŒäžã«çŽïŒæéïŒåã¯åå¿ãå®
çµãããŸã§ïŒããã¹ã²ã³ãšåå¿ãããã溶åªåã³
éå°éã®ãã¹ã²ã³ãçå»ããŠææã®æ°èŠãª17αâ
ã¯ããã«ã«ããã«ãªãã·â17βâã«ã«ãã³é žãšã¹
ãã«äžéäœãåŸããããããã¯äžèšäžè¬åŒïŒïŒ
ã§è¡šããããã ãåŒäžR1ãR4ãR5åã³ïŒ¡ç°ã¯äžèšã«åããR3â³ã¯
æ°ŽçŽ ååãαâã¡ãã«ãβâã¡ãã«åã¯Î±â
OCOClåºã瀺ã åºçºåæãšããäžè¬åŒïŒïŒã®ååç©ã®R3â²ã
ããããã·åºã§ããå Žåã16âäœåã³17âäœãžã®
ã¯ããã«ã«ããã«ãªãã·åºã®åœ¢æã確å®ãªãã®ãš
ããããã«å åéã®ãã¹ã²ã³ãéåžžçšãããã
ïŒå³ã¡äžè¬åŒïŒïŒã®R3â²ãαâOHã§ããå Žåã
åŸãããäžè¬åŒïŒïŒã®äžééäœã«ãããR3â³ã¯
αâOCOClåºã§ããïŒãäžè¬åŒïŒïŒã®äžéäœ
ãã次ãã§äžæŽ»æ§æº¶åªäžã奜ãŸããã¯é žã¹ã«ãã³
ãžã€ãŒäŸãã°ããªãšãã«ã¢ãã³ã®ååšäžã«
R2OMâ²ã§ç€ºãããååç©ãšåå¿ãããŠã察å¿ã
ãäžè¬åŒïŒïŒã®ååç©ãåŸããR2OMâ²ãšããŠ
R2OHã§ç€ºãããã¢ã«ã³ãŒã«ãçšããå Žåãåå¿
æ¹æ³ã¯äžè¿°ããååç©ïŒïŒããååç©ïŒïŒã®
åå¿ãšåæ§ã§ããããŸãR2OMâ²ãšããŠR2OMã§
瀺ãããååç©ãçšããå Žåãåå¿æ¹æ³ã¯äžè¿°ã
ãååç©ïŒïŒããååç©ïŒïœïŒã®åå¿ãšåæ§
ã§ãããäžè¬åŒïŒïŒã®ååç©ã«ãããR3â³ã
OCOClåºã®å Žåãéåžžå åéã®R2OMâ²ãçšãã
ãã16âåã³17αâ眮æåºã®äž¡è å ±OCOOR2åºã«
å€æãããããŸããã®åæå·¥çšã®æçµæ®µéãšããŠ
éåžžäžè¬åŒïŒïœïŒã®16âããããã·åã³ã¹ã«ã
ã€ãã«âåã³ã¹ã«ããã«âåºå«æååç©ãçæã
ãã äžèšæ¹æ³ã®å€æ³ãšããŠãã¹ããã€ãæ³17αâã
ãããã·â17βâã«ã«ãã³é žïŒäžè¬åŒïŒïŒã®åº
çºåæïŒãäžèšããããã«ãã¹ã²ã³ãšåå¿ããã
ããšãã§ããããã«ããäžåŒã§è¡šãããã17αâ
ã¯ããã«ã«ããã«ãªãã·â17βâã«ã«ãã³é žäžé
äœãååŸã§ããã ãåŒäžR3â³ãR4ãR5åã³ïŒ¡ç°ã¯äžèšã«åããã ããã次ãã§åè¿°ããããã«R2OMâ²ãšåå¿ã
ããŠã察å¿ããäžè¬åŒïŒïŒã®ååç©ãåŸããã
ã®æ°èŠãªäžéäœã¯æ¬¡ãã§å¯Ÿå¿ããäžè¬åŒïŒïœïŒ
ã®ååç©ã«å€æã§ãããã¹ã«ãã€ãã«åã³ã¹ãã
ã«èªå°äœãæçµå·¥çšã§è£œé ã§ããã äžè¬åŒïŒïœïŒã®ååç©ã補é ããããã®ä»ã®
ã²ãšã€ã®æ¹æ³ã§ã¯ãäžèšäžè¬åŒïŒïŒã®17αâã
ãããã·â17βâã«ã«ãã³é žãšã¹ãã«ãçšããã
ãã®æ¹æ³ã«ããã°äžè¬åŒïŒïŒã®äžéäœããåŒ
ãåŒãïŒããã¯ãã¹ã²ã³ãšïŒåœéã®
R2OHãšããåžžæ³ã«ãã補é ãããïŒã®ã«ãŒãã
ãŒãã®éå°éãšãé žè§Šåªã®ååšäžã«åå¿ãããŠã
察å¿ããäžè¬åŒïŒïŒã®ååç©ãåŸããR2ã®æ§
質ã«å¿ããŠã
ãŒãã®éå°éãšãé žè§Šåªã®ååšäžã«åå¿ãããŠã
察å¿ããäžè¬åŒïŒïŒã®ååç©ãåŸããR2ã®æ§
質ã«å¿ããŠã
ãåŒãè©Šè¬ã¯ãŸãã«ãŒãã
ãŒãè©Šè¬ã®æ²žç¹ã§ã®åã¯å¯Ÿå¿ããR2OHã®æ²žç¹ã§
ã®æº¶åªãšããŠãæ©èœãã該R2OHã¯åå¿æ··åç©ã
ãéåžžé€å»ãããŠåå¿ãå®çµããåŸãããŸãäžèš
è©Šè¬ã¯é©åœãªäžæŽ»æ§ææ©æº¶åªäŸãã°ãã³ãŒã³ãã
ã«ãšã³çã®è³éŠæçåæ°ŽçŽ ããžã¯ããã¡ã¿ã³ãã¯
ãããã«ã çã®ããã²ã³åçåæ°ŽçŽ çãšäœµçšãã
ãŠãããããŸããã®æ¹æ³ã®æçµå·¥çšãšããŠäžè¬åŒ
ïŒïœïŒã®ã¹ã«ãã€ãã«åã³ã¹ã«ããã«ååç©ã
é垞補é ããããããã¯R1ãç¡«é»ååãå«ãäž
è¬åŒïŒïŒã®äžéäœããŸãé žååå¿ããã次ãã§
åŸãããäžè¬åŒïŒïŒã®ã¹ã«ãã€ãã«åã¯ã¹ã«ã
ãã«ååç©ã
ã®æº¶åªãšããŠãæ©èœãã該R2OHã¯åå¿æ··åç©ã
ãéåžžé€å»ãããŠåå¿ãå®çµããåŸãããŸãäžèš
è©Šè¬ã¯é©åœãªäžæŽ»æ§ææ©æº¶åªäŸãã°ãã³ãŒã³ãã
ã«ãšã³çã®è³éŠæçåæ°ŽçŽ ããžã¯ããã¡ã¿ã³ãã¯
ãããã«ã çã®ããã²ã³åçåæ°ŽçŽ çãšäœµçšãã
ãŠãããããŸããã®æ¹æ³ã®æçµå·¥çšãšããŠäžè¬åŒ
ïŒïœïŒã®ã¹ã«ãã€ãã«åã³ã¹ã«ããã«ååç©ã
é垞補é ããããããã¯R1ãç¡«é»ååãå«ãäž
è¬åŒïŒïŒã®äžéäœããŸãé žååå¿ããã次ãã§
åŸãããäžè¬åŒïŒïŒã®ã¹ã«ãã€ãã«åã¯ã¹ã«ã
ãã«ååç©ã
ãåŒããšåå¿ãããããšã«
ããåŸãããã
éžæãããäžè¬åŒïŒïœïŒã®ååç©ã補é ãã
ããã®ä»ã®ã²ãšã€ã®æ¹æ³ã¯ãéåžžã®æ¹æ³ã«ããè¡
ãªãåŸããäŸãã°R1åã¯R2ãããã²ã³çœ®æã®äž
è¬åŒïŒïœïŒã®ååç©ã¯ã該ããã²ã³ãä»ã®ãã
ã²ã³ã«çœ®æããããã®ããã²ã³äº€æåå¿ã«äŸãã
ããšãã§ããã該åå¿ã®åå¿æ§ã¯ClïŒBrïŒïŒ©ã®
é ã§ããããŸãäŸãã°äžè¬åŒïŒïœïŒã®17βâã«
ã«ãã³é žã¯ããã¢ã«ãã«ãšæ²åã¢ã«ã«ãªéå±äŸã
ã°æ²åãããªãŠã ãšã®åå¿ã«ããã°å¯Ÿå¿ãã17β
âã«ã«ãã³é žãšãŒãã¢ã«ãã«ãååŸã§ãããåæ§
ã«ããã åå¡©äŸãã°èåãªããŠã ã17βâã«ã«ã
ã³é žã¯ããã¢ã«ãã«ãšåå¿ãããããšã«ãã察å¿
ãã17βâã«ã«ãã³é žããã¢ã¢ã«ãã«ãååŸã§ã
ããäžèšååå¿ã«å¥œé©ãªæº¶åªã¯ãããµã¡ãã«ãªã³
é žã¢ãããã¢ã»ãã³ããšã¿ããŒã«ãã¡ãã«ãšãã«
ã±ãã³ããžã¡ãã«ã¢ã»ãã¢ããããžã¡ãã«ãã«ã
ã¢ããåã³ã¢ã»ããããªã«ããæã矀ããé©å®éž
æãããã åæ§ã«ããŠçžå¯Ÿç溶解æ§ã«åºã¥ãããã²ã³äº€æ
åå¿ã«ãã€ãŠãäžè¬åŒïŒïœïŒã®17βâã«ã«ãã³
é žã¯ããã¢ã«ãã«åã¯17βâã«ã«ãã³é žãšãŒãã¢
ã«ãã«ã察å¿ãããã«ãªãã¢ã«ãã«èªå°äœã«å€æ
ã§ããããã®åå¿ã«ã¯åŒåéãçšãããããŸãé©
åœãªææ©æº¶åªäŸãã°ã¢ã»ããããªã«äžã§è¡ãªãã
ãããã®åå¿ã¯ç¹ã«R1ããã«ãªãã¡ãã«åã¯ã
ã«ãªããšãã«åºã§ããååç©ã®è£œé ã«æå©ã§ã
ãã äžè¬åŒïŒïŒã®ã¹ããã€ãæ§åºçºåæã補é ã
ãããã®21âããããã·ãã¬ã°ãããã³é¡ã¯ãå
æ¥çã«å ¥æã§ãããåã¯å ¬ç¥ã®æ¹æ³ã«ãã補é ã§
ãããåæ§ã«äžè¿°ããåçš®æ¹æ³ã«å©çšãããéâ
ã¹ããã€ãæ§åºçºåæãåæ¥çã«å ¥æã§ãããåžž
æ³ã«ãã補é ã§ããã ãŸããäžè¬åŒïŒïŒã®åºçºåæãäžè¬åŒ
R2OCOClåã¯R2OCOBrïŒR2ã¯äžèšã«åãïŒã®å
åç©ãšåå¿ãããããšã«ãã€ãŠãäžåŒã§è¡šããã
ãäžéäœãååŸã§ããã ãåŒäžR2ãR3â²ãR4ãR5åã³ïŒ¡ç°ã®ç¹ç·ã¯äžèšã«
åãã äžèšååç©ïŒXIïŒãåé¢ãããåã¯åé¢ããã
ãšãªã次ãã§éšåçå æ°Žå解ããŠã察å¿ããäžè¬
åŒïŒïŒã®äžéäœã«å€æããã äžè¬åŒïŒïŒã®åºçºåæãšR2OCOClåã¯
R2OCOBrãšã®åå¿ã¯ãäžèšããäžè¬åŒïŒïŒã®
ååç©ãšR2OCOClåã¯R2OCOBrãšã®åå¿ãšåäž
æ¡ä»¶äžã«è¡ãªããããäœãäžè¬åŒïŒïŒã®åºçºå
æïŒã¢ã«ã«å¯ŸãR2OCOClåã¯R2OCOBrã¯ïŒã¢ã«
åã¯ãã以äžçšãããããåŸãããäžè¬åŒïŒXIïŒ
ã®åå¿çæç©ã®éšåçå æ°Žå解ã¯ãäžæŽ»æ§æº¶åªäž
觊åªã®ååšäžã«è¡ãªããããé©åœãªè§ŠåªãšããŠã¯
ããªãšãã«ã¢ãã³ãããªã¡ãã«ã¢ãã³çã®ã¢ã«ã
ã«ç¬¬ïŒçŽã¢ãã³ïŒããªãžã³ãïŒïŒïŒâãžã¡ãã«ã¢
ããããªãžã³ããããªã³çã®è³éŠæã¢ãã³ïŒãžãš
ãã«ã¢ãã³ããžã¡ãã«ã¢ãã³çã®ã¢ã«ãã«ç¬¬ïŒçŽ
ã¢ãã³ïŒæ°Žé žåãããªãŠã ãæ°Žé žåã«ãªãŠã ãé
çé žã«ãªãŠã çã®ç¡æ©å¡©åºçãå©çšã§ããã奜ãŸ
ããã¯ããªãžã³åã³éçé žã«ãªãŠã ã䜿çšã§ã
ããäžæŽ»æ§æº¶åªãšããŠã¯ãæ°ŽïŒãšã¿ããŒã«ãã¡ã¿
ããŒã«çã®äœçŽã¢ã«ã³ãŒã«é¡ïŒãžã¡ãã«ãšãŒã
ã«ããžãšãã«ãšãŒãã«ããžã¡ããã·ãšã¿ã³ããžãª
ããµã³ãããã©ããããã©ã³çã®ãšãŒãã«é¡ïŒãž
ã¯ããã¡ã¿ã³ãã¯ãããã«ã çã®ããã²ã³åçå
æ°ŽçŽ é¡ïŒããªãžã³ãããªãšãã«ã¢ãã³çã®ç¬¬ïŒçŽ
ã¢ãã³é¡ïŒåã¯ä¹çã®ïŒãããã¯ãã以äžã®æ··å
溶åªçãçšãåŸããåå¿ã¯éåžžçŽïŒã100âã奜
ãŸããã¯å®€æž©ã50âã®æž©åºŠäžïŒã48æéã奜ãŸã
ãã¯ïŒãïŒæéãèŠããŠè¡ãªãããã æ¬çºæã¯ãŸãäžåŒã§è¡šããããæ°èŠãªååç©ã
ãæäŸãããã®ã§ããã ãåŒäžR1ãR2ãR3ãR4ãR5åã³ç°ïŒ¡ã«ãããç¹
ç·ã¯äžèšã«åãã äžèšäžè¬åŒïŒïœïŒã§è¡šãããã11âã±ãåå
ç©ã¯ã察å¿ããäžè¬åŒïŒïœïŒã®11βâãããã
ã·ååç©ã®è£œé ã«ã€ãåè¿°ããæ¹æ³ã«åŸã補é ã
ãããšãã§ãããäŸãã°11âã±ãåºãæãã察å¿
ããäžè¬åŒïŒïŒã®åºçºåæãR2OCOClåã¯
R2OCOBrãšåå¿ãããããšã«ããã11âã±ãåº
ãæããäžè¬åŒïŒïŒã«å¯Ÿå¿ããæ°èŠãªäžéäœã
åŸããããããã次ãã§ãã®éå±å¡©ã«å€æãã
ããããã¯11βâããããã·åºã«ä»£ã11âã±ãåº
ãæãã以å€ã¯äžè¬åŒïŒïŒã®ããã«çžåœããã
次ãã§äžèšéå±å¡©ãR1Wãšåå¿ãããããšã«ã
ãã察å¿ããäžè¬åŒïŒïœïŒã®ååç©ãåŸããäž
èšæ¹æ³ã«ããããã¹ãŠã®åå¿æ¡ä»¶ã¯ã察å¿ããäž
è¬åŒïŒïœïŒã®ååç©ã®è£œé ã«ã€ããŠåè¿°ãããš
ããã§ãããåæ§ã«R1ãã¹ã«ãã€ãã«âåã¯ã¹
ã«ããã«âå«æåºã§ããäžè¬åŒïŒïœïŒã®ååç©
ã®è£œé ã¯ã察å¿ããäžè¬åŒïŒïœïŒã®ååç©ã«ã€
ãæ¡çšããããšåæ§ã®æ¹æ³ã«ããããã®å·¥çšã®æ
çµæ®µéã§è¡ãªããããæŽã«äžè¬åŒïŒïœïŒã®åå
ç©ã®è£œé ã«ã€ãåè¿°ãããã¹ãŠã®å€æ³ã¯ããã®äž
è¬åŒïŒïœïŒã®ååç©ã®è£œé ã«ãé©çšã§ãããã
ã®å Žååã«çšãããã11βâããããã·ã¹ããã€
ãã«ä»£ã察å¿ãã11âãªããœåºçºåæãçšããã°
ãããäŸãã°äžè¬åŒïŒïŒãïŒïŒãïŒïŒãïŒïŒã
ïŒïŒåã³ïŒXIïŒã«ããã11âããããã·åºãã
11âãªããœåºã«å€ãã以å€ã¯ãåè¿°ããïŒïŒâ
ïŒïŒâïŒïŒâïŒïœïŒïŒïŒïŒâïŒïŒâïŒ
ïœïŒïŒïŒïŒâïŒïŒâïŒïœïŒïŒïŒïŒâïŒïŒâ
ïŒïœïŒïŒïŒïŒâïŒïœïŒçã®åå¿ãšåäžæäœã
æ¡çšã§ããã ãŸããäžè¬åŒïŒïœïŒã®ååç©ã¯ã察å¿ããäž
è¬åŒïŒïœïŒã®ååç©ãšé žåå€ãšãåå¿ãããã
ãšã«ãã€ãŠã補é ã§ãããäžè¬åŒïŒïœïŒã®åå
ç©ã察å¿ããäžè¬åŒïŒïœïŒã®ååç©ã«å€æãã
é žååå¿ã¯ãé©åœãªæº¶åªäžé žåå€ãçšããŠè¡ãªã
ããã溶åªãšããŠã¯éåžžã®ãã®äŸãã°æ°Žãææ©é ž
ïŒè»é žãé ¢é žãããªãã«ãªãé ¢é žçïŒãã¢ã«ã³ãŒã«
ïŒã¡ã¿ããŒã«ããšã¿ããŒã«çïŒãããã²ã³åçåæ°Ž
çŽ ïŒã¯ãããã«ã ããžã¯ããã¡ã¿ã³çïŒçãçšã
åŸããé žåå€ãšããŠãããããã·åºãã«ã«ããã«
åºã«é žåããéã«çšããããéåžžã®åçš®ã®ãã®ã
äŸãã°ã¯ããã¯ãã é žããªãžããŠã ãäžé žåã¯ã
ã âããªãžã³æ¶²ãéé žåæ°ŽçŽ ãäºã¯ãã é žãäºã¯
ãã é žå¡©ïŒäºã¯ãã é žãããªãŠã ãäºã¯ãã é žã«
ãªãŠã çïŒãéãã³ã¬ã³é žãéãã³ã¬ã³é žå¡©ïŒé
ãã³ã¬ã³é žãããªãŠã ãéãã³ã¬ã³é žã«ãªãŠã ïŒ
çãçšãåŸããé žåå€ã¯éåžžäžè¬åŒïŒïœïŒã®å
åç©ïŒã¢ã«ã«å¯ŸããŠïŒã¢ã«ä»¥äžã奜ãŸããã¯ïŒã
ïŒã¢ã«çšããããšãã§ãããåå¿ã¯éåžžïŒã40
âã奜ãŸããã¯å®€æž©ä»è¿ã®æž©åºŠäžã«çŽïŒã30æé
è¡ãªãããã äžè¬åŒïŒïœïŒã®æ°èŠååç©ã¯ãããèªäœæç
ç掻æ§ãæãããšå ±ã«ãçäœå ïŒã€ã³ããïŒåã¯
è©Šéšç®¡å ïŒã€ã³ãããïŒã«ãããŠã察å¿ãã11β
âããããã·ååç©ã®åé§äœãšããŠæçšã§ããã
該äžè¬åŒïŒïœïŒã®ååç©ã¯ãã€ã³ãããã«ãã
ãŠã11âãªããœåºã11βâããããã·åºã«éå ã
ãããã¹ããã€ãæ§ç©è³ªã®ä»ã®éšåã¯å€åãããª
ãé©åœãªå ¬ç¥ã®éå å€ãçšããŠãéå ããããäž
èšéå ãè¡ãªãã«ã¯ã埮çç©ã«ããéå ãæå©ã§
ããããååŠçéå ã亊å¯èœã§ãããæŽã«äžè¬åŒ
ïŒïœïŒã®ååç©ã¯ãäŸãã°æœ°çæ§å€§è žççã®åŠ
眮ã®ããã«é©åœãªæäžåœ¢æ äŸãã°æ»çæ³šè žå€çã«
調補ãããŠããããä¹çã®æäžåœ¢æ ã«ãããŠã¯ã
äžè¬åŒïŒïœïŒã®ååç©ã¯äœå äŸãã°çµè žå ã§ã
ã¯ããªã¢ã«ãã埮çç©åŠçã«éå ãããŠããã掻
æ§ãª11βâããããã·ã¹ããã€ããšãªããããã¯
æççäœçšãèªçºããã äžè¬åŒïŒïœïŒäžç¹ã«å¥œãŸãã矀ã«ã¯ãR1å
ã³R2ãäžè¬åŒïŒïœïŒã«ãããããããšåãã§
ããäžã€æ®ãã®æ§é å¯å€éšãã³ãŒããŸã³ïŒå³ã¡
R3ãR4åã³R5ã®å€«ã ãæ°ŽçŽ ååã§ãããïŒïŒïŒ
âäœçµåã飜åïŒããã¬ãããœã³ïŒå³ã¡R3ãR4å
ã³R5ã®å€«ã ãæ°ŽçŽ ååã§ãããïŒïŒïŒâäœçµå
ãäžé£œåïŒãåã¯ä¹çã®6αâåã³ïŒåã¯9αâãã«
ãªãåã³16αâåã¯16βâã¡ãã«âåå±äœã®ãã
ããšåäžã§ãããã®ãå å«ãããç¹ã«R1åã³R2
ãåè¿°ãã第ïŒã®å¥œãŸããååç©ã«ã€ãå®çŸ©ãã
ãåºã§ãããã®ã¯å¥œé©ã§ãããä¹çèªå°äœäžã®æ
é©ãªãã®ã¯ãR2ãC1-6ã¢ã«ãã«åºåã³R1ãC1-6
ã¢ã«ãã«ãã¢ãããâC1-6ã¢ã«ãã«ïŒç¹ã«ã¯ãã
ã¡ãã«ïŒåã¯âCH2ââïŒC1-6ã¢ã«ãã«ïŒåº
ïŒç¹ã«âCH2ââCH3åºïŒã®ãã®ã§ããã æ¬çºæåååç©ã«ã€ãè¡ãªã€ãåçš®ã®æŽ»æ§è©Šéš
ã®çµæã以äžã®éããæ¬çºæã®äžè¬åŒïŒïŒã®ã¹
ããã€ãé¡ã¯åŒ·åãªæçç掻æ§åã³æå°éã®å šèº«
ç掻æ§ïŒæ¯æ§ãæããããšã確èªãããããã®å±
æ掻æ§ãšå šèº«ç掻æ§ãšã®å¥œãŸããåé¢ã®ç¹ããã
æ¬çºæååç©ã¯ãå±æççç¶æ ã®åŠçœ®ã«æå¹ã§ã
ããå ¬ç¥ã®å€©ç¶ãããã¯åæã®ç³è³ªã³ã«ãã³ã¹ã
ãã€ãé¡äŸãã°ã³ãŒããŸã³ããã€ããã³ãŒããŸ
ã³ããã€ããã³ãŒããŸã³17αâããã¬ãŒããããŒ
ã¿ãŒã¡ã¿ãŸã³17âãã¬ã¬ãŒããããªã¢ã ã·ãã
ã³ãããŒã¿ãŒã¡ã¿ãŸã³ãžããããªããŒãçã«èŠã
ããåŠãé倧ãªå šèº«çã®å¯äœçšã䜵ãªããããã
ãªãã ïŒèžè ºé瞮詊éšïŒ äŸè©Šåç©ãšããŠäœéçŽ40ã45ïœã®éæ§ã¹ãã©ãŒ
ã°ïŒããŠãªãŠãŒã©ãããçšãããåã©ããã®åè³
ã®äžæ¹ããäžèšã«ç€ºãæ¬çºæååç©ã®æå®éãå«
ã溶液ïŒãšã¿ããŒã«ïŒã€ãœãããã«ããªã¹ããŒã
åã¯ã¢ã»ãã³ïŒã€ãœãããã«ããªã¹ããŒãã90ïŒ
10ïŒã®ç·èš25ÎŒã§åŠçãããã³ã³ãããŒã«ãšã
ãŠäŸè©Šååç©ãå«ãŸãªãäžèšæ¶²ã§åæ§ã«åŠçãã
äŸè©Šåç©çŸ€ãäœæããã24æéåŸãå šäŸè©Šåç©ã
殺ãèšéãããŸããã®èžè ºãæåºããŠèšéããã
çµæãäžèšç¬¬ïŒè¡šã«ç€ºããèžè ºééã¯mgïŒ100ïœ
ã©ãããšããŠç€ºãã
ããã®ä»ã®ã²ãšã€ã®æ¹æ³ã¯ãéåžžã®æ¹æ³ã«ããè¡
ãªãåŸããäŸãã°R1åã¯R2ãããã²ã³çœ®æã®äž
è¬åŒïŒïœïŒã®ååç©ã¯ã該ããã²ã³ãä»ã®ãã
ã²ã³ã«çœ®æããããã®ããã²ã³äº€æåå¿ã«äŸãã
ããšãã§ããã該åå¿ã®åå¿æ§ã¯ClïŒBrïŒïŒ©ã®
é ã§ããããŸãäŸãã°äžè¬åŒïŒïœïŒã®17βâã«
ã«ãã³é žã¯ããã¢ã«ãã«ãšæ²åã¢ã«ã«ãªéå±äŸã
ã°æ²åãããªãŠã ãšã®åå¿ã«ããã°å¯Ÿå¿ãã17β
âã«ã«ãã³é žãšãŒãã¢ã«ãã«ãååŸã§ãããåæ§
ã«ããã åå¡©äŸãã°èåãªããŠã ã17βâã«ã«ã
ã³é žã¯ããã¢ã«ãã«ãšåå¿ãããããšã«ãã察å¿
ãã17βâã«ã«ãã³é žããã¢ã¢ã«ãã«ãååŸã§ã
ããäžèšååå¿ã«å¥œé©ãªæº¶åªã¯ãããµã¡ãã«ãªã³
é žã¢ãããã¢ã»ãã³ããšã¿ããŒã«ãã¡ãã«ãšãã«
ã±ãã³ããžã¡ãã«ã¢ã»ãã¢ããããžã¡ãã«ãã«ã
ã¢ããåã³ã¢ã»ããããªã«ããæã矀ããé©å®éž
æãããã åæ§ã«ããŠçžå¯Ÿç溶解æ§ã«åºã¥ãããã²ã³äº€æ
åå¿ã«ãã€ãŠãäžè¬åŒïŒïœïŒã®17βâã«ã«ãã³
é žã¯ããã¢ã«ãã«åã¯17βâã«ã«ãã³é žãšãŒãã¢
ã«ãã«ã察å¿ãããã«ãªãã¢ã«ãã«èªå°äœã«å€æ
ã§ããããã®åå¿ã«ã¯åŒåéãçšãããããŸãé©
åœãªææ©æº¶åªäŸãã°ã¢ã»ããããªã«äžã§è¡ãªãã
ãããã®åå¿ã¯ç¹ã«R1ããã«ãªãã¡ãã«åã¯ã
ã«ãªããšãã«åºã§ããååç©ã®è£œé ã«æå©ã§ã
ãã äžè¬åŒïŒïŒã®ã¹ããã€ãæ§åºçºåæã補é ã
ãããã®21âããããã·ãã¬ã°ãããã³é¡ã¯ãå
æ¥çã«å ¥æã§ãããåã¯å ¬ç¥ã®æ¹æ³ã«ãã補é ã§
ãããåæ§ã«äžè¿°ããåçš®æ¹æ³ã«å©çšãããéâ
ã¹ããã€ãæ§åºçºåæãåæ¥çã«å ¥æã§ãããåžž
æ³ã«ãã補é ã§ããã ãŸããäžè¬åŒïŒïŒã®åºçºåæãäžè¬åŒ
R2OCOClåã¯R2OCOBrïŒR2ã¯äžèšã«åãïŒã®å
åç©ãšåå¿ãããããšã«ãã€ãŠãäžåŒã§è¡šããã
ãäžéäœãååŸã§ããã ãåŒäžR2ãR3â²ãR4ãR5åã³ïŒ¡ç°ã®ç¹ç·ã¯äžèšã«
åãã äžèšååç©ïŒXIïŒãåé¢ãããåã¯åé¢ããã
ãšãªã次ãã§éšåçå æ°Žå解ããŠã察å¿ããäžè¬
åŒïŒïŒã®äžéäœã«å€æããã äžè¬åŒïŒïŒã®åºçºåæãšR2OCOClåã¯
R2OCOBrãšã®åå¿ã¯ãäžèšããäžè¬åŒïŒïŒã®
ååç©ãšR2OCOClåã¯R2OCOBrãšã®åå¿ãšåäž
æ¡ä»¶äžã«è¡ãªããããäœãäžè¬åŒïŒïŒã®åºçºå
æïŒã¢ã«ã«å¯ŸãR2OCOClåã¯R2OCOBrã¯ïŒã¢ã«
åã¯ãã以äžçšãããããåŸãããäžè¬åŒïŒXIïŒ
ã®åå¿çæç©ã®éšåçå æ°Žå解ã¯ãäžæŽ»æ§æº¶åªäž
觊åªã®ååšäžã«è¡ãªããããé©åœãªè§ŠåªãšããŠã¯
ããªãšãã«ã¢ãã³ãããªã¡ãã«ã¢ãã³çã®ã¢ã«ã
ã«ç¬¬ïŒçŽã¢ãã³ïŒããªãžã³ãïŒïŒïŒâãžã¡ãã«ã¢
ããããªãžã³ããããªã³çã®è³éŠæã¢ãã³ïŒãžãš
ãã«ã¢ãã³ããžã¡ãã«ã¢ãã³çã®ã¢ã«ãã«ç¬¬ïŒçŽ
ã¢ãã³ïŒæ°Žé žåãããªãŠã ãæ°Žé žåã«ãªãŠã ãé
çé žã«ãªãŠã çã®ç¡æ©å¡©åºçãå©çšã§ããã奜ãŸ
ããã¯ããªãžã³åã³éçé žã«ãªãŠã ã䜿çšã§ã
ããäžæŽ»æ§æº¶åªãšããŠã¯ãæ°ŽïŒãšã¿ããŒã«ãã¡ã¿
ããŒã«çã®äœçŽã¢ã«ã³ãŒã«é¡ïŒãžã¡ãã«ãšãŒã
ã«ããžãšãã«ãšãŒãã«ããžã¡ããã·ãšã¿ã³ããžãª
ããµã³ãããã©ããããã©ã³çã®ãšãŒãã«é¡ïŒãž
ã¯ããã¡ã¿ã³ãã¯ãããã«ã çã®ããã²ã³åçå
æ°ŽçŽ é¡ïŒããªãžã³ãããªãšãã«ã¢ãã³çã®ç¬¬ïŒçŽ
ã¢ãã³é¡ïŒåã¯ä¹çã®ïŒãããã¯ãã以äžã®æ··å
溶åªçãçšãåŸããåå¿ã¯éåžžçŽïŒã100âã奜
ãŸããã¯å®€æž©ã50âã®æž©åºŠäžïŒã48æéã奜ãŸã
ãã¯ïŒãïŒæéãèŠããŠè¡ãªãããã æ¬çºæã¯ãŸãäžåŒã§è¡šããããæ°èŠãªååç©ã
ãæäŸãããã®ã§ããã ãåŒäžR1ãR2ãR3ãR4ãR5åã³ç°ïŒ¡ã«ãããç¹
ç·ã¯äžèšã«åãã äžèšäžè¬åŒïŒïœïŒã§è¡šãããã11âã±ãåå
ç©ã¯ã察å¿ããäžè¬åŒïŒïœïŒã®11βâãããã
ã·ååç©ã®è£œé ã«ã€ãåè¿°ããæ¹æ³ã«åŸã補é ã
ãããšãã§ãããäŸãã°11âã±ãåºãæãã察å¿
ããäžè¬åŒïŒïŒã®åºçºåæãR2OCOClåã¯
R2OCOBrãšåå¿ãããããšã«ããã11âã±ãåº
ãæããäžè¬åŒïŒïŒã«å¯Ÿå¿ããæ°èŠãªäžéäœã
åŸããããããã次ãã§ãã®éå±å¡©ã«å€æãã
ããããã¯11βâããããã·åºã«ä»£ã11âã±ãåº
ãæãã以å€ã¯äžè¬åŒïŒïŒã®ããã«çžåœããã
次ãã§äžèšéå±å¡©ãR1Wãšåå¿ãããããšã«ã
ãã察å¿ããäžè¬åŒïŒïœïŒã®ååç©ãåŸããäž
èšæ¹æ³ã«ããããã¹ãŠã®åå¿æ¡ä»¶ã¯ã察å¿ããäž
è¬åŒïŒïœïŒã®ååç©ã®è£œé ã«ã€ããŠåè¿°ãããš
ããã§ãããåæ§ã«R1ãã¹ã«ãã€ãã«âåã¯ã¹
ã«ããã«âå«æåºã§ããäžè¬åŒïŒïœïŒã®ååç©
ã®è£œé ã¯ã察å¿ããäžè¬åŒïŒïœïŒã®ååç©ã«ã€
ãæ¡çšããããšåæ§ã®æ¹æ³ã«ããããã®å·¥çšã®æ
çµæ®µéã§è¡ãªããããæŽã«äžè¬åŒïŒïœïŒã®åå
ç©ã®è£œé ã«ã€ãåè¿°ãããã¹ãŠã®å€æ³ã¯ããã®äž
è¬åŒïŒïœïŒã®ååç©ã®è£œé ã«ãé©çšã§ãããã
ã®å Žååã«çšãããã11βâããããã·ã¹ããã€
ãã«ä»£ã察å¿ãã11âãªããœåºçºåæãçšããã°
ãããäŸãã°äžè¬åŒïŒïŒãïŒïŒãïŒïŒãïŒïŒã
ïŒïŒåã³ïŒXIïŒã«ããã11âããããã·åºãã
11âãªããœåºã«å€ãã以å€ã¯ãåè¿°ããïŒïŒâ
ïŒïŒâïŒïŒâïŒïœïŒïŒïŒïŒâïŒïŒâïŒ
ïœïŒïŒïŒïŒâïŒïŒâïŒïœïŒïŒïŒïŒâïŒïŒâ
ïŒïœïŒïŒïŒïŒâïŒïœïŒçã®åå¿ãšåäžæäœã
æ¡çšã§ããã ãŸããäžè¬åŒïŒïœïŒã®ååç©ã¯ã察å¿ããäž
è¬åŒïŒïœïŒã®ååç©ãšé žåå€ãšãåå¿ãããã
ãšã«ãã€ãŠã補é ã§ãããäžè¬åŒïŒïœïŒã®åå
ç©ã察å¿ããäžè¬åŒïŒïœïŒã®ååç©ã«å€æãã
é žååå¿ã¯ãé©åœãªæº¶åªäžé žåå€ãçšããŠè¡ãªã
ããã溶åªãšããŠã¯éåžžã®ãã®äŸãã°æ°Žãææ©é ž
ïŒè»é žãé ¢é žãããªãã«ãªãé ¢é žçïŒãã¢ã«ã³ãŒã«
ïŒã¡ã¿ããŒã«ããšã¿ããŒã«çïŒãããã²ã³åçåæ°Ž
çŽ ïŒã¯ãããã«ã ããžã¯ããã¡ã¿ã³çïŒçãçšã
åŸããé žåå€ãšããŠãããããã·åºãã«ã«ããã«
åºã«é žåããéã«çšããããéåžžã®åçš®ã®ãã®ã
äŸãã°ã¯ããã¯ãã é žããªãžããŠã ãäžé žåã¯ã
ã âããªãžã³æ¶²ãéé žåæ°ŽçŽ ãäºã¯ãã é žãäºã¯
ãã é žå¡©ïŒäºã¯ãã é žãããªãŠã ãäºã¯ãã é žã«
ãªãŠã çïŒãéãã³ã¬ã³é žãéãã³ã¬ã³é žå¡©ïŒé
ãã³ã¬ã³é žãããªãŠã ãéãã³ã¬ã³é žã«ãªãŠã ïŒ
çãçšãåŸããé žåå€ã¯éåžžäžè¬åŒïŒïœïŒã®å
åç©ïŒã¢ã«ã«å¯ŸããŠïŒã¢ã«ä»¥äžã奜ãŸããã¯ïŒã
ïŒã¢ã«çšããããšãã§ãããåå¿ã¯éåžžïŒã40
âã奜ãŸããã¯å®€æž©ä»è¿ã®æž©åºŠäžã«çŽïŒã30æé
è¡ãªãããã äžè¬åŒïŒïœïŒã®æ°èŠååç©ã¯ãããèªäœæç
ç掻æ§ãæãããšå ±ã«ãçäœå ïŒã€ã³ããïŒåã¯
è©Šéšç®¡å ïŒã€ã³ãããïŒã«ãããŠã察å¿ãã11β
âããããã·ååç©ã®åé§äœãšããŠæçšã§ããã
該äžè¬åŒïŒïœïŒã®ååç©ã¯ãã€ã³ãããã«ãã
ãŠã11âãªããœåºã11βâããããã·åºã«éå ã
ãããã¹ããã€ãæ§ç©è³ªã®ä»ã®éšåã¯å€åãããª
ãé©åœãªå ¬ç¥ã®éå å€ãçšããŠãéå ããããäž
èšéå ãè¡ãªãã«ã¯ã埮çç©ã«ããéå ãæå©ã§
ããããååŠçéå ã亊å¯èœã§ãããæŽã«äžè¬åŒ
ïŒïœïŒã®ååç©ã¯ãäŸãã°æœ°çæ§å€§è žççã®åŠ
眮ã®ããã«é©åœãªæäžåœ¢æ äŸãã°æ»çæ³šè žå€çã«
調補ãããŠããããä¹çã®æäžåœ¢æ ã«ãããŠã¯ã
äžè¬åŒïŒïœïŒã®ååç©ã¯äœå äŸãã°çµè žå ã§ã
ã¯ããªã¢ã«ãã埮çç©åŠçã«éå ãããŠããã掻
æ§ãª11βâããããã·ã¹ããã€ããšãªããããã¯
æççäœçšãèªçºããã äžè¬åŒïŒïœïŒäžç¹ã«å¥œãŸãã矀ã«ã¯ãR1å
ã³R2ãäžè¬åŒïŒïœïŒã«ãããããããšåãã§
ããäžã€æ®ãã®æ§é å¯å€éšãã³ãŒããŸã³ïŒå³ã¡
R3ãR4åã³R5ã®å€«ã ãæ°ŽçŽ ååã§ãããïŒïŒïŒ
âäœçµåã飜åïŒããã¬ãããœã³ïŒå³ã¡R3ãR4å
ã³R5ã®å€«ã ãæ°ŽçŽ ååã§ãããïŒïŒïŒâäœçµå
ãäžé£œåïŒãåã¯ä¹çã®6αâåã³ïŒåã¯9αâãã«
ãªãåã³16αâåã¯16βâã¡ãã«âåå±äœã®ãã
ããšåäžã§ãããã®ãå å«ãããç¹ã«R1åã³R2
ãåè¿°ãã第ïŒã®å¥œãŸããååç©ã«ã€ãå®çŸ©ãã
ãåºã§ãããã®ã¯å¥œé©ã§ãããä¹çèªå°äœäžã®æ
é©ãªãã®ã¯ãR2ãC1-6ã¢ã«ãã«åºåã³R1ãC1-6
ã¢ã«ãã«ãã¢ãããâC1-6ã¢ã«ãã«ïŒç¹ã«ã¯ãã
ã¡ãã«ïŒåã¯âCH2ââïŒC1-6ã¢ã«ãã«ïŒåº
ïŒç¹ã«âCH2ââCH3åºïŒã®ãã®ã§ããã æ¬çºæåååç©ã«ã€ãè¡ãªã€ãåçš®ã®æŽ»æ§è©Šéš
ã®çµæã以äžã®éããæ¬çºæã®äžè¬åŒïŒïŒã®ã¹
ããã€ãé¡ã¯åŒ·åãªæçç掻æ§åã³æå°éã®å šèº«
ç掻æ§ïŒæ¯æ§ãæããããšã確èªãããããã®å±
æ掻æ§ãšå šèº«ç掻æ§ãšã®å¥œãŸããåé¢ã®ç¹ããã
æ¬çºæååç©ã¯ãå±æççç¶æ ã®åŠçœ®ã«æå¹ã§ã
ããå ¬ç¥ã®å€©ç¶ãããã¯åæã®ç³è³ªã³ã«ãã³ã¹ã
ãã€ãé¡äŸãã°ã³ãŒããŸã³ããã€ããã³ãŒããŸ
ã³ããã€ããã³ãŒããŸã³17αâããã¬ãŒããããŒ
ã¿ãŒã¡ã¿ãŸã³17âãã¬ã¬ãŒããããªã¢ã ã·ãã
ã³ãããŒã¿ãŒã¡ã¿ãŸã³ãžããããªããŒãçã«èŠã
ããåŠãé倧ãªå šèº«çã®å¯äœçšã䜵ãªããããã
ãªãã ïŒèžè ºé瞮詊éšïŒ äŸè©Šåç©ãšããŠäœéçŽ40ã45ïœã®éæ§ã¹ãã©ãŒ
ã°ïŒããŠãªãŠãŒã©ãããçšãããåã©ããã®åè³
ã®äžæ¹ããäžèšã«ç€ºãæ¬çºæååç©ã®æå®éãå«
ã溶液ïŒãšã¿ããŒã«ïŒã€ãœãããã«ããªã¹ããŒã
åã¯ã¢ã»ãã³ïŒã€ãœãããã«ããªã¹ããŒãã90ïŒ
10ïŒã®ç·èš25ÎŒã§åŠçãããã³ã³ãããŒã«ãšã
ãŠäŸè©Šååç©ãå«ãŸãªãäžèšæ¶²ã§åæ§ã«åŠçãã
äŸè©Šåç©çŸ€ãäœæããã24æéåŸãå šäŸè©Šåç©ã
殺ãèšéãããŸããã®èžè ºãæåºããŠèšéããã
çµæãäžèšç¬¬ïŒè¡šã«ç€ºããèžè ºééã¯mgïŒ100ïœ
ã©ãããšããŠç€ºãã
ãè¡šã
èžè
ºééã«ãããå€åã«ããå
šèº«çäœçšåã³ã
ã®æ¯æ§ã枬å®ãåŸããèžè ºééã®æžå°ã倧ããçš
å šèº«ç掻æ§ã¯åŒ·ããäžèšç¬¬ïŒè¡šããããã€ããã³
ãŒããŸã³å³ã¡å€©ç¶ã®ç³è³ªã³ãŒãã³ã€ãã¯ãã³ã³ã
ããŒã«ãšå¯Ÿæ¯ããŠé¡èãªèžè ºééæžå°ãæ¹èµ·ããŠ
ããããšãæããã§ãããåäžæäžéã§ã®æ¬çºæ
ååç©ã«ãããäžèšæžå°éã¯ããäœããã®ã§ã
ãããã®ããšãããæ¬çºæååç©ã¯ãã€ããã³ãŒ
ããŸã³ã«æ¯ãå šèº«çäœçšãããäœãããšãå€ãã ïŒç®èèŒçœè©ŠéšïŒ ããã±ã³ãžãŒåããèŒçœè©ŠéšïŒMckenzieâ
typehuman blanching studyïŒããæ¬çºæåå
ç©ã17αâãšããã·ã«ã«ããã«ãªãã·â11βâã
ãããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â
17βâã«ã«ãã³é žã¯ããã¡ãã«ã«ã€ãããã®èŒçœ
å¹æã調ã¹ãããã«è¡ãªã€ããããã«èŒçœãèµ·ã
ååç©ã®äœçšã¯ããã®æçç掻æ§ãšå¯æ¥ã«é¢é£ã
ãããšãç¥ãããŠããã äŸè©Šååç©ããšã¿ããŒã«ïŒã€ãœãããã«ããªã¹
ããŒãïŒ90ïŒ10åã¯70ïŒ30ïŒã«æº¶ãããŠ0.03ã
0.01ã0.003ã0.001åã³0.0003Mæ¿åºŠã®æ¶²ãäœæ
ãããå溶液ã®50ÎŒéšåæšæ¬ããã¢ã¬ã«ã®ãŒè©Š
éšã«éåžžçšããããå 垯ã®ã¬ãŒãŒéšåã«å¥ã ã«é©
çšãã該å 垯ãåè ã«æœçšããããã®ïŒæéåŸå
垯ããšãã¯ãããå 垯é€å»ã®ïŒãïŒæéåŸãäŸè©Š
ååç©ã®æãäœæ¿åºŠã«ãããŠãèŒçœã¯èŠ³å¯ãã
ãã æ¯èŒã®ãããã€ããã³ãŒããŸã³ã«ã€ãåäžè©Šéš
ãè¡ãªã€ãæããã€ããã³ãŒããŸã³0.03M以äžã®
æ¿åºŠã«ãããŠèŒçœã¯èŠ³å¯ãããªãã€ããæŽã«ãã®
0.03Mãã€ããã³ãŒããŸã³ã«èŠãããèŒçœã¯ã
17αâãšããã·ã«ã«ããã«ãªãã·â11βâããã
ãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17βâ
ã«ã«ãã³é žã¯ããã¡ãã«ã®0.001M䜿çšã®å Žåãš
ã»ãŒåçã§ãã€ãã ïŒè³æµ®è «è©ŠéšïŒ äŸè©Šåç©ãšããŠäœéçŽ150ïœã®ã¹ãã©ãŒã°ïŒã
ãŠãªãŠãŒã©ãããçšãããäŸè©Šååç©åŠç矀ã«ã
ããŠã¯ãäŸè©Šååç©ã®æå®éããã¯ããã³æ²¹ïŒïŒ
ãå«æããã¢ã»ãã³ã«æº¶è§£ãã該溶液50ÎŒãäŸ
è©Šåç©ã®å³è³å é¢ã«æœçšãããå¯Ÿç §çŸ€ã¯åæ§ã«ã
ãŠè³Šåœ¢å€å³ã¡ïŒïŒ ã¯ããã³æ²¹ã¢ã»ãã³æ¶²ã®ã¿ã§åŠ
çãããã¯ããã³æ²¹ã®å¡åžïŒæéåŸãåè³ã®äžå®
éšåãã麻é äžã§åé€ããã次ã«ã¹ããã€ãåŠçœ®
ã®48æéåŸã«ãäŸè©Šåç©ã殺ããèžè ºåã³å¯è ã
æåºããŠèšéãããã¯ããã³æ²¹ã«ããèªçºããã
è³æµ®è «ã«å¯Ÿããå±æçã¹ããã€ãæäžã«ããæå¶
å¹æã®è©Šéšçµæãäžèšç¬¬ïŒè¡šã«ç€ºãã
ã®æ¯æ§ã枬å®ãåŸããèžè ºééã®æžå°ã倧ããçš
å šèº«ç掻æ§ã¯åŒ·ããäžèšç¬¬ïŒè¡šããããã€ããã³
ãŒããŸã³å³ã¡å€©ç¶ã®ç³è³ªã³ãŒãã³ã€ãã¯ãã³ã³ã
ããŒã«ãšå¯Ÿæ¯ããŠé¡èãªèžè ºééæžå°ãæ¹èµ·ããŠ
ããããšãæããã§ãããåäžæäžéã§ã®æ¬çºæ
ååç©ã«ãããäžèšæžå°éã¯ããäœããã®ã§ã
ãããã®ããšãããæ¬çºæååç©ã¯ãã€ããã³ãŒ
ããŸã³ã«æ¯ãå šèº«çäœçšãããäœãããšãå€ãã ïŒç®èèŒçœè©ŠéšïŒ ããã±ã³ãžãŒåããèŒçœè©ŠéšïŒMckenzieâ
typehuman blanching studyïŒããæ¬çºæåå
ç©ã17αâãšããã·ã«ã«ããã«ãªãã·â11βâã
ãããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â
17βâã«ã«ãã³é žã¯ããã¡ãã«ã«ã€ãããã®èŒçœ
å¹æã調ã¹ãããã«è¡ãªã€ããããã«èŒçœãèµ·ã
ååç©ã®äœçšã¯ããã®æçç掻æ§ãšå¯æ¥ã«é¢é£ã
ãããšãç¥ãããŠããã äŸè©Šååç©ããšã¿ããŒã«ïŒã€ãœãããã«ããªã¹
ããŒãïŒ90ïŒ10åã¯70ïŒ30ïŒã«æº¶ãããŠ0.03ã
0.01ã0.003ã0.001åã³0.0003Mæ¿åºŠã®æ¶²ãäœæ
ãããå溶液ã®50ÎŒéšåæšæ¬ããã¢ã¬ã«ã®ãŒè©Š
éšã«éåžžçšããããå 垯ã®ã¬ãŒãŒéšåã«å¥ã ã«é©
çšãã該å 垯ãåè ã«æœçšããããã®ïŒæéåŸå
垯ããšãã¯ãããå 垯é€å»ã®ïŒãïŒæéåŸãäŸè©Š
ååç©ã®æãäœæ¿åºŠã«ãããŠãèŒçœã¯èŠ³å¯ãã
ãã æ¯èŒã®ãããã€ããã³ãŒããŸã³ã«ã€ãåäžè©Šéš
ãè¡ãªã€ãæããã€ããã³ãŒããŸã³0.03M以äžã®
æ¿åºŠã«ãããŠèŒçœã¯èŠ³å¯ãããªãã€ããæŽã«ãã®
0.03Mãã€ããã³ãŒããŸã³ã«èŠãããèŒçœã¯ã
17αâãšããã·ã«ã«ããã«ãªãã·â11βâããã
ãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17βâ
ã«ã«ãã³é žã¯ããã¡ãã«ã®0.001M䜿çšã®å Žåãš
ã»ãŒåçã§ãã€ãã ïŒè³æµ®è «è©ŠéšïŒ äŸè©Šåç©ãšããŠäœéçŽ150ïœã®ã¹ãã©ãŒã°ïŒã
ãŠãªãŠãŒã©ãããçšãããäŸè©Šååç©åŠç矀ã«ã
ããŠã¯ãäŸè©Šååç©ã®æå®éããã¯ããã³æ²¹ïŒïŒ
ãå«æããã¢ã»ãã³ã«æº¶è§£ãã該溶液50ÎŒãäŸ
è©Šåç©ã®å³è³å é¢ã«æœçšãããå¯Ÿç §çŸ€ã¯åæ§ã«ã
ãŠè³Šåœ¢å€å³ã¡ïŒïŒ ã¯ããã³æ²¹ã¢ã»ãã³æ¶²ã®ã¿ã§åŠ
çãããã¯ããã³æ²¹ã®å¡åžïŒæéåŸãåè³ã®äžå®
éšåãã麻é äžã§åé€ããã次ã«ã¹ããã€ãåŠçœ®
ã®48æéåŸã«ãäŸè©Šåç©ã殺ããèžè ºåã³å¯è ã
æåºããŠèšéãããã¯ããã³æ²¹ã«ããèªçºããã
è³æµ®è «ã«å¯Ÿããå±æçã¹ããã€ãæäžã«ããæå¶
å¹æã®è©Šéšçµæãäžèšç¬¬ïŒè¡šã«ç€ºãã
ãè¡šã
äžèšç¬¬ïŒè¡šããçšããããæ¬çºæååç©å³ã¡
17αâãšããã·ã«ã«ããã«ãªãã·â11βâããã
ãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17βâ
ã«ã«ãã³é žã¯ããã¡ãã«ã¯ãã¯ããã³æ²¹ã«ããæ¹
èµ·ãããè³ã®æµ®è «ïŒããã«ããééå¢å ïŒãå®è³ª
çã«æå¶ããããšãæããã§ãããå³ã¡è©²ååç©
ã¯å®éã«æçç掻æ§ãæããããšãå€ããäžæ¹æ¬
ååç©ã¯ãããŒã¿ãŒã¡ã¿ãŸã³ 17âãã¬ã¬ãŒããš
ã¯ç°ãªã€ãŠãã³ã³ãããŒã«ãšå¯Ÿæ¯ããŠèžè ºééã®
ææãªæžå°ãæ¹èµ·ããªããå³ã¡å šèº«çäœçšãã»ãš
ãã©ç€ºããªãããšãæããã§ããã ïŒèèœè «åœ¢æè©ŠéšïŒ äŸè©Šååç©ãã¢ã»ãã³ã«æº¶è§£ããäœæãããå
çš®æ¿åºŠã®è¢«æ€æ¶²ã綿è¬çäžã«æ³šå ¥ããããããã
也ç¥ã次ãã§åäŸè©Šåç©ïŒã©ããïŒã®èéšç®äžã®
å·Šå³ã«ïŒåã¥ã€å蟌ããïŒæ¥åŸäŸè©Šåç©ã殺ãã
å蟌ãŸãã綿çåã³ãã®åšå²ã«åœ¢æãããèèœçµ
ç¹ïŒå èœè «ïŒãæåºãã也ç¥åŸèšéããããŸãèž
è ºåã³å¯è ãæåºãèšéããããã®è©Šéšã«ããã
èèœè «åœ¢ææå¶ã«å¯ŸããäŸè©Šååç©ã®æŽ»æ§ã¯ã該
ååç©ã®å±ææçç掻æ§ãçŽæ¥ç€ºããã®ã§ããã
å³ã¡èèœçµç¹ééãå°ããçšæçç掻æ§ã¯è¯å¥œã§
ãããäžæ¹èžè ºééã®ææãªæžå°ã¯ãææãªå šèº«
系掻æ§ã瀺ããã®ã§ãããéã«äŸè©Šååç©ãã³ã³
ãããŒã«ã«æ¯ãèžè ºééæžå°ãã»ãšãã©ç€ºããªã
å Žåãããã¯å šèº«çäœçšãæ¬ ããåã¯éåžžã«å°ã
ãããšãæå³ããã çµæãäžèšç¬¬ïŒè¡šã第ïŒè¡šäžŠã³ã«ç¬¬ïŒâïœåã³
ïŒâïœè¡šã«ç€ºãã
17αâãšããã·ã«ã«ããã«ãªãã·â11βâããã
ãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17βâ
ã«ã«ãã³é žã¯ããã¡ãã«ã¯ãã¯ããã³æ²¹ã«ããæ¹
èµ·ãããè³ã®æµ®è «ïŒããã«ããééå¢å ïŒãå®è³ª
çã«æå¶ããããšãæããã§ãããå³ã¡è©²ååç©
ã¯å®éã«æçç掻æ§ãæããããšãå€ããäžæ¹æ¬
ååç©ã¯ãããŒã¿ãŒã¡ã¿ãŸã³ 17âãã¬ã¬ãŒããš
ã¯ç°ãªã€ãŠãã³ã³ãããŒã«ãšå¯Ÿæ¯ããŠèžè ºééã®
ææãªæžå°ãæ¹èµ·ããªããå³ã¡å šèº«çäœçšãã»ãš
ãã©ç€ºããªãããšãæããã§ããã ïŒèèœè «åœ¢æè©ŠéšïŒ äŸè©Šååç©ãã¢ã»ãã³ã«æº¶è§£ããäœæãããå
çš®æ¿åºŠã®è¢«æ€æ¶²ã綿è¬çäžã«æ³šå ¥ããããããã
也ç¥ã次ãã§åäŸè©Šåç©ïŒã©ããïŒã®èéšç®äžã®
å·Šå³ã«ïŒåã¥ã€å蟌ããïŒæ¥åŸäŸè©Šåç©ã殺ãã
å蟌ãŸãã綿çåã³ãã®åšå²ã«åœ¢æãããèèœçµ
ç¹ïŒå èœè «ïŒãæåºãã也ç¥åŸèšéããããŸãèž
è ºåã³å¯è ãæåºãèšéããããã®è©Šéšã«ããã
èèœè «åœ¢ææå¶ã«å¯ŸããäŸè©Šååç©ã®æŽ»æ§ã¯ã該
ååç©ã®å±ææçç掻æ§ãçŽæ¥ç€ºããã®ã§ããã
å³ã¡èèœçµç¹ééãå°ããçšæçç掻æ§ã¯è¯å¥œã§
ãããäžæ¹èžè ºééã®ææãªæžå°ã¯ãææãªå šèº«
系掻æ§ã瀺ããã®ã§ãããéã«äŸè©Šååç©ãã³ã³
ãããŒã«ã«æ¯ãèžè ºééæžå°ãã»ãšãã©ç€ºããªã
å Žåãããã¯å šèº«çäœçšãæ¬ ããåã¯éåžžã«å°ã
ãããšãæå³ããã çµæãäžèšç¬¬ïŒè¡šã第ïŒè¡šäžŠã³ã«ç¬¬ïŒâïœåã³
ïŒâïœè¡šã«ç€ºãã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
ãè¡šã
äžèšç¬¬ïŒè¡šã第ïŒè¡šåã³ç¬¬ïŒâïœè¡šãããæ¬çº
æã®äŸè©Šååç©ã¯ãå ¬ç¥ã®ã¹ããã€ãã§ãããã€
ããã³ãŒããŸã³17âããã¬ãŒãåã³ããŒã¿ãŒã¡ã¿
ãŸã³ 17âãã¬ã¬ãŒãã«æ¯ããããå°éã®æäžé
ã§åªããæçç掻æ§ã瀺ãããšãå€ããäžæ¹å ¬ç¥
ã®ã¹ããã€ãé¡ã¯ãã¹ãèžè ºééã®æ¿ããæžå°ã
æ¹èµ·ããéåžžã«åŒ·åãªå šèº«çäœçšãå ·åããã®ã«
察ããæ¬çºæã®äŸè©Šååç©ã¯ãèžè ºééã®é倧ãª
æžå°ãæ¹èµ·ããªãããæå°éã®æžå°ãåŒãèµ·ãã®
ã¿ã§ãããå³ã¡æ¬çºæååç©ã¯ãå ¬ç¥ã®ã¹ããã€
ãæ§æççå€ã«æ¯ãé¡èã«åªããæ²»çã€ã³ããã¯
ã¹ïŒå³ã¡å šèº«çäœçšããã®å±ææççäœçšã®å
é¢ïŒã瀺ããã®ãæããã§ããã ãŸãäžèšç¬¬ïŒâïœè¡šãããæ¬çºæã®äŸè©Šååç©
ã¯ãåªããå±ææççäœçšãæããããšãå€ãã äžèšç¬¬ïŒè¡šåã³ç¬¬ïŒâïœè¡šã«ç€ºãçµæããããŸ
ãæ¬çºæååç©ã®ED40ãED50ãED60åã³çžå¯Ÿç
匷床ãç®åºããããšãã§ããããããäžèšç¬¬ïŒè¡š
ã«ç€ºããæ¬çºæååç©ã®ã²ãšã€ã§ãã11βâãã
ããã·â17αâã€ãœããããã·ã«ã«ããã«ãªãã·
ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«
ãã³é žã¯ããã¡ãã«ã®åEDã«ããã匷床ãïŒãš
ããŠãä»ã®ååç©ã®çžå¯ŸåŒ·åºŠãæ±ããããŸã
ED40ãED50åã³ED60ã¯ã倫ã èèœè «ééã40
ïŒ ã50ïŒ åã³60ïŒ æžå°ãããã«èŠããååç©æäž
éãæå³ããã
æã®äŸè©Šååç©ã¯ãå ¬ç¥ã®ã¹ããã€ãã§ãããã€
ããã³ãŒããŸã³17âããã¬ãŒãåã³ããŒã¿ãŒã¡ã¿
ãŸã³ 17âãã¬ã¬ãŒãã«æ¯ããããå°éã®æäžé
ã§åªããæçç掻æ§ã瀺ãããšãå€ããäžæ¹å ¬ç¥
ã®ã¹ããã€ãé¡ã¯ãã¹ãèžè ºééã®æ¿ããæžå°ã
æ¹èµ·ããéåžžã«åŒ·åãªå šèº«çäœçšãå ·åããã®ã«
察ããæ¬çºæã®äŸè©Šååç©ã¯ãèžè ºééã®é倧ãª
æžå°ãæ¹èµ·ããªãããæå°éã®æžå°ãåŒãèµ·ãã®
ã¿ã§ãããå³ã¡æ¬çºæååç©ã¯ãå ¬ç¥ã®ã¹ããã€
ãæ§æççå€ã«æ¯ãé¡èã«åªããæ²»çã€ã³ããã¯
ã¹ïŒå³ã¡å šèº«çäœçšããã®å±ææççäœçšã®å
é¢ïŒã瀺ããã®ãæããã§ããã ãŸãäžèšç¬¬ïŒâïœè¡šãããæ¬çºæã®äŸè©Šååç©
ã¯ãåªããå±ææççäœçšãæããããšãå€ãã äžèšç¬¬ïŒè¡šåã³ç¬¬ïŒâïœè¡šã«ç€ºãçµæããããŸ
ãæ¬çºæååç©ã®ED40ãED50ãED60åã³çžå¯Ÿç
匷床ãç®åºããããšãã§ããããããäžèšç¬¬ïŒè¡š
ã«ç€ºããæ¬çºæååç©ã®ã²ãšã€ã§ãã11βâãã
ããã·â17αâã€ãœããããã·ã«ã«ããã«ãªãã·
ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«
ãã³é žã¯ããã¡ãã«ã®åEDã«ããã匷床ãïŒãš
ããŠãä»ã®ååç©ã®çžå¯ŸåŒ·åºŠãæ±ããããŸã
ED40ãED50åã³ED60ã¯ã倫ã èèœè «ééã40
ïŒ ã50ïŒ åã³60ïŒ æžå°ãããã«èŠããååç©æäž
éãæå³ããã
ãè¡šã
ãè¡šã
ãè¡šã
å°ç¬¬ïŒè¡šäž(1)ã¯èèœçµç¹ééã40ïŒ
æå¶ããæ
äžéã(2)ã¯åãã50ïŒ æå¶ããæäžéåã³(3)ã¯å
ãã60ïŒ æå¶ããæäžéã§ãããïŒ ïŒå æ°å€ã¯
95ïŒ ä¿¡é Œéçã瀺ãã ïŒèžè ºé瞮詊éšïŒ å»è¬ãå šèº«ç³»ã«æäžããéã®ãã©ããã«ããã
èžè ºééã«å¯Ÿããæ¬çºæååç©ã®å¹æã調ã¹ãã
ãã«ãæŽã«æ°çš®ã®è©Šéšãè¡ãªã€ããä¹çã®è©Šéšã«
ãããŠã¯ãäŸè©Šåç©ãšããŠéæ§ã¹ãã©ãŒã°ïŒããŠ
ãªãŠãŒã©ãããçšããïŒåè©Šéšã«çšããã©ããã®
å¹³åäœéã¯ãåŸèšã«ç€ºãïŒã äŸè©Šååç©ã0.5ïŒ CMCïŒã«ã«ããã·ã¡ãã«ã»
ã«ããŒã¹ïŒäžã«æžæ¿ãããïŒæ¥éïŒæ¥ïŒéç®äžæ³š
å°ãããïŒæ¥ç®ïŒæçµæäžã®48æéåŸïŒãäŸè©Šå
ç©ã殺ããèžè ºééãèšç®ãããäœéå¢å ãæçµ
æäžã®24æéåŸã«æž¬å®ããŠãããè©Šéšçµæã第ïŒ
è¡šã第ïŒè¡šåã³ç¬¬ïŒè¡šã«ç€ºãããŸãæ¬çºæã®äŸè©Š
ååç©åã³å¯Ÿç §ã¹ããã€ãã«ã€ããŠã®TED40å€ã
TED50å€ïŒèžè ºçµç¹éçž®æäžéïŒthymolytic
effective dosesïŒå³ã¡èžè ºééã倫ã 40ïŒ åã³
50ïŒ æå¶ããã«èŠããæäžéïŒåã³çžå¯ŸåŒ·åºŠã第
10è¡šã«ç€ºãã第10è¡šã«ãããŠãå¯Ÿç §ã¹ããã€ããš
ããããŒã¿ãŒã¡ã¿ãŸã³ 17âãã¬ã¬ãŒãã«ã€ããŠ
ã®TED40åã³TED50ã倫ã ïŒãšããŠãä»ã®åå
ç©ã®çžå¯ŸåŒ·åºŠãæ±ãããå³ã¡èžè ºéçž®å¹æãé«ã
çšã該ååç©ã¯æ¯æ§ã匷ããšèšããã
äžéã(2)ã¯åãã50ïŒ æå¶ããæäžéåã³(3)ã¯å
ãã60ïŒ æå¶ããæäžéã§ãããïŒ ïŒå æ°å€ã¯
95ïŒ ä¿¡é Œéçã瀺ãã ïŒèžè ºé瞮詊éšïŒ å»è¬ãå šèº«ç³»ã«æäžããéã®ãã©ããã«ããã
èžè ºééã«å¯Ÿããæ¬çºæååç©ã®å¹æã調ã¹ãã
ãã«ãæŽã«æ°çš®ã®è©Šéšãè¡ãªã€ããä¹çã®è©Šéšã«
ãããŠã¯ãäŸè©Šåç©ãšããŠéæ§ã¹ãã©ãŒã°ïŒããŠ
ãªãŠãŒã©ãããçšããïŒåè©Šéšã«çšããã©ããã®
å¹³åäœéã¯ãåŸèšã«ç€ºãïŒã äŸè©Šååç©ã0.5ïŒ CMCïŒã«ã«ããã·ã¡ãã«ã»
ã«ããŒã¹ïŒäžã«æžæ¿ãããïŒæ¥éïŒæ¥ïŒéç®äžæ³š
å°ãããïŒæ¥ç®ïŒæçµæäžã®48æéåŸïŒãäŸè©Šå
ç©ã殺ããèžè ºééãèšç®ãããäœéå¢å ãæçµ
æäžã®24æéåŸã«æž¬å®ããŠãããè©Šéšçµæã第ïŒ
è¡šã第ïŒè¡šåã³ç¬¬ïŒè¡šã«ç€ºãããŸãæ¬çºæã®äŸè©Š
ååç©åã³å¯Ÿç §ã¹ããã€ãã«ã€ããŠã®TED40å€ã
TED50å€ïŒèžè ºçµç¹éçž®æäžéïŒthymolytic
effective dosesïŒå³ã¡èžè ºééã倫ã 40ïŒ åã³
50ïŒ æå¶ããã«èŠããæäžéïŒåã³çžå¯ŸåŒ·åºŠã第
10è¡šã«ç€ºãã第10è¡šã«ãããŠãå¯Ÿç §ã¹ããã€ããš
ããããŒã¿ãŒã¡ã¿ãŸã³ 17âãã¬ã¬ãŒãã«ã€ããŠ
ã®TED40åã³TED50ã倫ã ïŒãšããŠãä»ã®åå
ç©ã®çžå¯ŸåŒ·åºŠãæ±ãããå³ã¡èžè ºéçž®å¹æãé«ã
çšã該ååç©ã¯æ¯æ§ã匷ããšèšããã
ãè¡šã
ãè¡šã
å°ç¬¬ïŒè¡šã«ãããŠäŸè©Šåç©ãšããŠã¯ãäœé149
ã168ïœã®éæ§ã¹ãã©ãŒã°ïŒããŠãªãŠãŒã©ããã
çšããããŸãåæ°å€ã¯ïŒå¹³å±S.E.ïŒã瀺ãïŒã¯
ïŒ0.05ããïŒïŒã¯ïŒ°ïŒ0.01ãããŸãïŒïŒïŒã¯ïŒ°
ïŒ0.001ã倫ã 瀺ãã
ã168ïœã®éæ§ã¹ãã©ãŒã°ïŒããŠãªãŠãŒã©ããã
çšããããŸãåæ°å€ã¯ïŒå¹³å±S.E.ïŒã瀺ãïŒã¯
ïŒ0.05ããïŒïŒã¯ïŒ°ïŒ0.01ãããŸãïŒïŒïŒã¯ïŒ°
ïŒ0.001ã倫ã 瀺ãã
ãè¡šã
ãè¡šã
å°ç¬¬ïŒè¡šã«ãããŠäŸè©Šåç©ãšããŠã¯ãäœéçŽ
185ïœïŒ162ã209ïœïŒã®éæ§ã¹ãã©ãŒã°ïŒããŠãª
ãŠãŒã©ãããçšããããŸãåæ°å€ã¯ïŒå¹³å±S.
E.ïŒã瀺ããïŒã¯ïŒ°ïŒ0.05ããïŒïŒã¯ïŒ°ïŒ0.01ãã
ãŸãïŒïŒïŒã¯ïŒ°ïŒ0.001ã倫ã 瀺ãã
185ïœïŒ162ã209ïœïŒã®éæ§ã¹ãã©ãŒã°ïŒããŠãª
ãŠãŒã©ãããçšããããŸãåæ°å€ã¯ïŒå¹³å±S.
E.ïŒã瀺ããïŒã¯ïŒ°ïŒ0.05ããïŒïŒã¯ïŒ°ïŒ0.01ãã
ãŸãïŒïŒïŒã¯ïŒ°ïŒ0.001ã倫ã 瀺ãã
ãè¡šã
å°ç¬¬ïŒè¡šã«ãããŠäŸè©Šåç©ãšããŠã¯ãäœé91ã
112ïœã®éæ§ã¹ãã©ãŒã°ïŒããŠãªãŠãŒã©ãããçš
ããããŸãåæ°å€ã¯ïŒå¹³å±S.E.ïŒã瀺ããïŒã¯
ïŒ0.05ããïŒïŒã¯ïŒ°ïŒ0.01ãããŸãïŒïŒïŒã¯ïŒ°
ïŒ0.001ã倫ã 瀺ãã
112ïœã®éæ§ã¹ãã©ãŒã°ïŒããŠãªãŠãŒã©ãããçš
ããããŸãåæ°å€ã¯ïŒå¹³å±S.E.ïŒã瀺ããïŒã¯
ïŒ0.05ããïŒïŒã¯ïŒ°ïŒ0.01ãããŸãïŒïŒïŒã¯ïŒ°
ïŒ0.001ã倫ã 瀺ãã
ãè¡šã
å°ç¬¬10è¡šäž(a)ã¯ã100mgïŒKgïŒæ¥ã®æäžéã«ã
ããŠãããèžè ºééã®50ïŒ æžå°ã¯èªããããªãã
ãšã瀺ãã ïŒéèå æäžã«ããèžè ºé瞮詊éšïŒ æ¬çºæååç©ã®èžè ºéçž®äœçšããããŒã¿ãŒã¡ã¿
ãŸã³ 17âãã¬ã¬ãŒãã®ãããšå¯Ÿæ¯ããŠè©Šéšãè¡
ãªã€ãããã®è©Šéšã«ãããŠã¯è¢«éšè¬ãã©ããã«é
èå æäžãã綿çèèœè «åœ¢æè©Šéšã䜵çšãããäœ
éçŽ185ïœïŒ166ã196ïœïŒã®éæ§ã¹ãã©ãŒã°ïŒã
ãŠãªãŠãŒã©ãããçšããã倫ã 30mgã®äºã€ã®ç¶¿ç
ã殺èãåäŸè©Šåç©ã®èéšã®ç®äžå·Šå³ã«åïŒåã¥
ã€å蟌ãããã®æ¥ãå蟌ïŒæ¥ãšãããäŸè©Šååç©
ã0.8ïŒ ããªãœã«ããŒã80äžã«æžæ¿ããã綿çå
蟌ã®ç¿æ¥ããïŒæ¥éé£ç¶ããŠïŒæ¥ïŒåé泚ããã
å蟌ïŒæ¥ã«ãäŸè©Šåç©ã殺ããïŒã€ã®ç¶¿çããã®
倫ã ã®èèœè «ãšå ±ã«åãåºãã50âã®ãªãŒãã³äž
ã§äžå€ä¹Ÿç¥ããèšéããïŒä¹Ÿç¥èèœè «ééïŒãèž
è ºåã³æçµçäœéããèšé²ãããçµæã第11è¡šã«
瀺ãã ãã®è©Šéšã¯ãæ¬çºæã¹ããã€ããéèå ã«æäž
ãããšãã®å€±æŽ»æ§ã調ã¹ããã®ã§ãããæ¬äŸè©Šå
åç©ãšããŒã¿ãŒã¡ã¿ãŸã³ 17âãã¬ã¬ãŒããšã®å±
ææççã®çžå¯Ÿå䟡ã¯ç¬¬ïŒè¡šãã283ïŒ0.7ã§ã
ããããã¯æ¬äŸè©Šååç©ãããŒã¿ãŒã¡ã¿ãŸã³17â
ãã¬ã¬ãŒããããçŽ400å匷ãå±ææçç掻æ§ã
æããããšã瀺ããŠããããã®æ¬äŸè©Šååç©ãé
èå ã«æäžããå šèº«æ§æçç掻æ§ãããŒã¿ãŒã¡ã¿
ãŸã³ 17âãã¬ã¬ãŒããšæ¯èŒãããæ¬äŸè©Šååç©
ã«ããèèœè «åœ¢æã®æå¶ããã³èžè ºã®éçž®ã¯ããŒ
ã¿ãŒã¡ã¿ãŸã³ 17âãã¬ã¬ãŒãããã匱ãã€ãã
ãã®å®éšçµæããã容æã«ä»£è¬ïŒå€±æŽ»ïŒããªãå
åç©ã¯ãããšãã°ããŒã¿ãŒã¡ã¿ãŸã³17âãã¬ã¬ãŒ
ãã®å Žåã®åŠããå šèº«æ§æçç掻æ§ãçºçŸãããš
èããããã
ããŠãããèžè ºééã®50ïŒ æžå°ã¯èªããããªãã
ãšã瀺ãã ïŒéèå æäžã«ããèžè ºé瞮詊éšïŒ æ¬çºæååç©ã®èžè ºéçž®äœçšããããŒã¿ãŒã¡ã¿
ãŸã³ 17âãã¬ã¬ãŒãã®ãããšå¯Ÿæ¯ããŠè©Šéšãè¡
ãªã€ãããã®è©Šéšã«ãããŠã¯è¢«éšè¬ãã©ããã«é
èå æäžãã綿çèèœè «åœ¢æè©Šéšã䜵çšãããäœ
éçŽ185ïœïŒ166ã196ïœïŒã®éæ§ã¹ãã©ãŒã°ïŒã
ãŠãªãŠãŒã©ãããçšããã倫ã 30mgã®äºã€ã®ç¶¿ç
ã殺èãåäŸè©Šåç©ã®èéšã®ç®äžå·Šå³ã«åïŒåã¥
ã€å蟌ãããã®æ¥ãå蟌ïŒæ¥ãšãããäŸè©Šååç©
ã0.8ïŒ ããªãœã«ããŒã80äžã«æžæ¿ããã綿çå
蟌ã®ç¿æ¥ããïŒæ¥éé£ç¶ããŠïŒæ¥ïŒåé泚ããã
å蟌ïŒæ¥ã«ãäŸè©Šåç©ã殺ããïŒã€ã®ç¶¿çããã®
倫ã ã®èèœè «ãšå ±ã«åãåºãã50âã®ãªãŒãã³äž
ã§äžå€ä¹Ÿç¥ããèšéããïŒä¹Ÿç¥èèœè «ééïŒãèž
è ºåã³æçµçäœéããèšé²ãããçµæã第11è¡šã«
瀺ãã ãã®è©Šéšã¯ãæ¬çºæã¹ããã€ããéèå ã«æäž
ãããšãã®å€±æŽ»æ§ã調ã¹ããã®ã§ãããæ¬äŸè©Šå
åç©ãšããŒã¿ãŒã¡ã¿ãŸã³ 17âãã¬ã¬ãŒããšã®å±
ææççã®çžå¯Ÿå䟡ã¯ç¬¬ïŒè¡šãã283ïŒ0.7ã§ã
ããããã¯æ¬äŸè©Šååç©ãããŒã¿ãŒã¡ã¿ãŸã³17â
ãã¬ã¬ãŒããããçŽ400å匷ãå±ææçç掻æ§ã
æããããšã瀺ããŠããããã®æ¬äŸè©Šååç©ãé
èå ã«æäžããå šèº«æ§æçç掻æ§ãããŒã¿ãŒã¡ã¿
ãŸã³ 17âãã¬ã¬ãŒããšæ¯èŒãããæ¬äŸè©Šååç©
ã«ããèèœè «åœ¢æã®æå¶ããã³èžè ºã®éçž®ã¯ããŒ
ã¿ãŒã¡ã¿ãŸã³ 17âãã¬ã¬ãŒãããã匱ãã€ãã
ãã®å®éšçµæããã容æã«ä»£è¬ïŒå€±æŽ»ïŒããªãå
åç©ã¯ãããšãã°ããŒã¿ãŒã¡ã¿ãŸã³17âãã¬ã¬ãŒ
ãã®å Žåã®åŠããå šèº«æ§æçç掻æ§ãçºçŸãããš
èããããã
ãè¡šã
å°ç¬¬11è¡šäžåå€ã¯ïŒå¹³å±S.E.ïŒããïŒã¯ïŒ°ïŒ
0.05ããïŒïŒã¯ïŒ°ïŒ0.01ãããŸãïŒïŒïŒã¯ïŒ°ïŒ
0.001ã倫ã 瀺ãã å±æ綿çèèœè «åœ¢æè©Šéšã®ED50å€ïŒäŸãã°äž
èšç¬¬ïŒè¡šã«ç€ºãïŒåã³èžè ºé瞮詊éšã®TED40å€
ïŒäŸãã°äžèšç¬¬10è¡šã«ç€ºãïŒãããå ¬ç¥ã®ã¹ãã
ã€ãé¡ãšå¯Ÿæ¯ããŠæ¬çºæåååç©ã®çžå¯ŸåŒ·åºŠåã³
æ²»çã€ã³ããã¯ã¹ãæ±ãããçµæã¯ç¬¬12è¡šã®éã
ã§ãããæ¬çºæååç©ã¯ã匷åãªæçç掻æ§ãã
ã€ãã®ã§ããããå šèº«æ§å¯äœçšã極ããŠåŒ±ããšã
ãããšãå€ãã
0.05ããïŒïŒã¯ïŒ°ïŒ0.01ãããŸãïŒïŒïŒã¯ïŒ°ïŒ
0.001ã倫ã 瀺ãã å±æ綿çèèœè «åœ¢æè©Šéšã®ED50å€ïŒäŸãã°äž
èšç¬¬ïŒè¡šã«ç€ºãïŒåã³èžè ºé瞮詊éšã®TED40å€
ïŒäŸãã°äžèšç¬¬10è¡šã«ç€ºãïŒãããå ¬ç¥ã®ã¹ãã
ã€ãé¡ãšå¯Ÿæ¯ããŠæ¬çºæåååç©ã®çžå¯ŸåŒ·åºŠåã³
æ²»çã€ã³ããã¯ã¹ãæ±ãããçµæã¯ç¬¬12è¡šã®éã
ã§ãããæ¬çºæååç©ã¯ã匷åãªæçç掻æ§ãã
ã€ãã®ã§ããããå šèº«æ§å¯äœçšã極ããŠåŒ±ããšã
ãããšãå€ãã
ãè¡šã
ãè¡šã
æ¬çºæã®äžè¬åŒïŒïŒã®ååç©ã¯ãé©åœãªè¬ç
çã«èš±å®¹ãããæ äœãšå ±ã«ãå±æççã®æ²»ççšè¬
ççµæç©ãšããããšãã§ãããæ¬çºæã®ååç©
ã¯ãå šèº«æ§äœçšãæããªãç¹ãããå¿è«å šèº«æ§å¯
è ç®è³ªæ§æ²»çãæ瀺ããç çç¶æ äŸãã°å¯è ç®è³ª
äžå šçã®æ²»çãæå³ãããã®ã§ã¯ãªããæ¬çºæå
åç©ã®å°ãªããšãïŒçš®åã³ïŒãããã¯ãã以äžãš
è¬çæ äœãå«ãè¬ççµæç©ã«ããæ²»çå¯èœãªçç
ç¶æ ã®äŸãšããŠã¯æ¬¡ã®ãããªãã®ãæããããšã
ã§ãããå³ã¡äŸãã°ã¢ãããŒæ§ç®èçã座ç¡ã也
ç¬ãæ¥è§Šæ§ç®èççã®ç®èç§åŠççŸæ£ïŒäŸãã°æ°
管æ¯åæ¯çã®ã¢ã¬ã«ã®ãŒç¶æ ïŒæ¥æ§åã³æ ¢æ§ã®ã¢
ã¬ã«ã®ãŒåã³ççåå¿ãå«ãçŒåã³è³ã®çŸæ£ïŒåŒ
åžç³»çŸæ£ïŒæœ°çæ§å€§è žçïŒäžŠã³ã«çŽè žæ§ççãç
çŸãçŽè žèéçãé°çª©çãäºè£ãè¡åŸçåã³èé
çã«é¢é£ããççåã³çã¿çãäŸç€ºã§ããã
ãŸãæ¬çºæçµæç©ã¯ã移æ€ã«ããæ¹èµ·ãããçç
ãçµç¹æåŠã«å¯Ÿããäºé²èšºæå€ãšããŠå±æçã«ã
é©çšã§ããã æ¬çºæçµæç©ã«ãããæ äœåã³æäžåœ¢æ ã®éžæ
ã¯ã該çµæç©ãæäžãããæ¡ä»¶çã«å¿ããŠé©å®ã«
è¡ãªãããšãã§ããã å±ææäžã«é©ããåçš®å€åãšããŠã¯ãè»èå€ã
ããŒã·ãšã³ãã¯ãªãŒã ãç²æ«ã滎äžå€ïŒç¹çŒåã¯
ç¹è³å€ïŒãåŽé§å€ïŒéŒ»åã³åœåçšïŒã座å€ãæ»ç泚
è žå€ãååŒãããã¯åžå ¥å¯èœãªé å€ãããã¯é¡ç²
å€ïŒã¢ãã¿æ§æœ°çæ²»ççšïŒåã³ãšã¢ãŸãŒã«å€ãäŸ
瀺ã§ãããè»èå€åã³ã¯ãªãŒã ã¯ãé©åœãªå¢ç²å€
åã³ïŒåã¯ã²ã«åå€åã³ïŒåã¯ã°ãªã³ãŒã«é¡ãæ·»
å ããŠæ°Žæ§åºæãããã¯æ²¹æ§åºæãšå ±ã«è£œå€åã
ãããšãã§ãããäžèšåºæãšããŠã¯äŸãã°æ°Žå
ã³ïŒåã¯æ¶²äœãã©ãã€ã³çã®æ²¹ãããã¯èœåç
æ²¹ããŽãæ²¹çã®æ€ç©æ§æ²¹æã¯ãããã¬ã³ã°ãªã³ãŒ
ã«ãïŒïŒïŒâãã¿ã³ãžãªãŒã«çã®ã°ãªã³ãŒã«æº¶åª
çãäŸç€ºã§ãããå¢ç²å€ã¯äžèšåºæã«å¿ããŠçšã
ããããã®äŸãšããŠã¯è»ãã©ãã€ã³ãã¹ãã¢ãªã³
é žã¢ã«ãããŠã ãã»ãã¹ãã¢ãªã«ã¢ã«ã³ãŒã«
ïŒcetostearyl alcholïŒãããªãšãã¬ã³ã°ãªã³ãŒã«ã
çŸèãæ°Žæ·»ã©ããªã³åã³èããåã³ïŒåã¯ã¢ãã¹
ãã¢ãªã³é žã°ãªã»ãªã«åã³ïŒåã¯éã€ãªã³æ§çé¢
掻æ§å€ãäŸç€ºã§ããã è»èåã³ã¯ãªãŒã äžã®ã¹ããã€ãã®æº¶è§£æ§ãæ¹
åããããã«ãè³éŠæã¢ã«ã³ãŒã«äŸãã°ãã³ãžã«
ã¢ã«ã³ãŒã«ãããšãã«ãšãã«ã¢ã«ã³ãŒã«ãããšã
ãã·ãšãã«ã¢ã«ã³ãŒã«çãçšããããšãã§ããã ããŒã·ãšã³ã¯æ°Žæ§åºæåã¯æ²¹æ§åºæãçšããŠè£œ
å€åãããããã¯éåžžïŒãããã¯ãã以äžã®æ·»å
å€å³ã¡çé¢æŽ»æ§å€ãåæ£å€ãæžæ¿åå€ãå¢ç²å€ã
溶åªãçè²å€åã³éŠæãå«ãã§ãããç²æ«ã¯åçš®
ã®ç²æ«åºæãçšããŠèª¿è£œããããç²æ«åºæãšããŠ
ã¯äŸãã°ã¿ã«ã¯ãã©ã¯ããŒã¹åã¯ã¹ã¿ãŒããäŸç€º
ã§ããã滎äžå€ã亊ïŒä»¥äžã®åæ£å€ãæžæ¿åå€å
ã¯å¯æº¶åå€çãå«ãæ°Žæ§åºå€ãçšããŠèª¿è£œãã
ããåŽé§å€ã¯äŸãã°ãžã¯ãããžãã«ãªãã¡ã¿ã³ã
ããªã¯ãããã«ãªãã¡ã¿ã³çã®é©åœãªæšé²å€ãçš
ããŠãšã¢ãŸãŒã«ã®åœ¢æ ã«èª¿è£œããããšãã§ããã æ¬çºæçµæç©ã«ãããæå¹æåå«æéã¯ãçšã
ãããååç©ã調補ãããå€ååã³æäžæ¡ä»¶çã«
å¿ããŠé©å®ã«æ±ºå®ã§ãããé垞補å€ã¯äžè¬åŒ
ïŒïŒã®ååç©ãçŽ0.0001ãçŽ5.0ééïŒ å«ãããš
ãã§ãããå±ææäžçšè£œå€ã¯éåžž0.0001ã2.5é
éïŒ ã奜ãŸããã¯0.01ã0.5ééïŒ ã®äžè¬åŒïŒïŒ
ã®ååç©ãå«ãã§ãããããã¯äžæ¥äžåãããã¯
å¿ èŠæã«æäžããåŸãããŸãäžè¬ã«æ¬çºæååç©
ã¯ãå ¬ç¥ã®ç³è³ªã³ã«ãã³ã¹ããã€ãé¡ãå«ãéåžž
ã®çµæç©ãšåºæ¬çã«åæ§ã®å±ææäžçšçµæç©ã®åœ¢
æ ã«èª¿è£œã§ããããã®å Žåãã®æäžã¬ãã«ã¯ãå ¬
ç¥ã®é«æŽ»æ§ãªè¬å€äŸãã°ã¡ãã« ãã¬ãããœãã³
ã¢ã»ããŒãåã³ãã¯ãã¡ã¿ãŸã³ãžããããªããŒã
ãšå¯Ÿæ¯ããŠåæ§ã§ãããåã¯æ¬çºæååç©äžæã
匷åãªãã®ã®å Žåã¯ä»»æã«äœãããããšãã§ãã
ãŸãå ¬ç¥ã®äœæŽ»æ§ãªè¬å€äŸãã°ãããã³ã«ããŸã³
ãšå¯Ÿæ¯ããã°ãããªãäœãæäžã¬ãã«ãšããããš
ãã§ããã ããããŠåæ¯ã®æ²»ççšã®é©åœãªåžå ¥å€ã¯ãæ¬çº
æååç©äŸãã°17αâãšããã·ã«ã«ããã«ãªãã·
â11βâããããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒ
âãªã³â17βâã«ã«ãã³é žã¯ããã¡ãã«ãå«ãèš
éæäžãšã¢ãŸãŒã«åäœåœ¢æ ã«èª¿è£œã§ãããã®èª¿è£œ
ã¯éåžžã®æ¹æ³ã«åŸãåŸããããããšã¢ãŸãŒã«åäœ
圢æ ã¯ãŸãäŸãã°ããªã¯ãããã«ãªãã¡ã¿ã³åã³
ãžã¯ãããžãã«ãªãã¡ã¿ã³çã®æšé²å€äžã«äžèšå
åç©ã®åŸ®çŽ°çµæ¶æžæ¿ç©åã³ãªã¬ã€ã³é žåã¯ä»ã®é©
åœãªåæ£å€ãå«ãã§ããŠããããååäœã¯äžèšæ
å¹æåååç©ã®10mgãå«ãã§ããããã®çŽ50ÎŒïœ
ãåäœåã«ããæŸåºããããæ¬çºæååç©äžæã
匷åãªãã®ã®ã²ãšã€ã§ããäŸãã°17αâãšããã·
ã«ã«ããã«ãªãã·â9αâãã«ãªãâ11βâããã
ãã·â16αâã¡ãã«ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãš
ã³âïŒâãªã³â17βâã«ã«ãã³é žã¯ããã¡ãã«ã
çšããå Žåãååäœã¯è©²æå¹æåååç©ã®ïŒmgã
å«ãã§ãããåäœåã«ãããã®çŽ5ÎŒïœãæŸåºã
ããã æ¬çºæã®è¬ççµæç©ã®ä»ã®äŸãšããŠã¯ãåçš®ã®
ççæ§çŽè žçŸç ã®æ²»çã«é©ãã泡沫ãäŸç€ºã§ã
ããããã¯èéã«åã¯èå²ã«é©çšãããã該泡沫
ã¯ãç²çæ§æ³¡æ²«åºå€äŸãã°ãããã¬ã³ã°ãªã³ãŒ
ã«ããšããã·åã¹ãã¢ãªã«ã¢ã«ã³ãŒã«ãããªãªã
ã·ãšãã¬ã³â10âã¹ãã¢ãªã«ãšãŒãã«ãã»ãã«ã¢
ã«ã³ãŒã«ãã¡ãã«ãã©ãã³ããããã«ãã©ãã³ã
ããªãšã¿ããŒã«ã¢ãã³åã³æ°Žçã®åºå€äžã«äžè¬åŒ
ïŒïŒã®ååç©äŸãã°17αâãšããã·ã«ã«ããã«
ãªãã·â11βâããããã·ã¢ã³ããã¹ãâïŒâãš
ã³âïŒâãªã³â17βâã«ã«ãã³é žã¯ããã¡ãã«ã®
0.1ïŒ åã³å±æ麻é å€äŸãã°å¡©é žãã©ã¢ãã·ã³ã®
ïŒïŒ ãå«ãã§ããããŸãäžæŽ»æ§æšé²å€ãå«ãã§ã
ããæ¬çºæååç©äžãã匷åãªããã䜿çšããå Ž
åã¯ãéåžžããå°éã®æå¹æåéãæ¡çšãããã
äŸãã°9αâãã«ãªãâ11βâããããã·â17αâ
ã¡ããã·ã«ã«ããã«ãªãã·â16αâã¡ãã«ã¢ã³ã
ãã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â17βâã«ã«
ãã³é žã¯ããã¡ãã«ã¯0.05ïŒ ã®æ¿åºŠã§çšããã®ã
ããã æ¬çºæã®ä»ã®è¬ç圢æ ã®äŸãšããŠã¯æ»çæ³šè žã«
é©ãã溶液ä¹è³æžæ¿æ¶²ãäŸç€ºã§ããããã®åäœæ
äžåœ¢æ ã¯éåžžæ¬çºæååç©äŸãã°17αâãšããã·
ã«ã«ããã«ãªãã·â11βâããããã·ã¢ã³ããã¹
ãâïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é žã¯ã
ãã¡ãã«ã®40mgïŒåã¯ãã匷åãªæ¬çºæååç©äŸ
ãã°9αâãã«ãªãâ11βâããããã·â17αâã€
ãœããããã·ã«ã«ããã«ãªãã·â16βâã¡ãã«ã¢
ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â17βâ
ã«ã«ãã³é žã¯ããã¡ãã«åã¯9αâãã«ãªãâ11β
âããããã·â16αâã¡ãã«â17αâããããã·
ã«ã«ããã«ãªãã·ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³
âïŒâãªã³â17βâã«ã«ãã³é žã¯ããã¡ãã«ã®å Ž
åã«ã¯ãããã®å€«ã 20mgïŒããå¡©åãããªãŠã ã
ããªãœã«ããŒã80åã³ïŒãïŒãªã³ã¹ïŒçŽ28.3ã
170ïœïŒã®æ°ŽïŒæ°Žã¯çšææ·»å ãããïŒãšå ±ã«å«æ
ããŠãããäžèšæžæ¿æ¶²ã¯ã朰çæ§å€§è žçã®æ²»çã«
ãããŠã¯æ¯é±æ°åãé£ç¶ç滎泚ã«ãããåã¯æ»ç
è žæ³šãšããŠæäžãããã æ¬çºæã®ä»ã®è¬ç圢æ ã¯ãåŸèšããåå®æœäŸã«
瀺ãéãã§ããã äžèšèšè¿°ãããæŽã«è©³è¿°ãããŸã§ããªããåœæ¥
è ã¯æ¬çºæå 容ã®ãã¹ãŠãå åã«å©çšã§ããæã§
ãããåŸã€ãŠä»¥äžã«è¿°ã¹ãå®æœäŸã¯åã«æ¬çºæã
äŸèšãããã®ã§ãããæ¬çºæã¯äœããããã«éå®
ããããã®ã§ã¯ãªãã å®æœäŸ ïŒ ããã©ããããã©ã³120mlåã³ã¡ã¿ããŒã«30ml
ã«ãã€ããã³ãŒããŸã³ïŒ15ïœã0.04ã¢ã«ïŒã溶解
ãã溶液ã«ã«ã宀枩äžæ°Ž100mlã«ã¡ã¿éãšãŠçŽ é ž
ãããªãŠã ïŒ25.7ïœã0.12ã¢ã«ïŒã溶解ãã枩溶
液ïŒã»ãŒ50âïŒãæ·»å ãããåå¿æ··åç©ã宀枩äž
ã«ïŒæéæ¹æãã次ãã§æžå§äžã«æ¿çž®ããŠããã©
ããããã©ã³åã³ã¡ã¿ããŒã«ãçå»ãããåŸãã
ãåºäœãæ°Ž50mlãçšããŠç²ç ããéã«ããåé¢
ããæ°ŽæŽããç空äž50âã«ãŠïŒæé也ç¥ãããæ¯
ãããŠçæç©ã11βïŒ17αâãžããããã·ã¢ã³ã
ãã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é ž
ïŒå³ã¡ã³ã«ããšããã¯ã¢ã·ããïŒãã»ãŒ96ïŒ ã®å
çïŒ13.76ïœïŒã§åŸããããèç¹231ã234â 該çæç©ã¯äžèšæ§é åŒã§è¡šããããã å®æœäŸ ïŒ 11βïŒ17αâãžããããã·ã¢ã³ããã¹ãâïŒâ
ãšã³âïŒâãªã³â17βâã«ã«ãã³é žïŒ5wïŒïœïŒ ã
ïŒã¢ã«ïŒåã³ããªãšãã«ã¢ãã³ïŒïŒã¢ã«ïŒããžã¯
ããã¡ã¿ã³ã«æº¶è§£ããå·æº¶æ¶²ã«ã¯ãã«è»é žã¡ãã«
ïŒ3.9ã¢ã«ïŒã®50wïŒïœïŒ ãžã¯ããã¡ã¿ã³æº¶æ¶²ãæ·»
å ãããåå¿æ··åç©ã宀枩ã«ïŒæéæŸçœ®ãããç
æããããªãšãã«ã¢ãã³å¡©é žå¡©ã®æ²æŸ±ç©ãå»
ãã液ãïŒïŒ éçé žãããªãŠã ãåžïŒãïŒïŒ ïŒ
å¡©é žåã³æ°ŽãçšããŠæŽæµãããææ©å±€ãåé¢ãã
ç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥ããéããã液ãç
空äžã«æ¿çž®ãã泡沫ã次ã®ã¹ãããïŒäŸãã°äžèš
å®æœäŸïŒïŒã«äœ¿çšãããåã¯ã¯ãããã°ã©ãã«ã
ãçµæ¶åããŠåæã«äŸãããçæç©ã¯11βâãã
ããã·â17αâã¡ããã·ã«ã«ããã«ãªãã·ã¢ã³ã
ãã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é ž
ã§ãããã¯ãããã°ã©ãã€ãŒåã³çµæ¶åããåŸã®
èç¹ã¯198ã204âã§ããã IRïŒKBrïŒcm-13000ã2800ïŒïŒ£âïŒšïŒ 1750ã1735ã1720ïŒïŒ£ïŒïŒ¯ïŒ 1650ã1640ïŒïŒ£ïŒïŒ£âïŒïŒ¯ïŒ 該çæç©ã¯äžèšæ§é åŒã§è¡šããããã ã¯ãã«è»é žã¡ãã«ã®ä»£ãã«åéã®ã¯ãã«è»é žãš
ãã«ãçšããäžèšãšåæ§ã«æäœããŠ17αâãšãã
ã·ã«ã«ããã«ãªãã·â11βâããããã·ã¢ã³ãã
ã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é žã
åŸããã¯ãããã°ã©ãã€ãŒåã³çµæ¶ååŸã®èç¹ã¯
192ã195âã§ããã IRïŒKBrïŒcm-13500ïŒ11βââïŒšïŒ 3000ã2800ïŒïŒ£âïŒšïŒ 1740ïŒïŒ£ïŒïŒ¯ïŒ 1630ïŒïŒ£ïŒïŒ£âïŒïŒ¯ïŒ NMRïŒCDCl3ïŒÎŽ6.4ïŒïœãïŒãCOOïŒšïŒ 5.67ïŒïœãïŒãïŒïŒ£ïŒšïŒ 4.43ïŒïœãïŒãOHïŒ 4.13ïŒïœãïŒãïŒ7.5HzãCH2 CH3ïŒ å çŽ åæïŒC23H32O7ãšããŠïŒ èšç®å€ïŒïŒ ïŒ C65.69 H7.67 å®æž¬å€ïŒïŒ ïŒ C65.76 H7.74 ã¯ããè»é žã¡ãã«ã®ä»£ãã«åéã®ã¯ãã«è»é žã
ãã«ãçšããäžèšãšåæ§ã«æäœããŠ17αâããã
ã·ã«ã«ããã«ãªãã·â11βâããããã·ã¢ã³ãã
ã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é žã
åŸããããã©ããããã©ã³âãããµã³ããçµæ¶åŸ
ã®ãã®ååç©ã®èç¹ã¯164ã166âã§ããã ã¯ããè»é žã¡ãã«ã®ä»£ãã«åéã®ã¯ããè»é žã€
ãœãããã«ãçšããäžèšãšåæ§ã«æäœããŠ11βâ
ããããã·â17αâã€ãœããããã·ã«ã«ããã«ãª
ãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17βâ
ã«ã«ãã³é žãåŸããããã©ããããã©ã³âãããµ
ã³ããçµæ¶åŸã®ãã®ååç©ã®èç¹ã¯144.5ã146.5
âã§ããã å®æœäŸ ïŒ 11βâããããã·â17αâã¡ããã·ã«ã«ããã«
ãªãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17β
âã«ã«ãã³é žãçéã®1Næ°Žé žåãããªãŠã ãšã¡
ã¿ããŒã«äžã«ãŠçµåããããã®æº¶æ¶²ããšãã«ãšãŒ
ãã«ãçšããŠ100åã«åžéãããåŸãããæžæ¿æ¶²
ãïŒæéå·åŽããã次ãã§çæããçµæ¶ãé
ããææ°ãã·ã±ãŒã¿ãŒäžã§ä¹Ÿç¥ãããããµã¡ãã«
ãªã³é žã¢ããïŒ10wïŒïœïŒ ïŒã«æº¶è§£ããã é žå¡©å³ã¡11βâããããã·â17αâã¡ããã·ã«
ã«ããã«ãªãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãª
ã³â17βâã«ã«ãã³é žãããªãŠã ãïŒã¢ã«å«æã
ãäžèšæº¶æ¶²ãæ²åã¯ããã¡ãã«ïŒã¢ã«ãšçµåãã
ããåå¿æ··åç©ã宀枩äžã«ïŒæéç¶æãã次ãã§
é ¢é žãšãã«ãçšããŠ10åã«åžéãããåžéããã
åå¿æ··åç©ãïŒïŒ ããªç¡«é žãããªãŠã ãïŒïŒ éç
é žãããªãŠã åã³æ°ŽãçšããŠæŽæµãããææ©å±€ã
åé¢ããç¡«é žãã°ãã·ãŠã ãçšããŠä¹Ÿç¥ããé
ããã液ãç空äžã«æ¿çž®ãã泡沫ãšããã泡沫
ãé©åœãªæº¶åªïŒãšãã«ãšãŒãã«åã¯ããã©ããã
ãã©ã³ïŒãããµã³ïŒããçµæ¶åããããšã«ãã粟
補ãããæ¯ãããŠ11βâããããã·â17αâã¡ã
ãã·ã«ã«ããã«ãªãã·ã¢ã³ããã¹ãâïŒâãšã³â
ïŒâãªã³â17βâã«ã«ãã³é žã¯ããã¡ãã«ãåŸ
ããçµæ¶ååŸã®èç¹ã¯171ã173âã§ããã IRïŒKBrïŒcm-13000ã2800ïŒïŒ£âïŒšïŒ 1760ã1748ïŒïŒ£ïŒïŒ¯ïŒ 1650ïŒïŒ£ïŒïŒ£âïŒïŒ¯ïŒ NMRïŒCDCl3ïŒÎŽ5.67ïŒïœãïŒãïŒïŒ£ïŒšïŒ 5.82ã5.62ïŒABqãïŒãïŒ5.5HzãâOCH2ClïŒ 4.47ïŒïœãïŒãOHïŒ å çŽ åæïŒC23H31ClOãšããŠïŒ èšç®å€ïŒïŒ ïŒ C60.72 H6.87 Cl7.79 å®æž¬å€ïŒïŒ ïŒ C60.50 H7.06 Cl7.50 çæç©ã¯äžèšæ§é åŒã§è¡šããããã äžèšã§çšããã¹ããã€ãæ§é žã«ä»£ãåéã®17α
âãšããã·ã«ã«ããã«ãªãã·â11βâããããã·
ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«
ãã³é žãçšããäžèšãšåæ§ã«æäœããŠãäžéäœãš
ããŠ17αâãšããã·ã«ã«ããã«ãªãã·â11βâã
ãããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â
17βâã«ã«ãã³é žãããªãŠã ãããŸãæçµçæç©
ãšããŠ17αâãšããã·ã«ã«ããã«ãªãã·â11βâ
ããããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â
17βâã«ã«ãã³é žã¯ããã¡ãã«ãåŸããæçµåå
ç©ã®ç©æ§ã¯ä»¥äžã®éãã§ããã çµæ¶ååŸã®èç¹197ã200â IRïŒKBrïŒcm-13600ã3200ïŒïŒ¯âïŒšïŒ 3000ã2800ïŒïŒ£âïŒšïŒ 1763ã1740ïŒïŒ£ïŒïŒ¯ïŒ 1650ïŒïŒ£ïŒïŒ£âïŒïŒ¯ïŒ NMRïŒCDCl3ïŒÎŽ5.7ïŒïœãïŒãïŒïŒ£ïŒšïŒ 5.81ã5.62ïŒABqãïŒãïŒïŒHzãâOC 2ClïŒ å çŽ åæïŒC24H33ClO7ãšããŠïŒ èšç®å€ïŒïŒ ïŒ C61.46 H7.09 å®æž¬å€ïŒïŒ ïŒ C61.58 H7.08 äžèšã§çšããã¹ããã€ãæ§é žã«ä»£ãåéã®17α
âãããã·ã«ã«ããã«ãªãã·â11βâããããã·
ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«
ãã³é žãçšããäžèšãšåæ§ã«æäœããŠãäžéäœãš
ããŠ17αâãããã·ã«ã«ããã«ãªãã·â11βâã
ãããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â
17βâã«ã«ãã³é žãããªãŠã ãããŸãæçµçæç©
ãšããŠ17αâãããã·ã«ã«ããã«ãªãã·â11βâ
ããããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â
17βâã«ã«ãã³é žã¯ããã¡ãã«ãåŸããæçµåå
ç©ã®ç©æ§ã¯ä»¥äžã®éãã§ããã çµæ¶ååŸã®èç¹98ã100â IRïŒKBrïŒcm-13600ã3300ïŒïŒ¯âïŒšïŒ 3000ã2800ïŒïŒ£âïŒšïŒ 1765ïŒO2CïŒïŒ¯ïŒ 1735ïŒOCïŒïŒ¯ïŒ 1650ïŒïŒ£ïŒïŒ£âïŒïŒ¯ïŒ NMRïŒCDCl3ïŒÎŽ5.80ã5.60ïŒABqãïŒãïŒ4.5
HzãâOC 2ClïŒ 5.67ïŒïœãïŒãïŒïŒ£ïŒšïŒ 4.45ïŒïœãïŒãOHïŒ 4.08ïŒïœãïŒãïŒïŒHzãO2COCH2 âCH2ïŒ å çŽ åæïŒC26H37ClO7ãšããŠïŒ èšç®å€ïŒïŒ ïŒ C62.77 H7.44 Cl7.14 å®æž¬å€ïŒïŒ ïŒ C62.88 H7.23 Cl7.30 äžèšã§çšããã¹ããã€ãæ§é žã«ä»£ãåéã®11β
âããããã·â17αâã€ãœããããã·ã«ã«ããã«
ãªãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17β
âã«ã«ãã³é žãçšããäžèšãšåæ§ã«æäœããŠãäž
éäœãšããŠ11βâããããã·â17αâã€ãœããã
ãã·ã«ã«ããã«ãªãã·ã¢ã³ããã¹ãâïŒâãšã³â
ïŒâãªã³â17βâã«ã«ãã³é žãããªãŠã ãããŸã
æçµçæç©ãšããŠ11βâããããã·â17αâã€ãœ
ããããã·ã«ã«ããã«ãªãã·ã¢ã³ããã¹ãâïŒâ
ãšã³âïŒâãªã³â17βâã«ã«ãã³é žã¯ããã¡ãã«
ãåŸããããã©ããããã©ã³âãããµã³ããåçµ
æ¶ååŸã®æçµååç©ã®èç¹ã¯183.5ã184.5âã§ã
ãã äžèšã§çšããã¹ããã€ãæ§é žã«ä»£ã17αâãšã
ãã·ã«ã«ããã«ãªãã·â11βâããããã·ã¢ã³ã
ãã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é ž
ãçšãããŸãæ²åã¯ããã¡ãã«ã®ä»£ãã«åéã®å¡©
åããã«ãçšããïŒïŒ ããªç¡«é žãããªãŠã ã§æŽæµ
ãè¡ãªããªã以å€ã¯å®è³ªçã«äžèšãšåæ§ã«æäœã
ããæ¯ãããŠäžéäœãšããŠ17αâãšããã·ã«ã«ã
ãã«ãªãã·â11βâããããã·ã¢ã³ããã¹ãâïŒ
âãšã³âïŒâãªã³â17βâã«ã«ãã³é žãããªãŠã
ãããŸãæçµçæç©ãšããŠ17αâãšããã·ã«ã«ã
ãã«ãªãã·â11βâããããã·ã¢ã³ããã¹ãâïŒ
âãšã³âïŒâãªã³â17βâã«ã«ãã³é žããã«ãåŸ
ããã¢ã»ãã³ããåçµæ¶åŸã®æçµååç©ã®èç¹ã¯
148ã149âã§ããããŸãã¯ãããã°ã©ãã€ãŒåã³
çµæ¶ååŸã®æçµååç©ã®ç©æ§ã¯ä»¥äžã®éãã§ã
ãã IRïŒKBrïŒcm-13600ã3200ïŒïŒ¯âïŒšïŒ 3000ã2800ïŒïŒ£âïŒšïŒ 1750ïŒ2CïŒïŒ¯ïŒ 1670ïŒïŒ£ïŒïŒ£âïŒïŒ¯ïŒ NMRïŒCDCl3ïŒÎŽ5.64ïŒïœãïŒãâïŒïŒ£ïŒšïŒ 4.46ïŒïœãïŒãOHïŒ 4.32ã4.95ïŒïœãïŒãCOOC 2CH3ãCOOC
2CH2âïŒ å çŽ åæïŒC27H40O7ãšããŠïŒ èšç®å€ïŒïŒ ïŒ C67.99 H8.39 å®æž¬å€ïŒïŒ ïŒ C67.76 H7.47 å®æœäŸ ïŒ 17αâãšããã·ã«ã«ããã«ãªãã·â11βâãã
ããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17β
âã«ã«ãã³é žïŒïŒïœã7.13ããªã¢ã«ïŒã1Mæ°Žé ž
åãããªãŠã ã¡ã¿ããŒã«æº¶æ¶²7.13mlã§åŠçãã次
ãã§ãšãã«ãšãŒãã«500mlãå ããŠæ²æ®¿ãçãã
ãããæ²æ®¿ç©ãéã«ããåé¢ããäžå€ææ°ãã·
ã±ãŒã¿ãŒäžã§ä¹Ÿç¥ããŠææã®å¡©ãå³ã¡17αâãšã
ãã·ã«ã«ããã«ãªãã·â11βâããããã·ã¢ã³ã
ãã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é ž
ãããªãŠã 2.71ïœïŒ6.12ããªã¢ã«ïŒãé»è²ç²æ«ãš
ããŠåŸãã該塩ããããµã¡ãã«ãªã³é žã¢ãã40ml
ã«æº¶è§£ããã¯ããã¡ãã«ã¡ãã«ã¹ã«ãã€ãïŒ2.36
ïœã24.5ããªã¢ã«ïŒãåŸã ã«å ãããïŒåé以å
ã«åå¿æ··åç©äžã«å¡©åãããªãŠã ã®æ²æ®¿ãçæã
ããåå¿æ··åç©ã宀枩äžã«ïŒæéæ¹æãã次ãã§
ç·éã200mlã«ãªããŸã§é ¢é žãšãã«ãåžéããïŒ
ïŒ éçé žãããªãŠã åã³æ°ŽãçšããŠæŽæµãããæ
æ©å±€ãåé¢ããç¡«é žãã°ãã·ãŠã ãçšããŠä¹Ÿç¥
ããéããã液ãç空äžã«æ¿çž®ããåŸããã
ãªã€ã«ãå±é溶åªãšããŠé ¢é žãšãã«ãã¯ãããã«
ã åã³é ¢é žãçšããã·ãªã«ã²ã«ã«ã©ã ã¯ãããã°
ã©ãã€ãŒã«ããããã¯ãããã°ã©ãã€ãŒã«ããåŸ
ãããçæç©ããšãã«ãšãŒãã«ãšãããµã³ãšã®æ··
å溶åªããçµæ¶åããŠçœè²ç²æ«ç¶çµæ¶ãèç¹133
ã136âã®17αâãšããã·ã«ã«ããã«ãªãã·â11β
âããããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³
â17βâã«ã«ãã³é žã¡ãã«ããªã¡ãã«ãåŸãã該
çæç©ã¯äžèšæ§é åŒã§è¡šããããã ãžã¯ããã¡ã¿ã³ïŒmlã«17αâãšããã·ã«ã«ãã
ã«ãªãã·â11βâããããã·ã¢ã³ããã¹ãâïŒâ
ãšã³âïŒâãªã³â17βâã«ã«ãã³é žã¡ãã«ããªã¡
ãã«ïŒ0.48ïœãïŒããªã¢ã«ïŒã溶解ãã溶液ã«ã
ïœâã¯ããéå®æ¯éŠé žïŒ0.4ïœïŒéé ž0.34ïœã«çž
åœãïŒããªã¢ã«ïŒãå ãããçºç±åå¿ãèµ·ãã
ããããã«æ¢ããåå¿æ··åç©ã宀枩äžã«ïŒæéæ¹
æãããçæããæ²æ®¿ç©ãéã«ããååºãã
液ãç空äžã«æ¿çž®ããŠã17αâãšããã·ã«ã«ãã
ã«ãªãã·â11βâããããã·ã¢ã³ããã¹ãâïŒâ
ãšã³âïŒâãªã³â17βâã«ã«ãã³é žã¡ãã«ã¹ã«ã
ãã«ã¡ãã«ãçœè²æ³¡æ²«ãšããŠåŸãããã®ååç©ã¯
äžèšæ§é åŒã§è¡šããããã NMRïŒCDCl3ïŒÎŽ5.07ïŒïœãïŒãOC 2SO2ïŒ 2.97ïŒïœãïŒãSO2C 3ïŒ ïœâã¯ããéå®æ¯éŠé žïŒããªã¢ã«ãçšãã以å€
ã¯äžèšãšåæ§ã«æäœããŠã17αâãšããã·ã«ã«ã
ãã«ãªãã·â11βâããããã·ã¢ã³ããã¹ãâïŒ
âãšã³âïŒâãªã³â17βâã«ã«ãã³é žã¡ãã«ã¹ã«
ãã€ãã«ã¡ãã«ãåŸãã å®æœäŸ 5A å®æœäŸïŒã§çšãããã€ããã³ãŒããŸã³ã®ä»£ãã«
åéã®äžèšã«ç€ºãåºçºç©è³ªãçšããäžèšãšåæ§ã«
ããŠäžèšååç©ãåŸãã
çã«èš±å®¹ãããæ äœãšå ±ã«ãå±æççã®æ²»ççšè¬
ççµæç©ãšããããšãã§ãããæ¬çºæã®ååç©
ã¯ãå šèº«æ§äœçšãæããªãç¹ãããå¿è«å šèº«æ§å¯
è ç®è³ªæ§æ²»çãæ瀺ããç çç¶æ äŸãã°å¯è ç®è³ª
äžå šçã®æ²»çãæå³ãããã®ã§ã¯ãªããæ¬çºæå
åç©ã®å°ãªããšãïŒçš®åã³ïŒãããã¯ãã以äžãš
è¬çæ äœãå«ãè¬ççµæç©ã«ããæ²»çå¯èœãªçç
ç¶æ ã®äŸãšããŠã¯æ¬¡ã®ãããªãã®ãæããããšã
ã§ãããå³ã¡äŸãã°ã¢ãããŒæ§ç®èçã座ç¡ã也
ç¬ãæ¥è§Šæ§ç®èççã®ç®èç§åŠççŸæ£ïŒäŸãã°æ°
管æ¯åæ¯çã®ã¢ã¬ã«ã®ãŒç¶æ ïŒæ¥æ§åã³æ ¢æ§ã®ã¢
ã¬ã«ã®ãŒåã³ççåå¿ãå«ãçŒåã³è³ã®çŸæ£ïŒåŒ
åžç³»çŸæ£ïŒæœ°çæ§å€§è žçïŒäžŠã³ã«çŽè žæ§ççãç
çŸãçŽè žèéçãé°çª©çãäºè£ãè¡åŸçåã³èé
çã«é¢é£ããççåã³çã¿çãäŸç€ºã§ããã
ãŸãæ¬çºæçµæç©ã¯ã移æ€ã«ããæ¹èµ·ãããçç
ãçµç¹æåŠã«å¯Ÿããäºé²èšºæå€ãšããŠå±æçã«ã
é©çšã§ããã æ¬çºæçµæç©ã«ãããæ äœåã³æäžåœ¢æ ã®éžæ
ã¯ã該çµæç©ãæäžãããæ¡ä»¶çã«å¿ããŠé©å®ã«
è¡ãªãããšãã§ããã å±ææäžã«é©ããåçš®å€åãšããŠã¯ãè»èå€ã
ããŒã·ãšã³ãã¯ãªãŒã ãç²æ«ã滎äžå€ïŒç¹çŒåã¯
ç¹è³å€ïŒãåŽé§å€ïŒéŒ»åã³åœåçšïŒã座å€ãæ»ç泚
è žå€ãååŒãããã¯åžå ¥å¯èœãªé å€ãããã¯é¡ç²
å€ïŒã¢ãã¿æ§æœ°çæ²»ççšïŒåã³ãšã¢ãŸãŒã«å€ãäŸ
瀺ã§ãããè»èå€åã³ã¯ãªãŒã ã¯ãé©åœãªå¢ç²å€
åã³ïŒåã¯ã²ã«åå€åã³ïŒåã¯ã°ãªã³ãŒã«é¡ãæ·»
å ããŠæ°Žæ§åºæãããã¯æ²¹æ§åºæãšå ±ã«è£œå€åã
ãããšãã§ãããäžèšåºæãšããŠã¯äŸãã°æ°Žå
ã³ïŒåã¯æ¶²äœãã©ãã€ã³çã®æ²¹ãããã¯èœåç
æ²¹ããŽãæ²¹çã®æ€ç©æ§æ²¹æã¯ãããã¬ã³ã°ãªã³ãŒ
ã«ãïŒïŒïŒâãã¿ã³ãžãªãŒã«çã®ã°ãªã³ãŒã«æº¶åª
çãäŸç€ºã§ãããå¢ç²å€ã¯äžèšåºæã«å¿ããŠçšã
ããããã®äŸãšããŠã¯è»ãã©ãã€ã³ãã¹ãã¢ãªã³
é žã¢ã«ãããŠã ãã»ãã¹ãã¢ãªã«ã¢ã«ã³ãŒã«
ïŒcetostearyl alcholïŒãããªãšãã¬ã³ã°ãªã³ãŒã«ã
çŸèãæ°Žæ·»ã©ããªã³åã³èããåã³ïŒåã¯ã¢ãã¹
ãã¢ãªã³é žã°ãªã»ãªã«åã³ïŒåã¯éã€ãªã³æ§çé¢
掻æ§å€ãäŸç€ºã§ããã è»èåã³ã¯ãªãŒã äžã®ã¹ããã€ãã®æº¶è§£æ§ãæ¹
åããããã«ãè³éŠæã¢ã«ã³ãŒã«äŸãã°ãã³ãžã«
ã¢ã«ã³ãŒã«ãããšãã«ãšãã«ã¢ã«ã³ãŒã«ãããšã
ãã·ãšãã«ã¢ã«ã³ãŒã«çãçšããããšãã§ããã ããŒã·ãšã³ã¯æ°Žæ§åºæåã¯æ²¹æ§åºæãçšããŠè£œ
å€åãããããã¯éåžžïŒãããã¯ãã以äžã®æ·»å
å€å³ã¡çé¢æŽ»æ§å€ãåæ£å€ãæžæ¿åå€ãå¢ç²å€ã
溶åªãçè²å€åã³éŠæãå«ãã§ãããç²æ«ã¯åçš®
ã®ç²æ«åºæãçšããŠèª¿è£œããããç²æ«åºæãšããŠ
ã¯äŸãã°ã¿ã«ã¯ãã©ã¯ããŒã¹åã¯ã¹ã¿ãŒããäŸç€º
ã§ããã滎äžå€ã亊ïŒä»¥äžã®åæ£å€ãæžæ¿åå€å
ã¯å¯æº¶åå€çãå«ãæ°Žæ§åºå€ãçšããŠèª¿è£œãã
ããåŽé§å€ã¯äŸãã°ãžã¯ãããžãã«ãªãã¡ã¿ã³ã
ããªã¯ãããã«ãªãã¡ã¿ã³çã®é©åœãªæšé²å€ãçš
ããŠãšã¢ãŸãŒã«ã®åœ¢æ ã«èª¿è£œããããšãã§ããã æ¬çºæçµæç©ã«ãããæå¹æåå«æéã¯ãçšã
ãããååç©ã調補ãããå€ååã³æäžæ¡ä»¶çã«
å¿ããŠé©å®ã«æ±ºå®ã§ãããé垞補å€ã¯äžè¬åŒ
ïŒïŒã®ååç©ãçŽ0.0001ãçŽ5.0ééïŒ å«ãããš
ãã§ãããå±ææäžçšè£œå€ã¯éåžž0.0001ã2.5é
éïŒ ã奜ãŸããã¯0.01ã0.5ééïŒ ã®äžè¬åŒïŒïŒ
ã®ååç©ãå«ãã§ãããããã¯äžæ¥äžåãããã¯
å¿ èŠæã«æäžããåŸãããŸãäžè¬ã«æ¬çºæååç©
ã¯ãå ¬ç¥ã®ç³è³ªã³ã«ãã³ã¹ããã€ãé¡ãå«ãéåžž
ã®çµæç©ãšåºæ¬çã«åæ§ã®å±ææäžçšçµæç©ã®åœ¢
æ ã«èª¿è£œã§ããããã®å Žåãã®æäžã¬ãã«ã¯ãå ¬
ç¥ã®é«æŽ»æ§ãªè¬å€äŸãã°ã¡ãã« ãã¬ãããœãã³
ã¢ã»ããŒãåã³ãã¯ãã¡ã¿ãŸã³ãžããããªããŒã
ãšå¯Ÿæ¯ããŠåæ§ã§ãããåã¯æ¬çºæååç©äžæã
匷åãªãã®ã®å Žåã¯ä»»æã«äœãããããšãã§ãã
ãŸãå ¬ç¥ã®äœæŽ»æ§ãªè¬å€äŸãã°ãããã³ã«ããŸã³
ãšå¯Ÿæ¯ããã°ãããªãäœãæäžã¬ãã«ãšããããš
ãã§ããã ããããŠåæ¯ã®æ²»ççšã®é©åœãªåžå ¥å€ã¯ãæ¬çº
æååç©äŸãã°17αâãšããã·ã«ã«ããã«ãªãã·
â11βâããããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒ
âãªã³â17βâã«ã«ãã³é žã¯ããã¡ãã«ãå«ãèš
éæäžãšã¢ãŸãŒã«åäœåœ¢æ ã«èª¿è£œã§ãããã®èª¿è£œ
ã¯éåžžã®æ¹æ³ã«åŸãåŸããããããšã¢ãŸãŒã«åäœ
圢æ ã¯ãŸãäŸãã°ããªã¯ãããã«ãªãã¡ã¿ã³åã³
ãžã¯ãããžãã«ãªãã¡ã¿ã³çã®æšé²å€äžã«äžèšå
åç©ã®åŸ®çŽ°çµæ¶æžæ¿ç©åã³ãªã¬ã€ã³é žåã¯ä»ã®é©
åœãªåæ£å€ãå«ãã§ããŠããããååäœã¯äžèšæ
å¹æåååç©ã®10mgãå«ãã§ããããã®çŽ50ÎŒïœ
ãåäœåã«ããæŸåºããããæ¬çºæååç©äžæã
匷åãªãã®ã®ã²ãšã€ã§ããäŸãã°17αâãšããã·
ã«ã«ããã«ãªãã·â9αâãã«ãªãâ11βâããã
ãã·â16αâã¡ãã«ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãš
ã³âïŒâãªã³â17βâã«ã«ãã³é žã¯ããã¡ãã«ã
çšããå Žåãååäœã¯è©²æå¹æåååç©ã®ïŒmgã
å«ãã§ãããåäœåã«ãããã®çŽ5ÎŒïœãæŸåºã
ããã æ¬çºæã®è¬ççµæç©ã®ä»ã®äŸãšããŠã¯ãåçš®ã®
ççæ§çŽè žçŸç ã®æ²»çã«é©ãã泡沫ãäŸç€ºã§ã
ããããã¯èéã«åã¯èå²ã«é©çšãããã該泡沫
ã¯ãç²çæ§æ³¡æ²«åºå€äŸãã°ãããã¬ã³ã°ãªã³ãŒ
ã«ããšããã·åã¹ãã¢ãªã«ã¢ã«ã³ãŒã«ãããªãªã
ã·ãšãã¬ã³â10âã¹ãã¢ãªã«ãšãŒãã«ãã»ãã«ã¢
ã«ã³ãŒã«ãã¡ãã«ãã©ãã³ããããã«ãã©ãã³ã
ããªãšã¿ããŒã«ã¢ãã³åã³æ°Žçã®åºå€äžã«äžè¬åŒ
ïŒïŒã®ååç©äŸãã°17αâãšããã·ã«ã«ããã«
ãªãã·â11βâããããã·ã¢ã³ããã¹ãâïŒâãš
ã³âïŒâãªã³â17βâã«ã«ãã³é žã¯ããã¡ãã«ã®
0.1ïŒ åã³å±æ麻é å€äŸãã°å¡©é žãã©ã¢ãã·ã³ã®
ïŒïŒ ãå«ãã§ããããŸãäžæŽ»æ§æšé²å€ãå«ãã§ã
ããæ¬çºæååç©äžãã匷åãªããã䜿çšããå Ž
åã¯ãéåžžããå°éã®æå¹æåéãæ¡çšãããã
äŸãã°9αâãã«ãªãâ11βâããããã·â17αâ
ã¡ããã·ã«ã«ããã«ãªãã·â16αâã¡ãã«ã¢ã³ã
ãã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â17βâã«ã«
ãã³é žã¯ããã¡ãã«ã¯0.05ïŒ ã®æ¿åºŠã§çšããã®ã
ããã æ¬çºæã®ä»ã®è¬ç圢æ ã®äŸãšããŠã¯æ»çæ³šè žã«
é©ãã溶液ä¹è³æžæ¿æ¶²ãäŸç€ºã§ããããã®åäœæ
äžåœ¢æ ã¯éåžžæ¬çºæååç©äŸãã°17αâãšããã·
ã«ã«ããã«ãªãã·â11βâããããã·ã¢ã³ããã¹
ãâïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é žã¯ã
ãã¡ãã«ã®40mgïŒåã¯ãã匷åãªæ¬çºæååç©äŸ
ãã°9αâãã«ãªãâ11βâããããã·â17αâã€
ãœããããã·ã«ã«ããã«ãªãã·â16βâã¡ãã«ã¢
ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â17βâ
ã«ã«ãã³é žã¯ããã¡ãã«åã¯9αâãã«ãªãâ11β
âããããã·â16αâã¡ãã«â17αâããããã·
ã«ã«ããã«ãªãã·ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³
âïŒâãªã³â17βâã«ã«ãã³é žã¯ããã¡ãã«ã®å Ž
åã«ã¯ãããã®å€«ã 20mgïŒããå¡©åãããªãŠã ã
ããªãœã«ããŒã80åã³ïŒãïŒãªã³ã¹ïŒçŽ28.3ã
170ïœïŒã®æ°ŽïŒæ°Žã¯çšææ·»å ãããïŒãšå ±ã«å«æ
ããŠãããäžèšæžæ¿æ¶²ã¯ã朰çæ§å€§è žçã®æ²»çã«
ãããŠã¯æ¯é±æ°åãé£ç¶ç滎泚ã«ãããåã¯æ»ç
è žæ³šãšããŠæäžãããã æ¬çºæã®ä»ã®è¬ç圢æ ã¯ãåŸèšããåå®æœäŸã«
瀺ãéãã§ããã äžèšèšè¿°ãããæŽã«è©³è¿°ãããŸã§ããªããåœæ¥
è ã¯æ¬çºæå 容ã®ãã¹ãŠãå åã«å©çšã§ããæã§
ãããåŸã€ãŠä»¥äžã«è¿°ã¹ãå®æœäŸã¯åã«æ¬çºæã
äŸèšãããã®ã§ãããæ¬çºæã¯äœããããã«éå®
ããããã®ã§ã¯ãªãã å®æœäŸ ïŒ ããã©ããããã©ã³120mlåã³ã¡ã¿ããŒã«30ml
ã«ãã€ããã³ãŒããŸã³ïŒ15ïœã0.04ã¢ã«ïŒã溶解
ãã溶液ã«ã«ã宀枩äžæ°Ž100mlã«ã¡ã¿éãšãŠçŽ é ž
ãããªãŠã ïŒ25.7ïœã0.12ã¢ã«ïŒã溶解ãã枩溶
液ïŒã»ãŒ50âïŒãæ·»å ãããåå¿æ··åç©ã宀枩äž
ã«ïŒæéæ¹æãã次ãã§æžå§äžã«æ¿çž®ããŠããã©
ããããã©ã³åã³ã¡ã¿ããŒã«ãçå»ãããåŸãã
ãåºäœãæ°Ž50mlãçšããŠç²ç ããéã«ããåé¢
ããæ°ŽæŽããç空äž50âã«ãŠïŒæé也ç¥ãããæ¯
ãããŠçæç©ã11βïŒ17αâãžããããã·ã¢ã³ã
ãã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é ž
ïŒå³ã¡ã³ã«ããšããã¯ã¢ã·ããïŒãã»ãŒ96ïŒ ã®å
çïŒ13.76ïœïŒã§åŸããããèç¹231ã234â 該çæç©ã¯äžèšæ§é åŒã§è¡šããããã å®æœäŸ ïŒ 11βïŒ17αâãžããããã·ã¢ã³ããã¹ãâïŒâ
ãšã³âïŒâãªã³â17βâã«ã«ãã³é žïŒ5wïŒïœïŒ ã
ïŒã¢ã«ïŒåã³ããªãšãã«ã¢ãã³ïŒïŒã¢ã«ïŒããžã¯
ããã¡ã¿ã³ã«æº¶è§£ããå·æº¶æ¶²ã«ã¯ãã«è»é žã¡ãã«
ïŒ3.9ã¢ã«ïŒã®50wïŒïœïŒ ãžã¯ããã¡ã¿ã³æº¶æ¶²ãæ·»
å ãããåå¿æ··åç©ã宀枩ã«ïŒæéæŸçœ®ãããç
æããããªãšãã«ã¢ãã³å¡©é žå¡©ã®æ²æŸ±ç©ãå»
ãã液ãïŒïŒ éçé žãããªãŠã ãåžïŒãïŒïŒ ïŒ
å¡©é žåã³æ°ŽãçšããŠæŽæµãããææ©å±€ãåé¢ãã
ç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥ããéããã液ãç
空äžã«æ¿çž®ãã泡沫ã次ã®ã¹ãããïŒäŸãã°äžèš
å®æœäŸïŒïŒã«äœ¿çšãããåã¯ã¯ãããã°ã©ãã«ã
ãçµæ¶åããŠåæã«äŸãããçæç©ã¯11βâãã
ããã·â17αâã¡ããã·ã«ã«ããã«ãªãã·ã¢ã³ã
ãã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é ž
ã§ãããã¯ãããã°ã©ãã€ãŒåã³çµæ¶åããåŸã®
èç¹ã¯198ã204âã§ããã IRïŒKBrïŒcm-13000ã2800ïŒïŒ£âïŒšïŒ 1750ã1735ã1720ïŒïŒ£ïŒïŒ¯ïŒ 1650ã1640ïŒïŒ£ïŒïŒ£âïŒïŒ¯ïŒ 該çæç©ã¯äžèšæ§é åŒã§è¡šããããã ã¯ãã«è»é žã¡ãã«ã®ä»£ãã«åéã®ã¯ãã«è»é žãš
ãã«ãçšããäžèšãšåæ§ã«æäœããŠ17αâãšãã
ã·ã«ã«ããã«ãªãã·â11βâããããã·ã¢ã³ãã
ã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é žã
åŸããã¯ãããã°ã©ãã€ãŒåã³çµæ¶ååŸã®èç¹ã¯
192ã195âã§ããã IRïŒKBrïŒcm-13500ïŒ11βââïŒšïŒ 3000ã2800ïŒïŒ£âïŒšïŒ 1740ïŒïŒ£ïŒïŒ¯ïŒ 1630ïŒïŒ£ïŒïŒ£âïŒïŒ¯ïŒ NMRïŒCDCl3ïŒÎŽ6.4ïŒïœãïŒãCOOïŒšïŒ 5.67ïŒïœãïŒãïŒïŒ£ïŒšïŒ 4.43ïŒïœãïŒãOHïŒ 4.13ïŒïœãïŒãïŒ7.5HzãCH2 CH3ïŒ å çŽ åæïŒC23H32O7ãšããŠïŒ èšç®å€ïŒïŒ ïŒ C65.69 H7.67 å®æž¬å€ïŒïŒ ïŒ C65.76 H7.74 ã¯ããè»é žã¡ãã«ã®ä»£ãã«åéã®ã¯ãã«è»é žã
ãã«ãçšããäžèšãšåæ§ã«æäœããŠ17αâããã
ã·ã«ã«ããã«ãªãã·â11βâããããã·ã¢ã³ãã
ã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é žã
åŸããããã©ããããã©ã³âãããµã³ããçµæ¶åŸ
ã®ãã®ååç©ã®èç¹ã¯164ã166âã§ããã ã¯ããè»é žã¡ãã«ã®ä»£ãã«åéã®ã¯ããè»é žã€
ãœãããã«ãçšããäžèšãšåæ§ã«æäœããŠ11βâ
ããããã·â17αâã€ãœããããã·ã«ã«ããã«ãª
ãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17βâ
ã«ã«ãã³é žãåŸããããã©ããããã©ã³âãããµ
ã³ããçµæ¶åŸã®ãã®ååç©ã®èç¹ã¯144.5ã146.5
âã§ããã å®æœäŸ ïŒ 11βâããããã·â17αâã¡ããã·ã«ã«ããã«
ãªãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17β
âã«ã«ãã³é žãçéã®1Næ°Žé žåãããªãŠã ãšã¡
ã¿ããŒã«äžã«ãŠçµåããããã®æº¶æ¶²ããšãã«ãšãŒ
ãã«ãçšããŠ100åã«åžéãããåŸãããæžæ¿æ¶²
ãïŒæéå·åŽããã次ãã§çæããçµæ¶ãé
ããææ°ãã·ã±ãŒã¿ãŒäžã§ä¹Ÿç¥ãããããµã¡ãã«
ãªã³é žã¢ããïŒ10wïŒïœïŒ ïŒã«æº¶è§£ããã é žå¡©å³ã¡11βâããããã·â17αâã¡ããã·ã«
ã«ããã«ãªãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãª
ã³â17βâã«ã«ãã³é žãããªãŠã ãïŒã¢ã«å«æã
ãäžèšæº¶æ¶²ãæ²åã¯ããã¡ãã«ïŒã¢ã«ãšçµåãã
ããåå¿æ··åç©ã宀枩äžã«ïŒæéç¶æãã次ãã§
é ¢é žãšãã«ãçšããŠ10åã«åžéãããåžéããã
åå¿æ··åç©ãïŒïŒ ããªç¡«é žãããªãŠã ãïŒïŒ éç
é žãããªãŠã åã³æ°ŽãçšããŠæŽæµãããææ©å±€ã
åé¢ããç¡«é žãã°ãã·ãŠã ãçšããŠä¹Ÿç¥ããé
ããã液ãç空äžã«æ¿çž®ãã泡沫ãšããã泡沫
ãé©åœãªæº¶åªïŒãšãã«ãšãŒãã«åã¯ããã©ããã
ãã©ã³ïŒãããµã³ïŒããçµæ¶åããããšã«ãã粟
補ãããæ¯ãããŠ11βâããããã·â17αâã¡ã
ãã·ã«ã«ããã«ãªãã·ã¢ã³ããã¹ãâïŒâãšã³â
ïŒâãªã³â17βâã«ã«ãã³é žã¯ããã¡ãã«ãåŸ
ããçµæ¶ååŸã®èç¹ã¯171ã173âã§ããã IRïŒKBrïŒcm-13000ã2800ïŒïŒ£âïŒšïŒ 1760ã1748ïŒïŒ£ïŒïŒ¯ïŒ 1650ïŒïŒ£ïŒïŒ£âïŒïŒ¯ïŒ NMRïŒCDCl3ïŒÎŽ5.67ïŒïœãïŒãïŒïŒ£ïŒšïŒ 5.82ã5.62ïŒABqãïŒãïŒ5.5HzãâOCH2ClïŒ 4.47ïŒïœãïŒãOHïŒ å çŽ åæïŒC23H31ClOãšããŠïŒ èšç®å€ïŒïŒ ïŒ C60.72 H6.87 Cl7.79 å®æž¬å€ïŒïŒ ïŒ C60.50 H7.06 Cl7.50 çæç©ã¯äžèšæ§é åŒã§è¡šããããã äžèšã§çšããã¹ããã€ãæ§é žã«ä»£ãåéã®17α
âãšããã·ã«ã«ããã«ãªãã·â11βâããããã·
ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«
ãã³é žãçšããäžèšãšåæ§ã«æäœããŠãäžéäœãš
ããŠ17αâãšããã·ã«ã«ããã«ãªãã·â11βâã
ãããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â
17βâã«ã«ãã³é žãããªãŠã ãããŸãæçµçæç©
ãšããŠ17αâãšããã·ã«ã«ããã«ãªãã·â11βâ
ããããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â
17βâã«ã«ãã³é žã¯ããã¡ãã«ãåŸããæçµåå
ç©ã®ç©æ§ã¯ä»¥äžã®éãã§ããã çµæ¶ååŸã®èç¹197ã200â IRïŒKBrïŒcm-13600ã3200ïŒïŒ¯âïŒšïŒ 3000ã2800ïŒïŒ£âïŒšïŒ 1763ã1740ïŒïŒ£ïŒïŒ¯ïŒ 1650ïŒïŒ£ïŒïŒ£âïŒïŒ¯ïŒ NMRïŒCDCl3ïŒÎŽ5.7ïŒïœãïŒãïŒïŒ£ïŒšïŒ 5.81ã5.62ïŒABqãïŒãïŒïŒHzãâOC 2ClïŒ å çŽ åæïŒC24H33ClO7ãšããŠïŒ èšç®å€ïŒïŒ ïŒ C61.46 H7.09 å®æž¬å€ïŒïŒ ïŒ C61.58 H7.08 äžèšã§çšããã¹ããã€ãæ§é žã«ä»£ãåéã®17α
âãããã·ã«ã«ããã«ãªãã·â11βâããããã·
ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«
ãã³é žãçšããäžèšãšåæ§ã«æäœããŠãäžéäœãš
ããŠ17αâãããã·ã«ã«ããã«ãªãã·â11βâã
ãããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â
17βâã«ã«ãã³é žãããªãŠã ãããŸãæçµçæç©
ãšããŠ17αâãããã·ã«ã«ããã«ãªãã·â11βâ
ããããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â
17βâã«ã«ãã³é žã¯ããã¡ãã«ãåŸããæçµåå
ç©ã®ç©æ§ã¯ä»¥äžã®éãã§ããã çµæ¶ååŸã®èç¹98ã100â IRïŒKBrïŒcm-13600ã3300ïŒïŒ¯âïŒšïŒ 3000ã2800ïŒïŒ£âïŒšïŒ 1765ïŒO2CïŒïŒ¯ïŒ 1735ïŒOCïŒïŒ¯ïŒ 1650ïŒïŒ£ïŒïŒ£âïŒïŒ¯ïŒ NMRïŒCDCl3ïŒÎŽ5.80ã5.60ïŒABqãïŒãïŒ4.5
HzãâOC 2ClïŒ 5.67ïŒïœãïŒãïŒïŒ£ïŒšïŒ 4.45ïŒïœãïŒãOHïŒ 4.08ïŒïœãïŒãïŒïŒHzãO2COCH2 âCH2ïŒ å çŽ åæïŒC26H37ClO7ãšããŠïŒ èšç®å€ïŒïŒ ïŒ C62.77 H7.44 Cl7.14 å®æž¬å€ïŒïŒ ïŒ C62.88 H7.23 Cl7.30 äžèšã§çšããã¹ããã€ãæ§é žã«ä»£ãåéã®11β
âããããã·â17αâã€ãœããããã·ã«ã«ããã«
ãªãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17β
âã«ã«ãã³é žãçšããäžèšãšåæ§ã«æäœããŠãäž
éäœãšããŠ11βâããããã·â17αâã€ãœããã
ãã·ã«ã«ããã«ãªãã·ã¢ã³ããã¹ãâïŒâãšã³â
ïŒâãªã³â17βâã«ã«ãã³é žãããªãŠã ãããŸã
æçµçæç©ãšããŠ11βâããããã·â17αâã€ãœ
ããããã·ã«ã«ããã«ãªãã·ã¢ã³ããã¹ãâïŒâ
ãšã³âïŒâãªã³â17βâã«ã«ãã³é žã¯ããã¡ãã«
ãåŸããããã©ããããã©ã³âãããµã³ããåçµ
æ¶ååŸã®æçµååç©ã®èç¹ã¯183.5ã184.5âã§ã
ãã äžèšã§çšããã¹ããã€ãæ§é žã«ä»£ã17αâãšã
ãã·ã«ã«ããã«ãªãã·â11βâããããã·ã¢ã³ã
ãã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é ž
ãçšãããŸãæ²åã¯ããã¡ãã«ã®ä»£ãã«åéã®å¡©
åããã«ãçšããïŒïŒ ããªç¡«é žãããªãŠã ã§æŽæµ
ãè¡ãªããªã以å€ã¯å®è³ªçã«äžèšãšåæ§ã«æäœã
ããæ¯ãããŠäžéäœãšããŠ17αâãšããã·ã«ã«ã
ãã«ãªãã·â11βâããããã·ã¢ã³ããã¹ãâïŒ
âãšã³âïŒâãªã³â17βâã«ã«ãã³é žãããªãŠã
ãããŸãæçµçæç©ãšããŠ17αâãšããã·ã«ã«ã
ãã«ãªãã·â11βâããããã·ã¢ã³ããã¹ãâïŒ
âãšã³âïŒâãªã³â17βâã«ã«ãã³é žããã«ãåŸ
ããã¢ã»ãã³ããåçµæ¶åŸã®æçµååç©ã®èç¹ã¯
148ã149âã§ããããŸãã¯ãããã°ã©ãã€ãŒåã³
çµæ¶ååŸã®æçµååç©ã®ç©æ§ã¯ä»¥äžã®éãã§ã
ãã IRïŒKBrïŒcm-13600ã3200ïŒïŒ¯âïŒšïŒ 3000ã2800ïŒïŒ£âïŒšïŒ 1750ïŒ2CïŒïŒ¯ïŒ 1670ïŒïŒ£ïŒïŒ£âïŒïŒ¯ïŒ NMRïŒCDCl3ïŒÎŽ5.64ïŒïœãïŒãâïŒïŒ£ïŒšïŒ 4.46ïŒïœãïŒãOHïŒ 4.32ã4.95ïŒïœãïŒãCOOC 2CH3ãCOOC
2CH2âïŒ å çŽ åæïŒC27H40O7ãšããŠïŒ èšç®å€ïŒïŒ ïŒ C67.99 H8.39 å®æž¬å€ïŒïŒ ïŒ C67.76 H7.47 å®æœäŸ ïŒ 17αâãšããã·ã«ã«ããã«ãªãã·â11βâãã
ããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17β
âã«ã«ãã³é žïŒïŒïœã7.13ããªã¢ã«ïŒã1Mæ°Žé ž
åãããªãŠã ã¡ã¿ããŒã«æº¶æ¶²7.13mlã§åŠçãã次
ãã§ãšãã«ãšãŒãã«500mlãå ããŠæ²æ®¿ãçãã
ãããæ²æ®¿ç©ãéã«ããåé¢ããäžå€ææ°ãã·
ã±ãŒã¿ãŒäžã§ä¹Ÿç¥ããŠææã®å¡©ãå³ã¡17αâãšã
ãã·ã«ã«ããã«ãªãã·â11βâããããã·ã¢ã³ã
ãã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é ž
ãããªãŠã 2.71ïœïŒ6.12ããªã¢ã«ïŒãé»è²ç²æ«ãš
ããŠåŸãã該塩ããããµã¡ãã«ãªã³é žã¢ãã40ml
ã«æº¶è§£ããã¯ããã¡ãã«ã¡ãã«ã¹ã«ãã€ãïŒ2.36
ïœã24.5ããªã¢ã«ïŒãåŸã ã«å ãããïŒåé以å
ã«åå¿æ··åç©äžã«å¡©åãããªãŠã ã®æ²æ®¿ãçæã
ããåå¿æ··åç©ã宀枩äžã«ïŒæéæ¹æãã次ãã§
ç·éã200mlã«ãªããŸã§é ¢é žãšãã«ãåžéããïŒ
ïŒ éçé žãããªãŠã åã³æ°ŽãçšããŠæŽæµãããæ
æ©å±€ãåé¢ããç¡«é žãã°ãã·ãŠã ãçšããŠä¹Ÿç¥
ããéããã液ãç空äžã«æ¿çž®ããåŸããã
ãªã€ã«ãå±é溶åªãšããŠé ¢é žãšãã«ãã¯ãããã«
ã åã³é ¢é žãçšããã·ãªã«ã²ã«ã«ã©ã ã¯ãããã°
ã©ãã€ãŒã«ããããã¯ãããã°ã©ãã€ãŒã«ããåŸ
ãããçæç©ããšãã«ãšãŒãã«ãšãããµã³ãšã®æ··
å溶åªããçµæ¶åããŠçœè²ç²æ«ç¶çµæ¶ãèç¹133
ã136âã®17αâãšããã·ã«ã«ããã«ãªãã·â11β
âããããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³
â17βâã«ã«ãã³é žã¡ãã«ããªã¡ãã«ãåŸãã該
çæç©ã¯äžèšæ§é åŒã§è¡šããããã ãžã¯ããã¡ã¿ã³ïŒmlã«17αâãšããã·ã«ã«ãã
ã«ãªãã·â11βâããããã·ã¢ã³ããã¹ãâïŒâ
ãšã³âïŒâãªã³â17βâã«ã«ãã³é žã¡ãã«ããªã¡
ãã«ïŒ0.48ïœãïŒããªã¢ã«ïŒã溶解ãã溶液ã«ã
ïœâã¯ããéå®æ¯éŠé žïŒ0.4ïœïŒéé ž0.34ïœã«çž
åœãïŒããªã¢ã«ïŒãå ãããçºç±åå¿ãèµ·ãã
ããããã«æ¢ããåå¿æ··åç©ã宀枩äžã«ïŒæéæ¹
æãããçæããæ²æ®¿ç©ãéã«ããååºãã
液ãç空äžã«æ¿çž®ããŠã17αâãšããã·ã«ã«ãã
ã«ãªãã·â11βâããããã·ã¢ã³ããã¹ãâïŒâ
ãšã³âïŒâãªã³â17βâã«ã«ãã³é žã¡ãã«ã¹ã«ã
ãã«ã¡ãã«ãçœè²æ³¡æ²«ãšããŠåŸãããã®ååç©ã¯
äžèšæ§é åŒã§è¡šããããã NMRïŒCDCl3ïŒÎŽ5.07ïŒïœãïŒãOC 2SO2ïŒ 2.97ïŒïœãïŒãSO2C 3ïŒ ïœâã¯ããéå®æ¯éŠé žïŒããªã¢ã«ãçšãã以å€
ã¯äžèšãšåæ§ã«æäœããŠã17αâãšããã·ã«ã«ã
ãã«ãªãã·â11βâããããã·ã¢ã³ããã¹ãâïŒ
âãšã³âïŒâãªã³â17βâã«ã«ãã³é žã¡ãã«ã¹ã«
ãã€ãã«ã¡ãã«ãåŸãã å®æœäŸ 5A å®æœäŸïŒã§çšãããã€ããã³ãŒããŸã³ã®ä»£ãã«
åéã®äžèšã«ç€ºãåºçºç©è³ªãçšããäžèšãšåæ§ã«
ããŠäžèšååç©ãåŸãã
ãè¡šã
å®æœäŸ 5B
å®æœäŸïŒã§çšãããã€ããã³ãŒããŸã³ã®ä»£ãã«
åéã®äžèšã«ç€ºãåºçºç©è³ªãçšããäžèšãšåæ§ã«
ããŠäžèšååç©ãåŸãã
åéã®äžèšã«ç€ºãåºçºç©è³ªãçšããäžèšãšåæ§ã«
ããŠäžèšååç©ãåŸãã
ãè¡šã
㳠βãã«ã«ãã³é
ž
ãè¡šã
å®æœäŸ 6A
é©åœãªåºçºç©è³ªãçšãå®æœäŸïŒãšåæ§ã«æäœã
ãŠäžèšç¬¬13è¡šã«ç€ºãæ¬çºæã®æ°èŠäžéäœãåŸãã
ãŠäžèšç¬¬13è¡šã«ç€ºãæ¬çºæã®æ°èŠäžéäœãåŸãã
ãè¡šã
ãè¡šã
ååç©6AâïŒã6Aâ15ã¯ä»¥äžã®éãåœåãã
ãã 6AâïŒïŒ17αâãã³ãžã«ãªãã·ã«ã«ããã«ãªãã·
â11βâããããã·ã¢ã³ããã¹ãâïŒâãšã³â
ïŒâãªã³â17βâã«ã«ãã³é ž 6AâïŒïŒ17αâãšããã·ã«ã«ããã«ãªãã·â9α
âãã«ãªãâ11βâããããã·ã¢ã³ããã¹ãâ
ïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é ž 6AâïŒïŒ17αâãšããã·ã«ã«ããã«ãªãã·â9α
âãã«ãªãâ11βâããããã·â16βâã¡ãã«
ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â
17βâã«ã«ãã³é ž 6AâïŒïŒ17αâãšããã·ã«ã«ããã«ãªãã·â9α
âãã«ãªãâ11βâããããã·â16αâã¡ãã«
ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â
17βâã«ã«ãã³é ž 6AâïŒïŒ9αâãã«ãªãâ11βâããããã·â17α
âã€ãœããããã·ã«ã«ããã«ãªãã·â16αâã¡
ãã«ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³
â17βâã«ã«ãã³é ž 6AâïŒïŒ11βâããããã·â17αâã€ãœãããã·
ã«ã«ããã«ãªãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒ
âãªã³â17βâã«ã«ãã³é ž 6AâïŒïŒ9αâãã«ãªãâ11βâããããã·â17α
âã€ãœããããã·ã«ã«ããã«ãªãã·âãžãšã³â
ïŒâãªã³â17βâã«ã«ãã³é ž 6AâïŒïŒ11βâããããã·â17αâããããã·ã«
ã«ããã«ãªãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâ
ãªã³â17βâã«ã«ãã³é ž 6AâïŒïŒ9αâãã«ãªãâ11βâããããã·â16α
âã¡ãã«â17αâããããã·ã«ã«ããã«ãªãã·
ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â
17βâã«ã«ãã³é ž 6Aâ10ïŒ17αâã·ã¯ãããã·ã«ãªãã·ã«ã«ããã«
ãªãã·â11βâããããã·ã¢ã³ããã¹ãâïŒâ
ãšã³âïŒâãªã³â17βâã«ã«ãã³é ž 6Aâ11ïŒ9αâãã«ãªãâ11βâããããã·â17α
âã¡ããã·ã«ã«ããã«ãªãã·â16αâã¡ãã«ã¢
ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â17β
âã«ã«ãã³é ž 6Aâ12ïŒ17αâïœâãã³ãã«ãªãã·ã«ã«ããã«ãª
ãã·â9αâãã«ãªãâ11βâããããã·â16α
âã¡ãã«ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâ
ãªã³â17βâã«ã«ãã³é ž 6Aâ13ïŒ17αâãšããã·ã«ã«ããã«ãªãã·â6αïŒ
9αâãžãã«ãªãâ11βâããããã·â16αâã¡
ãã«ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³
â17βâã«ã«ãã³é ž 6Aâ14ïŒ17αâããšããã·ã«ã«ããã«ãªãã·â
9αâãã«ãªãâ11βâããããã·â16αâã¡ã
ã«ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â
17βâã«ã«ãã³é ž 6Aâ15ïŒ17αâïŒïŒâã¯ãããšããã·ã«ã«ããã«
ãªãã·ïŒâ9αâãã«ãªãâ11βâããããã·â
16αâã¡ãã«ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³â
ïŒâãªã³â17βâã«ã«ãã³é ž å®æœäŸ 6B é©åœãªåºçºç©è³ªãçšãå®æœäŸïŒãšåæ§ã«æäœã
ãŠäžèšç¬¬14è¡šã«ç€ºãæ¬çºæã®æ°èŠäžéäœãåŸãã
ãã 6AâïŒïŒ17αâãã³ãžã«ãªãã·ã«ã«ããã«ãªãã·
â11βâããããã·ã¢ã³ããã¹ãâïŒâãšã³â
ïŒâãªã³â17βâã«ã«ãã³é ž 6AâïŒïŒ17αâãšããã·ã«ã«ããã«ãªãã·â9α
âãã«ãªãâ11βâããããã·ã¢ã³ããã¹ãâ
ïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é ž 6AâïŒïŒ17αâãšããã·ã«ã«ããã«ãªãã·â9α
âãã«ãªãâ11βâããããã·â16βâã¡ãã«
ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â
17βâã«ã«ãã³é ž 6AâïŒïŒ17αâãšããã·ã«ã«ããã«ãªãã·â9α
âãã«ãªãâ11βâããããã·â16αâã¡ãã«
ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â
17βâã«ã«ãã³é ž 6AâïŒïŒ9αâãã«ãªãâ11βâããããã·â17α
âã€ãœããããã·ã«ã«ããã«ãªãã·â16αâã¡
ãã«ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³
â17βâã«ã«ãã³é ž 6AâïŒïŒ11βâããããã·â17αâã€ãœãããã·
ã«ã«ããã«ãªãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒ
âãªã³â17βâã«ã«ãã³é ž 6AâïŒïŒ9αâãã«ãªãâ11βâããããã·â17α
âã€ãœããããã·ã«ã«ããã«ãªãã·âãžãšã³â
ïŒâãªã³â17βâã«ã«ãã³é ž 6AâïŒïŒ11βâããããã·â17αâããããã·ã«
ã«ããã«ãªãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâ
ãªã³â17βâã«ã«ãã³é ž 6AâïŒïŒ9αâãã«ãªãâ11βâããããã·â16α
âã¡ãã«â17αâããããã·ã«ã«ããã«ãªãã·
ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â
17βâã«ã«ãã³é ž 6Aâ10ïŒ17αâã·ã¯ãããã·ã«ãªãã·ã«ã«ããã«
ãªãã·â11βâããããã·ã¢ã³ããã¹ãâïŒâ
ãšã³âïŒâãªã³â17βâã«ã«ãã³é ž 6Aâ11ïŒ9αâãã«ãªãâ11βâããããã·â17α
âã¡ããã·ã«ã«ããã«ãªãã·â16αâã¡ãã«ã¢
ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â17β
âã«ã«ãã³é ž 6Aâ12ïŒ17αâïœâãã³ãã«ãªãã·ã«ã«ããã«ãª
ãã·â9αâãã«ãªãâ11βâããããã·â16α
âã¡ãã«ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâ
ãªã³â17βâã«ã«ãã³é ž 6Aâ13ïŒ17αâãšããã·ã«ã«ããã«ãªãã·â6αïŒ
9αâãžãã«ãªãâ11βâããããã·â16αâã¡
ãã«ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³
â17βâã«ã«ãã³é ž 6Aâ14ïŒ17αâããšããã·ã«ã«ããã«ãªãã·â
9αâãã«ãªãâ11βâããããã·â16αâã¡ã
ã«ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â
17βâã«ã«ãã³é ž 6Aâ15ïŒ17αâïŒïŒâã¯ãããšããã·ã«ã«ããã«
ãªãã·ïŒâ9αâãã«ãªãâ11βâããããã·â
16αâã¡ãã«ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³â
ïŒâãªã³â17βâã«ã«ãã³é ž å®æœäŸ 6B é©åœãªåºçºç©è³ªãçšãå®æœäŸïŒãšåæ§ã«æäœã
ãŠäžèšç¬¬14è¡šã«ç€ºãæ¬çºæã®æ°èŠäžéäœãåŸãã
ãè¡šã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒ ãåŒäžãR1ã¯C1-6ã¢ã«ãã«åºãã¢ãããâC1-6
ã¢ã«ãã«åºãâCH2COOR6åºïŒR6ã¯C1-6ã¢ã«ãã«
åºïŒãâCH2ââïŒC1-6ã¢ã«ãã«ïŒåºïŒïŒ¹ã¯â
âãâSOâãSO2âåã¯ââã瀺ãïŒãåã¯â
CH2ãåŒãåºïŒR6ã¯äžèšã«åãïŒã§ããã R2ã¯C1-6ã¢ã«ãã«åºãC3-8ã·ã¯ãã¢ã«ãã«åºã
ãã³ãžã«åºåã¯ã¢ãããâC1-6ã¢ã«ãã«åºã§ã
ããR3ã¯æ°ŽçŽ ååãαâã¡ãã«åºãβâã¡ãã«
åºåã¯ãåŒãåºïŒR6ã¯äžèšã«åãïŒã§ã ããR4ã¯æ°ŽçŽ åååã¯åŒçŽ ååã§ãããR5ã¯æ°Ž
çŽ åååã¯åŒçŽ ååã§ãããã¯ã«ã«ããã«åã¯
βâããããã·ã¡ãã¬ã³åºã瀺ãã ç°ã«ãããç¹ç·ã¯ãïŒïŒïŒâäœçµåã飜åå
ã¯äžé£œåçµåã§ããããšã瀺ããã ã§è¡šããããååç©ã ïŒ ïŒºãβâããããã·ã¡ãã¬ã³åºã§ããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒ R1ãã¢ãããâC1-6ã¢ã«ãã«åºã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒ R2ãC1-6ã¢ã«ãã«åºã§ããç¹èš±è«æ±ã®ç¯å²
第ïŒé ã«èšèŒã®ååç©ã ïŒ R2ãC3-8ã·ã¯ãã¢ã«ãã«åºãããšãã«åºã
ãã³ãžã«åºåã¯ã¢ãããâC1-6ã¢ã«ãã«åºã§ãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒ R4åã³R5ãå ±ã«æ°ŽçŽ ååã§ããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé åã¯ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒ R4ãåŒçŽ ååãR5ãæ°ŽçŽ ååã§ããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒé åã¯ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒ R3ãαâã¡ãã«åã¯Î²âã¡ãã«åºã§ããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒ ïŒºãã«ã«ããã«åºã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é ã«èšèŒã®ååç©ã ïŒïŒ 11βâããããã·â17αâã¡ããã·ã«ã«ã
ãã«ãªãã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³â
17βã«ã«ãã³é žã¯ããã¡ãã«ã17αâãšããã·ã«
ã«ããã«ãªãã·â11βâããããã·ã¢ã³ããã¹ã
âïŒâãšã³âïŒâãªã³â17βâã«ã«ãã³é žã¯ãã
ã¡ãã«ã17αâãããã·ã«ã«ããã«ãªãã·â11β
âããããã·ã¢ã³ããã¹ãâïŒâãšã³âïŒâãªã³
â17βâã«ã«ãã³é žã¯ããã¡ãã«ã11βâããã
ãã·â17αâã€ãœããããã·ã«ã«ããã«ãªãã·ã¢
ã³ããã¹ãâïŒâãšã³âïŒâãªã³â17βâã«ã«ã
ã³é žã¯ããã¡ãã«ã11βâããããã·â17αâã€
ãœããããã·ã«ã«ããã«ãªãã·ã¢ã³ããã¹ãâïŒ
âãšã³âïŒâãªã³â17βâã«ã«ãã³é žïŒâã¯ãã
ãšãã«ã17αâãšããã·ã«ã«ããã«ãªãã·â11β
âããããã·ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒ
âãªã³â17βâã«ã«ãã³é žã¯ããã¡ãã«åã¯11β
âããããã·â17αâã€ãœããããã·ã«ã«ããã«
ãªãã·ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³
â17βâã«ã«ãã³é žã¯ããã¡ãã«ã§ããç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®ååç©ã ïŒïŒ 17αâãšããã·ã«ã«ããã«ãªãã·â9αâã
ã«ãªãâ11βâããããã·â16βâã¡ãã«ã¢ã³ã
ãã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â17βâã«ã«
ãã³é žã¯ããã¡ãã«ã9αâãã«ãªãâ11βâãã
ããã·â16αâã¡ãã«â17αâããããã·ã«ã«ã
ãã«ãªãã·ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâ
ãªã³â17βâã«ã«ãã³é žã¯ããã¡ãã«ã9αâãã«
ãªãâ11βâããããã·â17αâã€ãœããããã·
ã«ã«ããã«ãªãã·â16βâã¡ãã«ã¢ã³ããã¹ã¿â
ïŒïŒïŒâãžãšã³âïŒâãªã³â17βâã«ã«ãã³é žïŒ
âã¯ãããšãã«ã17αâãšããã·ã«ã«ããã«ãªã
ã·â9αâãã«ãªãâ11βâããããã·ã¢ã³ããã¹
ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â17βâã«ã«ãã³
é žã¯ããã¡ãã«ã17αâãšããã·ã«ã«ããã«ãªã
ã·â9αâãã«ãªãâ11βâããããã·â16αâã¡
ãã«ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â
17βâã«ã«ãã³é žã¯ããã¡ãã«ã9αâãã«ãªãâ
11βâããããã·â17αâã€ãœããããã·ã«ã«ã
ãã«ãªãã·â16αâã¡ãã«ã¢ã³ããã¹ã¿âïŒïŒïŒ
âãžãšã³âïŒâãªã³â17βâã«ã«ãã³é žã¯ããã¡
ãã«ã9αâãã«ãªãâ11βâããããã·â17αâ
ã€ãœããããã·ã«ã«ããã«ãªãã·â16βâã¡ãã«
ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â17β
âã«ã«ãã³é žã¯ããã¡ãã«ã9αâãã«ãªãâ11β
âããããã·â17αâã¡ããã·ã«ã«ããã«ãªãã·
â16αâã¡ãã«ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³â
ïŒâãªã³â17βâã«ã«ãã³é žã¯ããã¡ãã«ã9αâ
ãã«ãªãâ11βâããããã·â16αâã¡ãã«â17α
âãã³ãã«ãªãã·ã«ã«ããã«ãªãã·ã¢ã³ããã¹ã¿
âïŒïŒïŒâãžãšã³âïŒâãªã³â17βâã«ã«ãã³é ž
ã¯ããã¡ãã«ã17αâãšããã·ã«ã«ããã«ãªãã·
â9αâãã«ãªãâ11βâããããã·â16αâã¡ã
ã«ã¢ã³ããã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â
17βâã«ã«ãã³é žãã«ãªãã¡ãã«åã¯17αâïŒïŒâ
ã¯ãããšããã·ïŒã«ã«ããã«ãªãã·â9αâãã«
ãªãâ11βâããããã·â16αâã¡ãã«ã¢ã³ãã
ã¹ã¿âïŒïŒïŒâãžãšã³âïŒâãªã³â17βâã«ã«ã
ã³é žã¡ãã«ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®å
åç©ã ïŒïŒ äžè¬åŒ ãåŒäžãR1ã¯C1-6ã¢ã«ãã«åºãã¢ãããâC1-6
ã¢ã«ãã«åºãâCH2COOR6åºïŒR6ã¯C1-6ã¢ã«ãã«
åºïŒãâCH2ââïŒC1-6ã¢ã«ãã«ïŒåºïŒïŒ¹ã¯â
âãâSOâãSO2âåã¯ââã瀺ãïŒãåã¯â
CH2ãåŒãåºïŒR6ã¯äžèšã«åãïŒã§ããã R2ã¯C1-6ã¢ã«ãã«åºãC3-8ã·ã¯ãã¢ã«ãã«åºã
ãã³ãžã«åºåã¯ã¢ãããâC1-6ã¢ã«ãã«åºã§ã
ããR3ã¯æ°ŽçŽ ååãαâã¡ãã«åºãβâã¡ãã«
åºåã¯ãåŒãåºïŒR6ã¯äžèšã«åãïŒã§ã ããR4ã¯æ°ŽçŽ åååã¯åŒçŽ ååã§ãããR5ã¯æ°Ž
çŽ åååã¯åŒçŽ ååã§ãããã¯ã«ã«ããã«åã¯
βâããããã·ã¡ãã¬ã³åºã瀺ãã ç°ã«ãããç¹ç·ã¯ãïŒïŒïŒâäœçµåã飜åå
ã¯äžé£œåçµåã§ããããšã瀺ããã ã§è¡šããããååç©åã³R1åã³R2ã®å°ããšãäž
æ¹ãããâã¢ã«ãã«åºã§ããäžèšååç©ã®ç¬¬ïŒçŽ
ã¢ã³ã¢ããŠã å¡©ã®å°ããšãïŒçš®ãæå¹æåãšããŠ
å«æããããšãç¹åŸŽãšããæççå€ã
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16845380A | 1980-07-10 | 1980-07-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5745200A JPS5745200A (en) | 1982-03-13 |
JPS6411037B2 true JPS6411037B2 (ja) | 1989-02-23 |
Family
ID=22611544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56108755A Granted JPS5745200A (en) | 1980-07-10 | 1981-07-10 | Anti-inflammatory steroid and pharmacological composition containing the same |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS5745200A (ja) |
BE (1) | BE889563A (ja) |
SU (1) | SU1318169A3 (ja) |
ZA (1) | ZA814440B (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4607028A (en) * | 1983-08-18 | 1986-08-19 | Ciba-Geigy Corporation | Novel carboxylic acid esters |
SE8501693D0 (sv) * | 1985-04-04 | 1985-04-04 | Draco Ab | Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters |
IL78144A0 (en) * | 1985-04-04 | 1986-07-31 | Draco Ab | Novel androstane-17beta-carboxylic acid esters |
DE19947235A1 (de) * | 1999-09-30 | 2001-04-05 | Asta Medica Ag | Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten |
SI1775305T1 (sl) | 2000-08-05 | 2015-01-30 | Glaxo Group Limited | S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-((2-furanilkarboksil)oksi)- 11beta-hidroksi-16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo |
GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
SI1383786T1 (sl) * | 2001-04-30 | 2009-02-28 | Glaxo Group Ltd | Protivnetni 17.beta-karbotioatestrski derivati androstana s cikliÄno estrsko skupino na poloÅŸaju 17.alfa |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
ES2339351T3 (es) * | 2003-06-19 | 2010-05-19 | Nicholas S. Bodor | Mejora de la actividad y/o duracion de la accion de esteroides anti-inflamatorios blandos para la aplicacion topica u otra local. |
GB0523251D0 (en) * | 2005-11-15 | 2005-12-21 | Glaxo Group Ltd | Novel compounds |
TWI374147B (en) * | 2006-01-27 | 2012-10-11 | Sun Pharma Advance Res Company Ltd | Novel 11β-hydroxyandrosta-4-ene-3-ones |
US7687484B2 (en) * | 2006-05-25 | 2010-03-30 | Bodor Nicholas S | Transporter enhanced corticosteroid activity |
WO2018232007A1 (en) | 2017-06-13 | 2018-12-20 | Bodor Laboratories, Inc. | Potent soft anti-inflammatory corticosteroid compounds and uses therof |
-
1981
- 1981-06-30 ZA ZA814440A patent/ZA814440B/xx unknown
- 1981-07-09 SU SU813306552A patent/SU1318169A3/ru active
- 1981-07-09 BE BE2/59253A patent/BE889563A/fr not_active IP Right Cessation
- 1981-07-10 JP JP56108755A patent/JPS5745200A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
ZA814440B (en) | 1982-10-27 |
BE889563A (fr) | 1981-11-03 |
SU1318169A3 (ru) | 1987-06-15 |
JPS5745200A (en) | 1982-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2194053C2 (ru) | ÐÑПОзвПЎМÑе аМЎÑПÑÑеМа, ÑаÑЌаÑевÑОÑеÑÐºÐ°Ñ ÐºÐŸÐŒÐ¿ÐŸÐ·ÐžÑÐžÑ | |
KR860000266B1 (ko) | ììŒìì©ì ê°ë ì°ì± ì€í ë¡ìŽëì ì ì¡°ë°©ë² | |
US4242334A (en) | Corticoid 17-(alkyl carbonates) and processes for their preparation | |
US4996335A (en) | Soft steroids having anti-inflammatory activity | |
US4267173A (en) | Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor | |
US3943124A (en) | Chemical compounds | |
JPS6411037B2 (ja) | ||
JPS6139959B2 (ja) | ||
CS209919B2 (en) | Method of making the esters of the 4-halogen-9-fluor-3-oxo-androst-4-en and 4-halogen-9-fluor-3-oxoandrosta -1,4-dien-17beta-thiocarboxyl acid | |
CA1310009C (en) | Ester prodrugs of steroids | |
US4469689A (en) | Sulfonate containing ester prodrugs of corticosteroids | |
DE3786174T2 (de) | Weiche steroide mit anti-entzÃŒndungswirkung. | |
KR850001208B1 (ko) | 17α-ìì€ì¥ì-5β-ìœë¥Ží°ìœìŽë ë° 17α-ìì€ì¥ì-5α-ìœë¥Ží°ìœìŽëì ì ì¡°ë°©ë² | |
US4024131A (en) | 16-Methyl-9α-halo steroid esters, ethers and preparation thereof | |
US6610675B1 (en) | Inactive metabolite approach to soft drug design | |
DK165880B (da) | Androstan-17beta-carboxylsyreestere, fremgangsmaade til fremstilling heraf samt farmaceutisk praeparat indeholdende samme | |
US4427671A (en) | Steroids esterified in position 17 and thioesterified in position 21, a process for preparing them and their use as medicaments | |
JPS5837320B2 (ja) | ãã¬ã°ãã³ãµã³ãŠãŠããŠã¿ã€ ã ã»ã€ã㊠| |
DK146017B (da) | Analogifremgangsmaade til fremstilling af 17alfa-acyloxy-9alfa,21-dihalogen-11beta-hydroxy-6alfa-fluor-16beta-methyl-pregna-1,4-dien-3,20-dion-forbindelser | |
GB1589585A (en) | 12a-halocorticoids | |
KR810000311B1 (ko) | 7-í ë¡-3,20-ëì¥ì-1,4-íë ê·žëëì ë° -4-íë ê·žëšì ì ì¡° ë°©ë² | |
EP0136586A2 (en) | Novel corticoid derivatives and process for production thereof | |
CS208495B2 (en) | Method of making the alcyesters of the 4-halogen-3-oxo-androsta-1,4-dien beta-carboxyle acid | |
JPH0533235B2 (ja) | ||
CZ281275B6 (cs) | Karbothioáty androstanu |